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Vitamin B12 is an essential biomolecule for humans and it is only produced by  certain 
microorganisms. Its elegant, yet complex structure combined with its fascinating 
properties attracted research of some of the most extraordinary scientists in the past, 
which opened new horizons in medicine, crystallography and organic synthesis.
Studies on the mechanism of B12 dependent enzymes suggest that the coordination 
and electrochemical properties at the cobalt centre of cobalamins are essential for its 
biological activity. The crucial role of cobalamins for cell replication is also attractive for 
developing inhibitors of B12 dependent enzymes as novel anti-proliferating drugs.
Length'
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In this project, we developed modified B12 derivatives for fundamental and biological 
studies. We started with the conformational analysis of the sugar-phosphodiester 
backbone of B12, which was initially introduced by Eschenmoser and Kreppelt. Based 
on the understanding of the conformation of the loop structure at the f-side chain of B12 
and considering the successful modeling of sugar-phosphodiester with peptide bonds in 
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other natural products than B12, we developed a new class of modified B12 derivatives 
with peptide loops of different length, composition, chirality, charge and rigidity.
The modifications of the loop structure influenced the stability of the intramolecular 
coordination (base on stability), which resulted in a change of the electrochemical 
properties at the cobalt ion. Cyclic voltammetry experiments of the peptide B12 
derivatives showed that the Co(III)/Co(II) reduction potential and the strength of 
intramolecular coordination are linearly correlated. These results suggest that the 
coordination and electrochemical properties of peptide B12 can be simultaneously 
controlled. 
We cooperated with Fredrick Lyatuu and Prof. Wolfgang Buckel from the University of 
Marburg and PD Helmut Brandl from the University of Zurich in biological studies. 
Biological activity of peptide B12 derivatives has been tested with the microorganism 
Lactobacillus delbrueckii and the enzyme glutamate mutase showing (reduced) 
bioactivity  in both, “base on” as well as “base off/ histidine on” enzymes. This behavior 
is promising for the design of peptide B12s with therapeutic effects.
Peptide B12 derivatives were also shown to exhibit interesting coordination chemistry. 
Derivatives with a tuned “base on” stability, can be used as a probe to identify the 
coordination structures of other “incomplete” corrinoids with 1H NMR spectroscopy. This 
method is useful for applications in kinetic ligand exchange studies of corrinoids. 
Another highlight of this Ph.D. thesis is the discovery of a B12 derivative having an 
unprecedented intermolecular coordination fashion. By controlling the coordination sites 
at the cobalt center and by implementation of a more flexible deamino histidine 
backbone, we developed the first example of a self-assembled dimeric cobalamin in 
solution. Of note, cobalamins have been considered until now to be “notoriously 
monomeric”. Multi-intermolecular interactions offer the opportunity to develop even 
more complex structures that could be of interest for mimicking B12 related enzymes.
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Vitamin B12 ist essentiell für Menschen, kann aber nur von bestimmten 
Mikroorganismen produziert werden. Aufgrund seiner eleganten und komplexen 
Struktur sowie seiner einzigart igen Eigenschaften hat es einige der 
aussergewöhnlichsten Wissenschaftler fasziniert und ihre Arbeiten haben neue 
Horizonte in der Medizin, Kristallographie und Chemie eröffnet. Mechanismen B12-
abhängiger Enzyme lassen auf eine Abhängigkeit der biologischen Aktivität von den 
koordinativen-, und elektrochemischen Eigenschaften der Corrinoide schliessen.
Cobalamine spielen auch eine entscheidende Rolle bei der Zellteilung und sind somit 
attraktiv für die Entwicklung neuer Krebstherapeutika. 
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In diesem Projekt haben wir B12 Derivate für fundamentale und biologische 
Fragestellungen entwickelt. Wir sind dabei von Eschenmosers und Kreppelts 
Konformationsanalyse des Zuckerphosphatrückgrates von B12 ausgegangen. 
Basierend auf unserem Verständnis der Konformation der f-Seitenkette von B12 und 
Zusammenfassung v
unter Berücksichtigung der Modellierung von Zucker-Phosphodiesterbindungen in 
anderen Naturstoffen, haben wir eine neue Klasse von modifizierten B12-Derivaten mit 
einem Peptidrückgrat hergestellt, die sich in der Länge, Konfiguration, Ladung und 
Rigidität unterschieden. 
Die unterschiedlichen Modifikationen haben die intramolekulare Koordination und die 
Redoxeigenschaften am Kobaltzentrum beeinflusst. Durch elektrochemische Studien 
wurde eine lineare Abhängigkeit der Co(III)/ Co(II) Reduktionspotentiale von der Stärke 
der intramolekularen Koordination festgestellt. Diese Resultate zeigen, dass die 
Koordinations- und Elektrochemie der Peptid-B12 Derivate simultan kontrolliert werden 
kann.
Die biologische Aktivität der Peptid-B12 Derivate wurde mit dem Mikroorganismus 
Lactobacillus delbrueckii und dem Enzym Glutamat Mutase in Kooperation mit Fredrick 
Lyatuu und Prof. W. Buckel (Universität Marburg) und PD H. Brandl (Universität Zürich) 
untersucht. Es wurde eine (verminderte) biologische Aktivität für sowohl base on als 
auch base off/ histidine on abhängige Enzyme festgestellt. Dieses Verhalten ist 
vielversprechend für die Entwicklung von Peptid-B12 Derivaten mit therapeutischen 
Eigenschaften.
 Peptid-B12 Derivative mit einem flexiblen Rückgrat sind jedoch noch viel vielseitiger 
und zeigen eine sehr interessante Koordinationschemie. Derivate mit einer veränderten 
base-on Stabilität wurden erfolgreich für die Identifizierung der Koordinationsgeometrie 
am Metallzentrum verwandter Corrinoide mittels 1H NMR Spektroskopie eingesetzt. 
Diese Methode ist ein wichtiges Werkzeug für die Untersuchung kinetischer 
Ligandaustauschreaktionen am Metallzentrum von Corrinoiden. 
Einen weiteren Höhepunkt der Doktorarbeit stellt die Synthese des ersten 
intermolekular verbrückten Cbl-Dimers in Lösung dar. Dies wurde durch Kontrolle der 
Koordinationsgeometrie am Metallzentrum bei gleichzeitiger Einführung eines flexiblen 
Deaminohistidin-Rückgrates ermöglicht. Bis heute wurden Cobalamine als „notorisch 
monomere“ Verbindungen angesehen. Multiple intermolekulare Interaktionen eröffnen 
nun auch die Möglichkeit noch komplexere Strukturen zu entwickeln, die B12 abhängige 
Enzyme nachahmen könnten. 
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1. Introduction
1.1 Story of B12 – Past, present and future
The legendary story of vitamin B12 (B12), this most beautiful and unique biomolecule[1]
[2,3] started about a century ago in the 1920s, when George Whipple (1878-1976) 
discovered that liver was the most effective diet to treat anemic dogs due to blood 
loss[4]. At that time he was not aware of this beautiful and complicated vitamin, but the 
result was exciting and inspiring. George Richards Minot (1885-1950) and William Perry 
Murphy (1892-1987) immediately sensed the application of this  discovery to defeat a 
fatal human disease - pernicious anemia. They indeed succeeded to control the deadly 
anemia in 1926 with a daily diet of about half a kilogram of liver for the patients.[4] Their 
remarkable discoveries were honored with the Nobel Prize in medicine and physiology 
in 1934. 
Figure 1: (left) George Hoyt Whipple (middle) George Richards  Minot (right) William 
Parry Murphy.[4]
In the 1930s and 1940s, scientists were trying desperately to isolate this “magic drug” 
from liver, but without success. Mary Shaw Shorb, Karl Folkers and Alexander Todd 
creatively used the indication of bacterial assays to guide the isolation and finally 
crystalized B12 in 1948.[5] This fundamental success paved the way for future structural 
studies.
After successful isolation of B12, researchers continued with the next challenging 
project that was the structural elucidation of this molecule. The complexity of the 
structure  of B12 was beyond the limit of technologies  in the 1940s, without “decent” 
Introduction
1
NMR and X-ray crystallography. Nevertheless scientists still devoted great efforts to 
obtain  structural insights with various methods like pyrolysis and hydrolysis. Finally, 
chemists combined all the results and got a general idea about the composition of this 
molecule: a macrocycle ring, pyrole units, a six-coordinated trivalent cobalt ion with a 
cyanide ligand, a dimethylbenzimidazole base, an α-ribazole phosphate and a 2-
amino-1-propanol unit. [6-11] (Figure 2)
Figure 2: Proposed composition of B12 from pyrolysis and hydrolysis experiments.
The composition of B12 was  revealed fragment by fragment, meanwhile X-ray 
crystallography was maturing fast.[12] This technology opened a new era of structure 
determination. In 1956, Dorothy Crowfoot Hodgkin (1910-1994), one of the pioneers in 
the field, determined the structure of the most complicated biomolecule at that time, and 
had drawn a successful closure to a three decades’ exploration.[13-15] A Nobel Prize was 
granted to Dorothy Hodgkin for this marvelous work. 
Figure 3: (left) Dorothy Crowfoot Hodgkin (middle) Robert Burns Woodward (right) 
Albert Eschenmoser.
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After this scientific breakthrough, another ambitious project was emerging, which was 
the total synthesis of this molecule (Scheme 1),[16-18] by a combined effort of the groups 
of Robert B. Woodward (1917-1979) of Harvard University and Albert Eschenmoser of 
the ETH Zürich. This unprecedentedly complicated project took over 90 steps and was 
finally accomplished in 1971 after 11 years with the anticipation of more than 100 
coworkers. The meaning of this monumental achievement was far beyond B12 
chemistry, and “rarely before has a synthetic project yielded so much knowledge, 
including “novel bond-forming reactions and strategies, ingenious solutions to 
formidable synthetic problems, biogenetic considerations and hypotheses, and the 
seeds of the principles of orbital symmetry conservation known as the Woodward and 
Hoffmann rules”.[19]
Scheme 1: Synthetic strategy of B12 (more details see reference[16]).
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Besides the structural studies, the properties and functions  of cobalamins (Cbl) were 
intriguing as  well. The inorganic chemistry at the cobalt center is the basis for the 
understanding of Cbls in biological systems. Especially the electrochemistry of cobalt is 
critical to understand the B12 dependent enzymatic reactions, e.g. methyl transfer[20] 
and carbon rearrangement reactions[21]. Doris Lexa and colleagues investigated the 
redox chemistry of different B12 derivatives such as cyanocobalamin[22] and 
aquacobalamin[23]. Diagrams of redox potential versus the environmental parameters 
(pH, cyanide concentration, solvent etc.) are extremely useful to understand the 
processes of cobalt reduction (Scheme 2).[24,25]
Scheme 2: Redox equilibria of B12 derivatives (more details see reference[23])
Important insights into a catalytic mechanism of a B12 dependent enzyme was 
achieved by Martha Ludwig’s  group ion 1994. Her group solved the structure of a B12-
binding domain of methionine synthase (Figure 4), showing that the cofactor is bound in 
a “base off/his on” constitution. Based on this result they elegantly explained the methyl 
transfer process with a proton assisted base on/base off switch.[26] As the protein 
crystallization techniques and X-ray crystallography advanced rapidly, more and more 
B12 dependent enzyme structures  were disclosed such as methylmalonyl-coenzyme A 
mutase[27] in 1996, Glutamate mutase[21] in 1999, diol-dehydratase[28] in 2000, class  II 
ribonucleotide reductase[29] in 2002, transcobalamin II[30] in 2006 and intrinsic factor[31] in 
2007. With these structural data in hand, a deep understanding of the B12 function to 
an unprecedented molecular level has been achieved, but detailed mechanisms are still 
2656 
Sclreme I 
H 
rate remain approximately the same above pH 5.  (vii) 
Below pH 5, the wave system is more and more reversible as 
the pH decreases and the magnitude of the first wave rela- 
tive to the second one becomes larger and larger at a given 
sweep rate. (viii) Up to about pH 5 the background dis- 
charge is again shifted posi ively. Above this pH, the ob- 
served behavior becomes more complex due probably to the 
interference of Na+ discharge. This phenomenon needs fur- 
ther investigation. 
Discussion 
The general aspect of the CV curves above pH 3 and 
their variation with the sweep rate is typical of a reduction 
process involving a homogeneous chemical reaction pre- 
ceding the electron-transfer step.33,34 Owing to electron 
donation by the Bzm ligand the base-on form of B I ~ ~ ,  11-C,
is obviously less easily reduced than the base-off forms, 
11-0 and 11-OH+. The first cathodic wave may therefore be 
attributed to the reduction of the base-off forms and the 
second one to that of the base-on form (Scheme I). 
When the solution is made more and more acidic the pro- 
portion of the base-off components, in the form of 11-OH+, 
increases at the expense of the base-on form. The kinetic 
control by the coordination reaction diminishes accordingly 
and the system tends to become reversible as observed ex- 
perimentally. Conversely, when raising the pH the relative 
proportion of base-on and base-off (under the form of 11-0) 
species tends toward a limit and so does the kinetic charac- 
ter of the first cathodic wave in agreement with the experi- 
mental observations. 
The oxidation-reduction mechanism of the B12r-Bl~s 
couple may therefore be depicted by the above scheme, the 
relative role of each species depending on the pH. 
No kinetic influence of the protonation reactions either a t  
the Bzm nitrogen in the CO" and Co' base-off species or a t  
the cobalt atom in B I ~ ~  is apparent in the considered pH 
range even at very high sweep rate. 11-OH+ and 11-0 on 
one hand and I-OH2+, I-OH, and 1-0- on the other may 
therefore be considered at equilibrium whatever the sweep 
rate and the pH. The contribution of 11-OH+ to the first ca- 
thodic kinetic wave thus decreases when the pH is raised in 
favor of 11-0. The observed shift of the anodic peak by 30 
mV per decade when the system has reached its highest ir- 
reversibility is in agreement with a fast reoxidation of the 
B1zs base-off forms resulting first in a base-off Blzr followed 
by a rate-determining conversion into the base-on form.35,36 
The second cathodic wave corresponds to the direct re- 
duction of the base-on Blzr leading to a base-on B I ~ ~ ,  I-C-,
I 
N 
W 
which is expected to be extremely unstable due to the fact 
that Cot is certainly a very poor electrophile. The electron 
transfer is thus followed by the fast conversion of the base- 
on Bizs into its base-off forms. This is in agreement with the 
shifting of the second cathodic peak with the sweep rate. 
The magnitude of the shift rate and that of the peak width 
indicates that the rate-determining step is here the electron 
transfer itself and not the succeeding deligandation reaction 
which would lead to a 30-mV shift and a 50-mV ~ i d t h . ~ ~ , ~ ~  
This is most probably related to the high rate of the deli- 
gandation reaction rather than to an intrinsic slowness of 
the electron transfer.36 
Finally, the features of the CV curve in very acidic medi- 
um are consistent with a slow decomposition of the hydridic 
species evolving hydrogen and regenerating Bl zr, 16,22,37,38 
hence giving rise to a catalytic wave39-41 at  slow sweep 
rates. The positive shift of the background discharge may 
be attributed to the reduction of the cobalt hydride I-OH2+ 
which gives rise to a much more efficient catalytic H+ dis- 
charge. At higher pH a similar process may occur even 
though the equilibrium concentration of I-OH2+ becomes 
small. It cannot, however, be excluded that a base-on cobalt 
hydride might be formed through protonation of the initial 
reduction product of 11-C, I-C; which is expected to be 
markedly more basic than I-OH and that this CoH com- 
pound would relay I-OH2+ as a catalyst for the hydrogen 
discharge. This problem clearly needs further investigation. 
The standard potential Eo featuring the conversion of 
11-C + 11-0 + 11-OH+ into 1-0- + I-OH + I-OH2+ can b  
readily derived from the reversible CV curves which are ob- 
tained in a large range of sweep rates below pH 3 and at 
low sweep rate above pH 3. The variation of Eo with the pH 
is shown in Figure 9. 
The diagram is composed of two horizontal and two 
oblique segments whose slope is close to 60 mV/pH unit. 
The pH values featuring the transition between them are 
successively 1, 2.9, and 4.7. The second value is close to the 
approximate result previously obtained for ~ K A " ( N ) . ~ ~  We 
have verified by acid-base titration under an argon atmo- 
sphere of a solution of B12r prepared by exhaustive electrol- 
ysis of B12* on platinum that 2.9 is indeed the correct value 
for this ~ K A .  The third value is the same within experimen- 
tal error as the PKA of the free Bzm2 and may be taken as 
equal to the ~ K A  of the 11-OH+/II-0 and I-OH/I-0- cou- 
ples. It is noted that considering the ~ K A  of uncoordinated 
Bzm as the same in 11-0 and 1-0- implies that the standard 
potentials EOII.OH+/I-OH and Eo11.o/1.o- are also equal. As 
discussed previously25 the first ~ K A  is that of the couple I- 
Journal of the American Chemical Society / 98:9 / April 28,1976 
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waiting to be solved.
Figure 4: The cobalamin-binding domains of methionine synthase.[26]
The achievement in B12 chemistry in the past century was remarkable, from raw liver to 
enzyme structures, from pyrolysis to total synthesis, from scanty medicinal practice to 
well-designed molecular drugs, from unknown to two Nobel Prizes, from Woodward and 
Hoffmann rules to electrocyclic ring closure reaction. Nevertheless the story about this 
beautiful and complicated molecule will continue.
1 W. ASkt
The helical domain: A methyl cap. A
significant feature of the interaction of the
helix-bundle domain with the top of the
corrin is the shielding of the methyl ligand
of cobalamin. The turn between helices la.3
and l1a4 caps the top of the corrin, isolating
the methyl group from solvent (Fig. 4). It is
hard to see how the substrates can react
with cobalamin; major movements of the
upper domain would be required for in-line
methyl transfers to or from the cobalt of
cobalamin. There are only a few domain-
domain hydrogen bonds, and the single
connection between the helix-bundle do-
main and the COOH-terminal a/13 domain
could facilitate motions of the helical do-
A
main to allow access of substrates during
catalysis. Alternatively, methyl transfers
catalyzed by methionine synthase may pro-
ceed by single electron transfer mechanisms
(18), which have less stringent geometric
requirements than direct in-line displace-
ment mechanisms, and may permit ap-
proach of the substrates from the periphery
of the corrin.
The helical domain and the methyl cap
may occur only in methionine synthases.
The different upper faces of methyl- and
adenosylcobalamin are likely to interact
with different structural motifs in the two
classes of B12 enzymes, and the sequence
that contacts the upper face of methylco-
balamin in methionine synthase has no de-
tectable homologies with adenosylcobal-
amin-containing enzymes.
The ot/p domain as a common cobal-
amin-binding motif. Residues of the a/4
domain are involved in binding the lower
face of the corrin, as well as the dimethyl-
benzimidazole tail. All of the sequence sim-
ilarities among B12-dependent enzymes are
found in the region that corresponds to the
a$ domain of methionine synthase. Se-
quence alignments based on the location of
these B12-binding residues allow us to pro-
pose sequence fingerprints for cobalamin
binding (Fig. 5). Four of the seven con-
served residues of the consensus sequence
B
Fig. 3. The cobalamin-binding domains of methionine synthase. (A) A ribbon drawing
with atoms of the cobalamin and His759 in ball-and-stick mode. The drawing was
generated using MOLSCRIPT (32). The NH2-terminal helical bundle domain is shown
"above" the corrin. Kinks in helices 1a3 and lc4, evident in the drawing, occur at prolines
696 and 734. (B) A ribbon drawing in an orientation rotated 900 from that shown in panel
A. This orientation corresponds approximately to the topology diagram of panel C. In this
view a striking feature is the narrow first domain, which is similar in width to the corrin
macrocycle. In the intact enzyme, substrate-binding segments are expected to adjoin
this domain. (C) Topology diagram. The helices of the first domain form a bundle accord-
ing to the criteria of Harris et al. (33), with the front and back pairs of helices inclined at
angles of 500 to 55°. In domain 11, a doubly wound aJB fold, helices lla1 and 11a5 are
behind the sheet and llot2, 11a3, and 11a4 are in front. Helix lla6 makes substantial contacts
with helix 11a5, but may also pack against other domains in intact methionine synthase.
The corrin (COB) is indicated above the cleft between 1-sheet strands 1 and 3; the
dimethylbenzimidazole tail (shaded) adjoins strands 13 and ,B4 (Fig. 6). (D) Primary and
secondary structure of the cobalamin-binding fragments of methionine synthase. The
primary sequence of the cobalamin binding region of the metH gene from E coli K-12
(EC) extending from residues 651 to 896 (11), and a homologous sequence including
residues 621 to 867 of an open reading frame from Mycobacterium leprae (ML) (34) that
is presumed to encode a cobalamin-dependent methionine synthase, are shown. These
sequences have 27 percent identity overall, with conserved residues (boldface) concen-
trated in the cobalamin-binding regions. The secondary structural elements identified by
hydrogen bonding patterns and the algorithm of Kabsch and Sander (35) are indicated
below the sequences, and the regions assigned as fingerprints for both methyl- and
adenosylcobalamin enzymes (Fig. 5) are marked with overhead bars.
D
C 651QAEWRSWEVN KRLEYSLVKG ITEFIEQDTE EARQQATRPI
M 621EAELAKLPLF DRLAQRIVDG ERNGLDVDLD EAMTQ-KPPL
<3> <---Ial----> <----Ia2---> <-
EC 691EVIEGPLMDG MNVVGDLFGE GKMFLPQVVK SARVMKQAVA
ML 660AIINENLLDG MKTVGELFGS GQMQLPFVLQ SAEVMKAAVA
--Ia3 ---> <- I4
xc 731YLEPFIEASK EQ-GKTN--QKMV IATVKGDVHD IGKNIVGVWL
ML 700YLEPHMEKSD CDFGRGLAKGRIV LATVKGDVHD IGRNLVDIIL
EC 771QCNN-YEIVDL GVMVPAEKIL RTAKEVNADL IQLSQLITPS
ML 743-SNNGYEVVNL GIKQPITNIL EVAEDKSADV VGMSGLLVKS
--> <II02-> <----IW2--> <-IIP3> <---
EC 811LDEMVNVAKE MERQGFT-IPL LIGGATTSKA HTAVKIEQNY
M$ 783TVIMKENLEE MNTRGVAEKFPV LLGGAALTRS YVENDLAEVY
---IIX3--------> <I114> <-IIa4-> <3>
* 0* 0* 0* * 0* * 0
EC 851SGPTVYVQNA SRTVGWAAL LSDTQRDDFV ARTRKEYETV RIQHGR
M 825EGEVHYARDA FEGLKLMDTI MSAKRARRCA GEPGVLSCRS RPQ
<II05> <----IIa5----> <--------IIa6- ----->
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1.2 Traveling of B12 - Origin, transportation and destination
Neither plants nor animals are capable of producing B12 independently.[32] Only about 
two dozens of microorganisms such as Acetobacterium, Aerobacter, Bacillus are known 
to produce this important class of cofactors.[33,34] 
Humans can obtain B12 through the daily diet, mainly from fish, shellfish, meat, liver, 
eggs and milk or taking vitamin pills  as  an alternative.[35] After uptake, B12 is delivered 
with the assistance of haptocorrin, intrinsic factor, transcobalamin II[36] and 
transcobalamin receptor into the cells.[37] This  sophisticated delivery system has high 
binding constants to the selected Cbls  and makes sure that only “complete” corrinoids 
are passed to the enzymes (Scheme 3).[3,38] 
Scheme 3: The transportation of B12 in human beings (left). The selectivities  of the 
transporters and/or changes of conformation and valence values of B12 (right).
The final destinations of Cbls in humans are the enzymes methionine synthase and 
methylmalonyl-CoA mutase and only tiny daily doses of B12 (1 - 2 µg) are required. 
Excess B12 is either stored in the liver (2 - 3 mg) or excreted through the urine.[34]
! • haptocorrin!
! •  intrinsic!factor!!!
! •  transcobalamin!II!
•  transcobalamin!receptor!
• LMBD1!
• MMACHC!
• methionine!synthase!
• methylmalonyl<CoA!mutase!
broad!speciﬁcity!of!B12!analog!
B12!derivaCves!with!nucleoCde!tail!
‘base!on’!consCtuCon!(TCIIIB12)!
‘base!on’,!TCR:TCIIIB12!
free!lysosomal!B12!
decyanaCon,!Co(II),!Co(III),!‘base!oﬀ’!
Co(I),!Co(II),!Co(III),!‘base!oﬀ’!
Co(I),!Co(II),!Co(III),!‘base!oﬀ’!
Introduction
6
1.3 Function of B12 – Coenzyme, thymine and cell division
Figure 5: Structures of five B12 derivatives with different upper ligands (R = CN, 
cyanoCbl; R = OH, hydroxoCbl; R = OH2, aquaCbl; R = adenosyl, AdoCbl).
Cbls participate in enzymatic reactions as their alkylated forms methylcobalamin and 
adenosylcobalamin, respectively (Fig 5).[39]
Methylcobalamin is a cofactor of methionine synthase that regenerates methionine from 
homocysteine by a transfer of the methyl group from 5-methyl-folate.[20,40-42] As a 
byproduct tetrahydrofolate (THF) is generated and converted by a B12-independent 
process to 5,10-methylene-THF, which is involved in the synthesis of thymine group 
(Scheme 4, up).[43] As one of the four nucleobases of DNA, insufficiency of thymine 
obviously impedes the replication of DNA and therefore retards the cell division.[44] This 
behavior causes failure of blood cell production and results in fatal pernicious anemia.
[45,46]
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Scheme 4: (up) The catalytic (red) and reactivation (blue) cycles  of E. coli MetH[47]; 
(down) Proposed mechanism of the carbon skeleton rearrangement between (2R)-
methylmalonyl CoA and succinyl-CoA[48].
substrate-binding domain and requires a different arrangement
of modules (Fig. 2). During the catalytic cycle, the enzyme
oscillates between a conformation with the CH3-H4folate-
binding and Cob domains positioned for methylation of cobal-
amin (Fol:Cob) and a conformation with the Hcy and Cob
domains positioned for demethylation (Hcy:Cob). Recent stud-
ies have examined the distribution of molecular species in the
MeCbl form of MetH and shown that the enzyme exists as an
ensemble of interconverting conformations. The distribution of
states at equilibrium depends on the oxidation and ligation state
of the cobalamin, on the temperature, and on the concentrations
of substrates or products (9, 11).
In this study, we have used disulfide cross-linking to lock the
C-terminal fragment of WT MetH into the reactivation confor-
mation before crystallization. Specifically, we engineered unique
cysteine residues positioned to form a disulfide that would span
the Cap and Cob domains of MetH. The I690C/G743C
MetH(649–1227) becomes locked in the reactivation conforma-
tion. The axial ligand to the cobalamin moiety, His-759, is
dissociated from the cobalamin. Relative to the distance fromC!
of His-759 to cobalt in the Cap:Cob conformation (7), the cobalt
is displaced by 2.9 Å in the reactivation conformation. Unex-
pectedly, the displaced His-759 is now involved in intermodular
contacts with the AdoMet module. The N"2 nitrogen of His-759
interacts with the AdoMet domain directly through Asp-1093
and via a water molecule to Glu-1069. These interactions would
be expected to stabilize the AdoMet:Cob conformation, andmay
rationalize the failure of the cob(I)alamin form of MetH to
interconvert between AdoMet:Cob and Fol:Cob conformations
of the enzyme.
Results and Discussion
Introduction of a Disulfide Cross-Link to Reduce the Conformational
Flexibility of MetH. A remaining challenge for understanding the
complex reaction sequence of MetH is to understand how the
domains interact and rearrange during the reaction cycle. Crystal
structures of the full length enzyme in the different conforma-
tions are essential for achieving this goal. Unfortunately, crys-
tallization of the full-length enzyme has been unsuccessful to
date, presumably due to the conformational f lexibility of MetH.
A different strategy was thus required to tackle this problem, and
we chose originally to implement it in the C-terminal fragment
of MetH. We used an intramodular disulfide cross-link to reduce
the conformational f lexibility of MetH.
The structure of the C-terminal MetH fragment in the
AdoMet:Cob conformation was used to select residues suitable
for mutation to cysteines (8). The stereochemical criteria for
selecting appropriate residues are described in ref. 12. The
residues chosen were in different domains of the cobalamin
module, with Ile-690 in the Cap domain andGly-743 in the linker
connecting the Cap and Cob domains. This disulfide cross-link
is expected to tether the enzyme in the AdoMet:Cob confor-
mation because it shortens the nine residue linker region be-
tween the Cap and Cob domains by four residues and is
positioned so as to restrict movement of the Cap relative to the
Cob domain. To eliminate the possibility of intramolecular
disulfide linkages between the cysteine mutants and the native
cysteines at positions 772, 1042 and 1142 of MetH(649–1227),
the two cysteine mutations had to be introduced at positions with
C! separations of at least 6 Å or more from each of the native
cysteines.
Expression and Characterization of I690C/G743CMetH(649–1227).The
mutant enzyme was overexpressed and purified to !95% purity
as judged by electrophoretic analysis under denaturing condi-
tions and is isolated as a mixture of cob(II)alamin and aquaco-
balamin forms. Reductive methylation in an electrochemical cell
in the presence of AdoMet converted the protein to the meth-
ylcobalamin form. The methylated enzyme is very light sensitive,
so to prevent photolysis of the methyl-cobalt bond, all subse-
quent experiments were performed in the dark. Whereas WT
MetH(649–1227) at room temperature gave a spectrum consis-
tent with His-onMeCbl, with an absorbancemaximum at 525 nm
("525 " 9,400 M#1 cm#1), the spectrum of I690C/G743C
MetH(649–1227) showed a maximum at 452 nm and an "452 of
10200$ 100M#1 cm#1. This blue shift of the #max compared with
WT MetH indicates that I690C/G743C MetH(649–1227) is
mostly His-off.
I690C/G743C MetH(649–1227) Is Found in both His-On and -Off States.
The methylcobalamin form of both WT and I690C/G743C
MetH(649–1227) showed temperature-dependent changes in
absorbance consistent with an interconversion between a His-off
species at high temperature and a His-on species at low tem-
peratures, as shown in Fig. 3. These changes were used to
calculate equilibrium constants [K " (% His-off)/(% His-on)].
From the plot of ln K vs. T#1, we calculated %H " 27.5 kcal/mol
and %S" 83.2 cal/mol/K for the interconversion between His-on
and His-off species of WT MetH(649–1227). These values
yielded a %G of& 1.73 kcal/mol at 37°C, where the positive value
indicates a preference to remain in the His-on conformation. A
value for %G of & 2.55 kcal/mol was determined previously for
the full-length WT enzyme (11). This more positive value is
probably due to the larger number of His-on conformations in
the full-length enzyme (Fig. 2). Similar experiments were per-
Fig. 1. The catalytic (red) and reactivation (blue) cycles of E. coli MetH.
During catalysis the cobalamin cofactor is alternately methylated by CH3-
H4folate and demethylated by Hcy. The cob(I)alamin form of the enzyme is
occasionally oxidized to form the inactive cob(II)alamin form. Return of this
species to the catalytic cycle involves reduction with electrons derived from
reduced flavodoxin and methylation with a methyl group derived from
AdoMet.
Fig. 2. Cartoon of a minimal set of conformations for the methylcobalamin
forms of MetH(2–1227) (Upper) and MetH(649–1227) (Lower). The Hcy-
bindingmodule is shown in green, the folate-bindingmodule in light yellow,
the cobalamin-binding domain in red, the Cap domain in dark yellow, and the
AdoMet-binding domain in blue. The corrin ring of the cobalamin is repre-
sented by the square, and the vertical line below it indicates the His-on
conformation of the Hcy:Cob, Fol:Cob, and Cap:Cob conformations. In the
AdoMet:Cob conformation, the histidine is displaced and the corrin moves
away from the cobalamin-binding domain to assume a His-off conformation.
4116 ! www.pnas.org"cgi"doi"10.1073"pnas.0800329105 Datta et al.
Thymine(group(
R(
via a cyclopropinyl radical: the stereochemical course of
the alternative dissociative pathway via acrylate and the
formyl-CoA radical would be very similar, but with the
stereochemical discrimination being the appropriate position-
ing of acrylate. There is no reason to invoke rotation of the
acrylate intermediate proposed in ref 21 as long as the
succinyl radical (species III) has a C2,C3 torsion angle close
to 0°.
CONCLUSIONS
Putting together the structure of the substrate complex with
the previously reported “open” structure of the enzyme in
the absence of substrate (6), we can delineate some key steps
in the structural course of the reaction. The starting point is
the enzyme with adenosylcobalamin bound and with the
substrate-binding TIM barrel domain broken open and the
active site accessible to the bulky substrate. When the
substrate binds, the active site closes down on the substrate,
and this conformational change drives the adenosyl group
off the cobalt, by steric interference with TyrR89, forming
the adenosyl radical. Kinetic information suggests that the
lifetime of the adenosyl radical is very short (2, 3) and that
the substrate radical is formed immediately. The structure
we see of the substrate complex represents the intermediate
stages of the reaction, with 5!-deoxyadenosine in a weakly
bound site and the substrate radical rearranging to the product
radical. When the adenosyl radical is re-formed, it can react
with the CoII atom, to regenerate adenosylcobalamin, favor-
ing the opening up of the structure to release the product.
The rate-limiting step (at least in wild-type enzyme) appears
to be product release, consistent with the large conforma-
tional change i volv d. The r arrang m nt step itself in-
volves no si nificant confo mati nal change, consistent with
its relatively high speed (13).
A curious feature of the enzyme is its apparent lack of a
tight binding site for the intermediate 5!-deoxyadenosine,
which has proved rather elusiv in th crystallographic
experiments and is only weakly visualized here. Fortunately
for the enzyme (o perhaps by d sign), the adenosyl radical
has only a very short life during the r action, since a loosely
bound radical could be very destructive. The longer lived
substrate radical is presumably tightly bound, like the
substrate and product themselves. A major role of the enzyme
is to prevent side reactions of the reactive radical intermedi-
ates, presumably by preventing too much free motion in the
active site.
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FIGURE 4: Stereochemical course of the reaction starting from
succinyl-CoA. In the first stage, the HRe hydrogen is closer to the
adenosyl radical than the HSi. (2S)-Methylmalonyl-CoA and
intermediates leading to it would clash with TyrR89; thus this
tyrosine controls the stereochemical fate of the reaction.
FIGURE 5: Schematic view f interactions in the active site. Note
that the exact positioning of 5!-deoxyadenosine is unclear, so the
interactions cannot be certain (see text).
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Adenosylcobalamin (AdoCbl) is  the cofactor of methylmalonyl CoA mutase, which 
catalyses a reversible carbon skeleton rearrangement between methylmalonyl CoA and 
succinyl-CoA (Scheme 4, down).[48] This is  a crucial step in the extraction of energy from 
proteins and fats  for humans.[34] Succinyl-CoA participates  in the tricarboxylic acid cycle 
(TCA), responsible for aerobic respiration in cells.[49] AdoCbl also widely exists in other 
organisms than humans as  a coenzyme for different apoenzymes such as glutamate 
mutase[50,51], ribonucleotide reductase[21] and diol-dehydratase[28,52]. Although the 
apoenzymes are different in structure, they catalyze similar types of rearrangement 
reactions.
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1.4 Properties of B12 – Structure, derivatives and constitutions
f"side'chain'
α"face'(lower)'
β"face'(upper)'
a'
c'
d'
e'
f'
g'
Figure 6: Structure of B12 (Charges on the corrin rings have been omitted).
B12, as a member of water-soluble vitamins, is the most complicated and also the only 
metal containing vitamin.[53] The core of B12 is  a trivalent cobalt ion, which is tetra-
coordinated by a corrin ring in the equatorial positions. In the axial positions of the corrin 
are bound a cyano group on the top (β-face) and a nucleobase on the bottom (α-face) 
of the molecule. The seven amide side chains of the corrin ring are pointing to the β-
face (a-, c-, and g-side chains) and the α-face (b-, d-, e- and f-side chains), respectively 
(Figure 6). The ligands on the upper and lower sides can be substituted in various ways, 
whereas coordination to the lower face is limited by strong coordination of the Dmbz 
base.
Figure 7: Possible modification sites of B12.
Most modifications of B12 focused on the upper ligands with either coordinative or 
Elonga'on(
Replacement(
Flip(
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covalent bonds to the metal center. The former ones such as in cyano-B12 are relatively 
light stable. The latter organometallic ones are light sensitive due to the low activation 
energy of the Co-C bond.[54]
Modifications of B12 extend almost every part of the molecule ranging from the upper 
ligands to the lower ones, from side chains of the corrin ring to the replacement of the 
central metal ion, from binuclear metal complex to extension at the ribose group (Figure 
7).[55,56] Most of these efforts are intended to study structural influence on the 
bioactivities.[57-59] Nevertheless the difficulty of understanding interactions between 
cofactors  and proteins  are extremely challenging and more practical methods  are 
required to control enzymatic activity.
Constitution represents another interesting topic in B12 chemistry. “Complete” corrinoids 
exist in the intramolecular “base on” constitutions unless the base is trapped by 
environmental parameters such as protonation[60] (Figure 8, left) or encapsulation of the 
base[61] (Figure 8, middle). Decoordination can also be caused by other strong 
competitive ligands like cyanide,[62] which is  the fundamental principle of cyanide 
detection with B12 derivatives.[63]
Figure 8: Three examples of “free” base off B12: (left) protonation of the Dmbz base; 
(middle) encapsulation of the bases; (right) substitution by cyanide ligand.
Compared to the B12 derivatives in non-biological environments, protein-bound 
cobalamins exhibit “base on”[29], “base on/his on”[30] and “base off/his on”[26] 
constitutions (Figure 9).
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“Base-on” cobalamins are generally buried inside the cavity of proteins by multiple 
hydrogen bonds between the protein and the amides-, the ribose-, and phosphodiester 
functionalities of the cofactor (Figure 9, top right).[29] Of note, in transcobalamin II, an 
imidazole group of the protein coordinates to the upper face of the corrin ring to further 
fix its position (Figure 9, top left).[30]
Figure 9: (top and bottom left) Three binding modes of coenzyme B12; (bottom right) 
Stabilization of the methylcobalamin in the methionine synthase reaction[26] - the proton 
relay.
The “base off/his on” constitution is quite unique and fascinating.[26] The dissociated 
Dmbz base of the cofactor is buried in a hydrophobic pocket of the protein, and a 
histidine group from the protein coordinates  to the cobalt ion (Figure 9, bottom left). This 
critical constitutional change is  the activation mechanism of methionine synthase.[20,26,42] 
According to crystal structure analysis of methionine synthase, there is a protein relay 
S Sv r AS lUI
anchors the highly reactive cobalamin co-
factor (Fig. 6).
The remaining three residues of the con-
sensus sequence shown in Fig. 5, Asp757,
His759, and Leu806, are contributed by the
loops that connect strand IL131 to helix Ilal
and strand Il13 to helix Ihx3 (Fig. 4). The
conserved histidine is the lower ligand to
the cobalt in the structure of the 27-kD
fragment of methionine synthase, Asp757 is
in position to hydrogen bond with His759,
and Leu806 adjoins the histidine ligand. To
confirm that methylcobalamin is also coor-
dinated to a histidine residue in the intact
protein, we used electron paramagnetic res-
onance spectroscopy (Fig. 7). This tech-
nique should be a useful probe for demon-
strating the presence of histidine coordina-
tion to cobalt in other cobalamin-depen-
dent enzymes. The conservation of the
residues in the sequence motif shown in Fig.
5 suggests that the replacement of the di-
methylbenzimidazole by a histidine ligand
may be a common feature of cobalamin-
binding to proteins.
A catalytic quartet in the reaction
mechanism of B12-dependent methionine
synthase. The replacement of dimethylbenz-
imidazole with a histidine residue was un-
expected and has profound implications for
the catalytic mechanisms of B12-dependent
enzymes. As a result of this substitution, the
control that the lower ligand exerts on the
stability and reactivity of cobalamin deriv-
atives is directly modulated by the protein
rather than by a substituent of the cofactor.
In the reaction catalyzed by methionine
synthase, the protein must altemately sta-
bilize methylcobalamin and cob(l)alamin
species. In free cobalamins these forms are
six and four coordinate, respectively (19).
Model studies have demonstrated that the
carbon cobalt bond is stabilized against ho-
molytic cleavage to form cob(II)alamin (2)
and against heterolytic cleavage to form
cob(I)alamin (3) by basic lower ligands that
increase the electron density on the cobalt.
The ligand to cobalt in methionine syn-
thase, His759, is part of a hydrogen-bonded
chain involving Asp757 and Ser810 that
could provide a pathway for transfer of pro-
tons from solvent to the buried histidine
(Fig. 8A). This feature of the structure
prompts us to propose that protonation-
deprotonation of the His-Asp pair might
modulate the stability and reactivity of co-
balamin in methionine synthase (20).
We suggest that, in the methylated form
of the enzyme, Asp757 and His759 share a
single proton, with one negative charge
delocalized across the two residues. Ligation
of His759 to methylcobalamin would favor
formation of the proposed imidazolate spe-
cies (21). Partial deprotonation of His759
would greatly increase the basicity of this
ligand, stabilizing the methylated form of
the enzyme. Reduction of enzyme-bound
cob(II)alamin to cob(I)alamin has been
shown to be associated with uptake of one
proton (22), and we postulate that de-
methylation of methylcobalamin to form
cob(I)alamin likewise involves protonation,
Fig. 7. Electron paramagnetic resonance (EPR) l l l
signals from cob(l)alamin in three different methi- v =9.17 4GHz
onine synthase preparations (38). Curve A, en- 2
zyme was isolated from E coli cells grown on l l
glucose minimal MOPS medium containing
14NH40C and 14N-labeled aquocobalamin. The in-
teraction of the cobalt nucleus (spin = 7/2) with
the unpaired electron in cob(ll)alamin results in Z
hyperfine splitting of the gz signal into an octet -
centered at g = 2 (330 mT), and the presence of A
a 14N (spin = 1) ligand attached to the lower axial
position of the cobalamin results in superhyperfine
splitting of each component of the octet into a
triplet. Curve B, enzyme isolated from cells grown c
in glucose minimal M9 medium containing 9.5 mM
15NH40C and 2.5 p.M 14N-labeled cyanocobal-
amin. The octet of doublets centered around g = l l l l
2 indicates that the lower axial ligand for the co- 250 300 350
balamin is labeled with 15N (spin = 1/2), and thus Magnetic field (mT)
derives from the protein rather than the nucleotide loop of the cobalamin. Curve C, enzyme isolated from
cells grown in glucose minimal M9 medium containing 15NH4C1, 14N-aquocobalamin and 200 F.M
14N-histidine. The reappearance of the octet of triplets indicates that the lower axial ligand is now
14N-labeled. Because exogenous histidine represses de novo histidine biosynthesis from NH40C but does
not serve as a nitrogen source for the biosynthesis of other amino acids in the presence of NH4C, this
experiment indicates that the lower axial ligand is a nitrogen in a histidyl residue from the protein.
A oD oD
\1~ c ~ ~0\;=(K (jJ
~4 B B~
,;(H759\I8o06 ==0 759 X->o =
-44118t( 07 1807
V758% 4V75 > . f\I j
D757 '.D757%
S81
P809
S810 809
Fig. 8. (A) A hydrogen bonding network involving B RS- RSCH3
His759, the lower axial ligand to methylcobalamin. CH3 \. % ()
The stereodrawing displays the interactions at the | \J /
lowerface of bound cobalamin. The dimethylbenz- Co/ H+,CO
imidazole nucleotide tail attached to corrin ring D /f U
has been truncated at the phosphate. Hydrogen N N
bonds comprising the network that connects N -
Ser810, Asp757, and His759 are dashed. The orien- t N
tation of Asp757 is maintained by additional hydro- H5H
gen bonds to the backbone nitrogens of His759, H759 H759 "
Leu806, and lie807. (B) Stabilization of the interme-
diates in the methionine synthase reaction. The 0/
enzyme alternates between methylcobalamin and D757 D757 H
cob(l)alamin forms. The methylcobalamin form of H
the enzyme (left) is six coordinate, with the lower
axial position occupied by the E-nitrogen of His759.
The side chain of His759 is shown as an imidazo- S810 H+ S810
late, stabilized by a hydrogen bond between the 8
nitrogen and Asp757. In contrast, cob(l)alamin CH3
(right) is assumed to be 4-coordinate. The His759- .
Asp757 pair has taken up a proton and the histi- N /H\
dine has moved away from the cobalt to minimize
electrostatic repulsion between the imidazole E-nitrogen and the two electrons in the dz2 orbital perpen-
dicularto the corrin of cob(l)alamin. Ser810 is hydrogen bonded to Asp757, and may participate in a proton
relay that transfers protons from solvent to and from the His759-Asp757 pair.
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mechanism during the catalytic cycle, triggered by the NH functionality of the histidine 
group (Figure 9, bottom right).[26] Matthews and coworkers  showed that the pH value of 
the environment affects the redox properties of the cobalt center supporting the proton 
relay theory.[64]
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1.5 Topics of B12 – Recent progress
The first 50 years of B12 chemistry were mainly focused on the exploration of its 
structure. From the 1960s to the 1980s, fundamental studies yielded deep insights  into 
the properties of natural as well as artificial corrinoids. 
Thanks to rapid developments  of NMR-[65] and crystallographic techniques[66] in the last 
20 years, structural biology became more and more powerful for studying the 
mechanism of enzymatic reactions. Although crystal structures of protein-cofactor 
complexes may not reflect the real, biological situation, it yields the most convincing 
mechanistic insight, especially with the help of complimentary multi-dimensional NMR-, 
and computational studies. Benefiting from these advancements, a deep understanding 
of B12 dependent enzymes has been gained.
Using B12 as imaging materials  or as drug delivery vehicles for medical application is 
an intriguing field. This method takes advantage of the natural high accumulation of B12 
in fast proliferating cells like cancer cells in order to either track or deliver drugs to 
specific locations.[67-69] One of the most sensitive methods to track B12 is radio labeling. 
Early attempts included direct labeling with radioactive cobalt[70] (56Co, 57Co, 58Co, 60Co) 
or iodine[71] (125I, 131I), but none of them gained any practical use. Later, two new 
radioactive isotopes 99mTc and 111In made a breakthrough in this field, and were not only 
tested in mice and pigs, but also in clinical studies.[72,73]
The impact of modifications of the stereochemistry at position C13[74,75] as well as the 
adenosyl ligand[76] on the biological activities were tested. Changing the electronic 
properties of the corrin ring by replacing the proton at position C10 with electron 
withdrawing groups (-Cl or -NO2) was another option.[77,78] All of these derivatizations 
resulted in the deactivation of the enzymes.[77]
Introduction
14
Figure 10: (left) Trimethylene B12 (right) norvitamin B12.
The modification of the loop structure or the coordinating base are expected to change 
the binding mode of the cofactor, thus decreasing the enzymes’ activity. Two studies on 
the loop modification were particularly interesting for us. Toraya and coworkers replaced 
the ribose group with multi-methylene groups (Figure 10, left),[58] which resulted in a 
decrease of the base on stability and low enzymatic activity in diol dehydratase. 
Kräutler and coworkers  did a precise surgery on natural B12 by removing the methyl 
group at position C176 (Figure 10, right), and this remote methyl group far away from 
the coordination center surprisingly destabilized the base on constitution by a factor of 
3.[79,80] These two studies suggest that the modification on the loop part has impact to 
the intrinsic coordination properties as well as biological activities.
Other appealing perspectives of B12 chemistry include studies regarding the evolutional 
origin of B12[81,82], structural mimics of B12 coenzymes[83,84], radical catalyst[85-87], B12 
labeling system[69], cyanide sensors[63,88-91], cobalamin regulated riboswitches[92-94] and 
colorimetric detection[68,95].
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1.6 Projects of B12 – Peptide backbone
1.6.1 Concept of peptide B12 – Simulation, correlation and suppression
B12 is extremely high efficient for the metabolism of humans. It participates  in cell 
division and only a very small amount of B12 is  consumed per day (1 - 2 µg).[37] B12 
deficiency is rather uncommon and only known for either vegetarian or people with 
malfunction of B12 absorption. Up to 2 - 3 mg are stored in the liver enough for keeping 
metabolic functions running for 3 years.
Sufficient supply of B12 is critical for healthy people, but not advantageous for cancer 
patients. B12 participates  in cell division and stimulates therefore the undesirable fast 
replication of cancer cells resulting in the progression of the disease.[96,97] Taking 
advantage of the critical role of B12 in the metabolism, an alternative mechanism of 
cancer treatment can be envisaged based on the suppression of cell replication through 
manipulation of B12, either by reducing the amount or by decreasing the activity of B12.
[98] The former strategy is based on the control of dietary B12 absorption, but the normal 
cells will suffer starvation as  well. A more promising solution is the latter one, replacing 
the highly active natural B12 with low-active artificial substitutes in order to suppress 
replication of fast proliferating cells, but the healthy cell can still survive.
The deactivation of B12 dependent enzymes can be realized by changing the structure 
of B12 cofactors in several ways. The upper ligands participate directly in the enzymatic 
reactions, and studies showed that hydrogen bond interactions  between the upper 
ligands and the proteins are crucial to the catalytic efficiency.[51] Therefore, the 
modification of upper ligands (methyl or adenosyl) can be one option for deactivation of 
B12 dependent enzymes. The lower base is also a potential candidate for this 
application. In “base off/his on” enzymes, the dmbz base and the tethering loop is not 
directly involved in the reaction and far away from the active center.[26] However, the 
loop acts like an anchor to fix the bonding site of the cofactor. Modification of the 
structure of the loop influences the activity of B12 dependent enzymes, as 
demonstrated by replacing the ribose group of B12 with methylene fragments that either 
reduce or deactivate the activity of diol dehydratase.[58] A third strategy is to exchange 
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either the metal center or modulate the redox properties at the cobalt ion. The former 
goal has already been achieved, but biological activity tests of these so called 
metbalamins are still lacking.[99-102] For the latter strategy, it is possible to influence the 
properties at the cobalt ion by modifications of the conjugated π-system of the corrin 
ring through C10 substitution.[77]
We focused on tuning of coordination- and electrochemical properties of the cobalt ion 
in B12 through modification of the lower face of the corrin. We assumed that changes of 
the “lower” base or the strength of intramolecular coordination can tune the electron 
density and thus influence the redox properties of the cobalt ion. Therefore, in 
enzymatic reaction with the cofactor bound in the base on constitution, homolysis of the 
Co-C bond as well as the activity of the enzyme might be tuned.
Figure 11: Conformational mimic of B12 in the ribose phosphodiester part with peptide 
structures (Charges on the corrin rings have been omitted).
Most important for the lower-face strategy is  the selection of alternative structures for 
the replacement of the ribose phosphodiester loop. Toraya and coworkers have used 
methylene fragments for this  purpose, but destabilization of intramolecular coordination 
was too dramatic and the implementation of structural alternatives seemed to be time 
consuming and challenging.[58] Peptide bonds  are resilient structures having a near 
planar conformation but still with some flexibility in folding. Prediction and design of 
different conformation of peptides is straightforward and we indented to mimic the 
Conforma(onal**
Simula(on*
With*
Pep(de*bonds*
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conformation of the linker of B12 (Figure 11).[103-106] With a big pool of various amino 
acid “building blocks”, the design of loop structures  with distinct properties is possible. 
The high affinity of peptide bond structures  to proteins was another consideration in 
regard of biological activity tests. Thus  a new class  of vitamin B12 with embedded 
peptide structure was proposed, and we call these derivatives peptide B12 (Figure 12).
Figure 12: (left) B12; (right) prototype of peptide B12.
The consequence of the modifications of the loops on the coordination chemistry and 
electrochemistry of the cobalt has been investigated. Furthermore, the bioactivity of the 
modified cofactors is also intriguing. 
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1.6.2 Coordination Chemistry of B12 derivatives 
Diastereomers of aquacyanocobinamides
“Incomplete” corrinoids have two stable isomeric coordination structures at the cobalt 
center,[107-109] and they are usually synthesized by cleavage of the phosphodiester bond 
of B12.[110] Friedrich and coworkers[111,112] devoted enormous effort to characterize the 
axial diastereomers of aquacyano Cbi and finally Brown's group assigned the isomers in 
a mixture of chemically enriched aquacyano Cbi 13C NMR spectroscopy.[113]
Figure 13: α-aqua,β-cyano cobinamide (left) and α-cyano,β-aqua cobinamide (right). 
Charges on the corrin rings have been omitted.
We intended to develop a convenient method for the synthesis, separation and 
identification of diastereomeric aquacyanocobinamides (Figure 13). This sub-project 
was important for mechanistic studies performed in our group concerning the 
application of incomplete corrinoids as optical sensors for cyanide.[88]
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Intermolecular coordination of “complete” corrinoids
Intermolecular interactions are important for the transportation, uptake, and enzymatic 
activities of cofactors in proteins,[114-116] but outside of proteins, “complete” corrinoids 
rarely have multiple intermolecular interaction with other molecules.
In porphyrin chemistry, self-assembly is a common phenomenon, and many examples 
of supramolecular chemistry of heme derivatives have been reported.[117-120] Corrinoids, 
on the other hand, have only been observed to dimerize in the solid-state[121] or with 
covalent bond[122,123]. We assumed that the relatively rigid ribose phosphodiester 
backbone and the strong intramolecular coordination of Dmbz to the cobalt ion impede 
the formation of complex structures (Figure 14, left).
Figure 14: (left) B12 (right) base off “complete” corrinoid with α-cyano,β-aqua structure 
at the cobalt center. Charges on the corrin rings have been omitted.
To overcome this limitation and render self-assembly possible, we intended to replace 
the rigid ribose phosphodiester loop with a flexible structure and the bulky Dmbz with an 
imidazole (Figure 14, right). To avoid intramolecular coordination at the α-side of the 
corrin, we wanted to block this  face with a strong ligand such as cyanide (Figure 14, 
right). We envisaged that realization of these two key elements would open the 
possibility for intermolecular coordination of “complete” corrinoids (Scheme 5).
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Scheme 5: Dimerization of “complete” corrinoids.
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2 Results and Discussion
2.1 Peptide B12 - Derivatization of the backbone of B12
The loop structure of B12 is critical to the strength of intramolecular coordination of 
Cbls.[81] We used peptide bond structures to simulate the conformation of the ribose 
phosphodiester part of B12, which result in the change of the electrochemistry of the 
cobalt ion. Furthermore, the impact of well-designed structural changes on the stability 
of intramolecular coordination is discussed. 
2.1.1 Conformational analysis - Guideline for the design of the loop
Figure 15: The bonds of the loop structure of B12 are labelled g to p.
Inspired by Eschenmoser and Kreppelt’s conformational analysis[81,124] of the loop 
structure of B12, we decided to apply this method to mimic and design the structure of 
the backbone in artificial peptide B12 derivatives. We were particularly interested in 
effective substitutes for partial eclipse conformations, since we expected that low-
energy conformations (e.g. anti-periplanar, synclinal) would adopt naturally. 
B12$Loop$
Results and Discussion
22
+1280&'&+1420&
B12
k
B12&loop& par/al'eclipse&
1,5'repulsion&an/'periplanar&
rota/on&
176&
Figure 16: 1,5 repulsion in B12 results in a conformational change of the k-bond from 
anti-periplanar to partial-eclipse.
By comparing results  from the “ideal” conformational analysis with crystal structure data 
of B12,[124] partial-eclipse conformations have been proposed in order to avoid 
unfavorable 1,5 repulsion or ring constrains. In an “ideal” conformation as defined by 
Eschenmoser,[124] 1,5 repulsion would be caused by the interactions between an oxygen 
of the phosphodiester moiety and the methyl group at C176, but it is circumvented by 
rotation of 38 to 52° around the k-bond to form the partial-eclipse conformation as 
shown in Figure 16. Partial-eclipse conformation is also caused by limited rotation 
around the o-bond in the ribose ring. We decided to replace the phosphodiester, and the 
ribose group in B12 with peptide bonds in order to mimic partial-eclipse conformations 
in bonds k and o (Figure 15).
Figure 17: The “ideal” conformation of the iminumoxide-form of a peptide bond.[124]
The iminiumoxide-form of a peptide bond has a planar structure in the O-CR-NR`H 
region and a (theoretical) anticlinal angle of torsion of ± 120° at the adjacent bonds 
!120°&
+120°&
!120°&
+120°&
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(Figure 17).[124] According to investigations of amides with –CH2-CON- and –CONH-
CH2- moieties, these values are actually in the region of ± 60°-180°.[125] The relatively 
well-defined conformational structural motif of the peptide bond provided us therefore 
the basic tools  for mimicking partial-eclipsed structures  in bonds k and o of B12 (Figure 
15).
Replacing the phospodiester group in the backbone of B12 with an amide bond leads to 
similar conformations in the region of the i, k and l bonds (Figure 18), but the “ideal” 
conformation of the m-bond in the “prototype” peptide B12 differs by 120° from that 
observed in B12 (Figure 18). We introduced therefore a flexible methylene group 
between the m-, and n-bonds of the loop to compensate for this conformational “error”.  
Figure 18: Simulation and comparison of the conformation of the natural and artificial 
backbone of B12 at bonds i, k, l and m.
Crystal data analysis of B12 revealed that the dihedral angle at the o-bond (Figure 19, 
right up) ranges from +152° to + 162°.[124] This structural motif can therefore also been 
replaced with a peptide bond (Figure 19). Assuming an ideal conformation of the latter, 
this mimic will only cause slight deviations (18°-28°).
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Figure 19: Simulation of the “ideal” structure of B12 at the o-bond.
The conformational analysis of the o-p-q bonds in the loop of the peptide B12 prototype 
is depicted in Figure 20 and compared to B12.
Figure 20: Simulation and comparison of the conformation of the natural and artificial 
backbone of B12 at bonds n, o, p, q.
As a complement to the conformational analysis, computational calculation of the lowest 
energy state was performed by Olivier Blacque (Table 1). These results suggest that the 
calculated or the ideal structure of the peptide backbone of the prototype differs  only in 
two positions (l and o, or i and l) from that of B12. The conformation of the other bonds 
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fit well with those from the crystal structure of B12 (Table 1).
Table 1: Comparison of the conformation at i - q bonds (°) between peptide B12 
prototype (computational calculation)b, pB12 (ideal conformation)c with B12 (crystal 
data)a:
i k l m o p q
B12a -63 134 -70 168 124 158 -148
pB12b -71 143 -173 151 -82 167 154
pB12c -180 120 -180 120 180 180 -120
|B12a - pB12b| 8 9 103 17 152 9 52
|B12a - pB12c| 117 14 110 60 56 22 28
Starting from the structure of the prototype, further adjustments of the structure as well 
as the conformation have been considered. To mimic the ribose group of B12, we 
introduced a proline group as a “U-turn” mimic to pre-organize the loop for better 
coordination to the cobalt center. Another interesting modification is the methyl group in 
different configurations at position C176 (Scheme 6). This  modification will be discussed 
in the next part in more detail.
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2.1.2 Peptide B12 derivatives - Coordination and redox chemistry
The peptide B12 derivatives  (2 - 5, the counter ion TFA is omitted) were synthesized 
from dicyano-cobyric acid (7) and peptide loops as shown in Scheme 6. The cobyric 
acid (7) was synthesized from B12 (1) according to Müller’s  method[126]. The peptide 
loops (8 - 11) were synthesized from dimethylbenzimidazole using standard peptide 
coupling reagents according to methods applied for the synthesis  of building blocks  of 
peptide nucleic acids (for details see experiment part).[127] Cobyric acid was then 
coupled with the loop parts with EDC•HCl and DMAP in DMF (Scheme 6). The isolated 
yields differed between 42 % and 80 %. The UV/vis and NMR spectra suggested 
intramolecular coordination by comparison to base-on B12 as discussed in reference[127] 
in more detail (Appendix I).
Scheme 6: Synthesis scheme of compound 2 - 5.[127]
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Spectrophotometric pH titrations of compounds 2 - 5 revealed that their pKa value 
varied between 0.62 and 1.64 (Figure 21). The methyl group of 4 at position C176 
enhances its base on stability (pKbase-off = 0.62) compared to 3 (pKbase-off = 0.97), which 
is  similar to the stabilizing effect observed for this functionality in B12. Kräutler et al. 
used conformational analysis of the i-bond in both B12 and norvitamin B12 to explain 
the stabilizing effect of the methyl group at C176 of (R)-configuration.[79]  The 
experimental results confirmed earlier prediction of Eschenmoser and Kreppelt.[81][124] 
We suggest the same form of analysis to explain the methyl group effect at C176 in 
peptide B12 derivatives 4 and 5 compared to 3 (Scheme 7). In compound 3, the (-) 
synclinal conformation at the i-bond is  the same as in B12 (1). It is energetically 
disfavored compared to its anti-periplanar conformation because of a gauche interaction 
(Scheme 7). This behavior is disadvantageous for simulating the conformation of B12 
with peptide B12 derivatives.  In order to overcome this limitation, we introduced 
compound 4 with an additional methyl group in R-configuration at C176.  In compound 
4, the (-) synclinal conformation is not anymore energetically disfavored compared to 
the anti-periplanar conformation, because of the same number of gauche interactions. It 
mimics therefore better the structure of B12 than compound 3 (Scheme 2). In contrast, 
the introduction of the methyl group in the opposite S-configuration (5, pKbase-off = 1.64) 
causes an additional gauche interaction in the (-) synclinal conformation and disfavors 
thereby the modeling of the conformation of B12 (Scheme 7). These considerations are 
experimentally supported by the base-on stabilities of the compounds (4 > 3 > 5) 
according to the spectrophotometric pH titrations (Figure 21).
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Scheme 7: The gauche effect of the methyl group in different conformations of 
compound 1, 3 - 5. (Up) The peptide B12 derivatives (3, 4 and 5) are in the same 
conformation (- synclinal) as B12 (1) at i-bond. (Down) The more or equally stable 
conformation at the i-bond of peptide B12 derivatives.
Cyclic voltammetry (CV) experiments of these derivatives showed that the reduction 
potential of the cobalt ion was influenced by the loop structure. (Figure 21)
Figure 21: The CV spectra of compound 1 to 5 (1: B12; 2 - 5: see Scheme 6). Inset: 
correlation of pKbase-off values versus reduction potentials.[127]
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The stability of the “base on” constitution (pKbase-off) and the reduction potential of the 
cobalt(III)/Co(II) couple are linearly correlated (Figure 21: inset), that can be explained 
by the strength of intramolecular coordination of the Dmbz base to the metal center. The 
stronger intramolecular coordination the shorter the Co-N bond (Figure 22, right), which 
results in a higher electron density at the cobalt ion and therefore leads to a lower 
reduction potential of Co(III) (Figure 22, left).
Figure 22: (Left) The Co(III)/Co(II) equilibrium of Cbl derivatives; (right) The 
coordination from Dmbz to the cobalt ion.
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2.1.3 Other B12 derivatives
Length'
Composi.on'
Chirality'
Charge'
Rigidity'
Figure 23: Eleven loop structures of peptide B12 derivatives  differing in length, 
configuration, rigidity, charge and chirality.
Other factors  that might influence the “base on” stability have been investigated as well. 
We focused on the impact of length, chirality, configuration, rigidity and charge on the 
base on/base off equilibrium (Figure 23).
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Figure 24: Structures of compounds 2, 12 and 13. Charges on the corrin rings have 
been omitted.
Proper length is  critical to the strength of intramolecular coordination based on the 
following consideration. Construction of part of the intramolecular ring is  basically to 
connect two fixed point A and point B in the ideal structure of B12 (Figure 25: case 1). 
Modifications of the loop are expected to result in a change of its folding, which will 
change the head-to-tail distance (Figure 25: case 2 or 3). The modified loops need to be 
stretched (case 2) or compressed (case 3) to fit the distance between the two points  A 
and B. In either of the above mentioned cases, the stability of the intramolecular 
coordination could be undermined because of compromising the ideal conformation. 
Figure 25: (left) Point A and B are positions in the ideal structure of B12. (right) The 
head-to-tail distance of the different loops can be longer (case 3) or shorter (case 2) 
than the distance of AB. Case 4 represents the mirror image of case 1 and has the 
same head-to-tail distance. Charges on the corrin rings have been omitted.
pKbase&oﬀ&=&2.58&& pKbase&oﬀ&=&1.38& pKbase&oﬀ&=&2.13&
2 12 13 
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We assumed that a short loop would cause tension in the intramolecular ring, which in 
turn would compromise the base on stability. Compound 12 with a shorter loop (Figure 
24, 12) than the prototype (2, Figure 24, middle) was synthesized to demonstrate this 
point. The spectrophotometric pH titration experiments showed that the pKbase off value 
of 12 is 2.58, which suggested that the base on stability of 12 is 16 times weaker than 
that of 2 (Figure 24). A long loop can avoid such tension, but lack of structure and 
preorganisation is a huge disadvantage as shown with 13 having an extra methylene 
group (Figure 24) compared to 2. The pKbase off value of 13 is  2.13, and its base on 
stability is 6 times weaker than that of 2.
Chiral configuration is another critical factor that determines the strength of 
intramolecular coordination. Apart from the simulation of the original conformation, 
mirror-simulation could be another possibility (Figure 25: case 1 and 4) for 
conformational simulation, since the mirror image does not change the head-to-tail 
distance. In an ideal situation, when the conformation of the AB loop part is not 
influenced by the surrounding environment, the mirror-simulated loop will have the 
same stability as the original one.
Figure 26: Peptide B12 derivatives  with different chiral configurations. Charges on the 
corrin rings have been omitted.
To prove this assumption, four peptide B12 derivatives with different configurations at 
C176 as well as the proline subunit were synthesized and their base on stabilities were 
compared (Figure 26, 4, 14, 5, 15). We obtained thereby two pairs of mirror-imaged AB 
pKbase&oﬀ&=&0.62&& pKbase&oﬀ&=&2.18&pKbase&oﬀ&=&1.45&
4 14 15 
pKbase&oﬀ&=&1.64&
5 
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loops (4 and 14, 5 and 15). The connecting points A and B with either a peptide bond or 
Dmbz moiety have planar conformation, and the mirror image should therefore not 
undermine the ideal conformations, so 4 and 14 (or 5 and 15) are expected to have the 
same pKbase off value. which was not supported by the spectrophotometric pH titration 
experiments (Figure 26, 0.62 v.s. 1.45, 1.62 v.s. 2.18). This behavior suggests that the 
the base on stabilities  of these compound are influenced by the environment such as 
the corrin ring part or the solvents.
As mentioned before, the mirror-image proposal is based on the assumption that the 
loops are in an isolated environment and they can adopt the ideal conformation without 
interference.  However, as part of the whole molecules, the original loop and mirror-
imaged loop were in different chemical environments  and therefore this  might result in 
different base on stabilities. This proposal was supported by the comparison of 1H NMR 
spectra of 4 and 14, which can be easily differentiated in the region between AB.
We also investigated the effect of the solvent on the conformation of the loops. From the 
1H NMR spectrum of 4, we observed two sets of signals for the base on species in both 
D2O and MeOD (in D2O: ≈ 9:1 and in MeOD: ≈ 1:1, according to the integrals of H10 
signals). These NMR experiments suggest that the aqueous environment stabilizes one 
conformation of 4, probably because this conformation can form some hydrogen bonds 
inside the molecule. For these speculations, further experimental and computational 
studies are necessary.
Figure 27: The structure of compound 16. Charges on the corrin rings have been 
omitted.
16 
Results and Discussion
34
Another example of a more rigid loop structure showed that the conformational mimic 
demands high precision. With a base exchange from Dmbz to pyridine that is directly 
connected to proline via an amide bond (Figure 27, 16), intramolecular coordination was 
not anymore possible.
Figure 28: The structure of compounds 17 and 18. Charges on the corrin rings have 
been omitted.
The influence of the charge of the loop on intramolecular coordination was also 
investigated with peptide B12 having methyl ester and carboxylate acid groups at 
position C176 (Figure 28, 17 and 18, pKbase off values  are 0.77 and 0.78 respectively). As 
expected, the charge did not effect the base on stability because it is  too far away from 
the coordination site. A charge effect might be expected if protonation (or deprotonation) 
is  directly exerted to the loop skeleton and induces  a change of conformation with a 
reduced or an increased energetic state. For example, a hypothetical -CO-CH2-CO- 
moiety within the backbone could response to an increased pH by a conformational 
change from non-planar to planar due to deprotonation of the enol form (Scheme 8).
Scheme 8: Conformational change between the tautomers.
17 18 
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2.2 Diastereomeric aquacyano cobinamide
Cobinamides (Cbi) are “incomplete” corrinoids  and their axial ligands strongly influence 
the electronic properties  of the corrin ring. Different combinations of axial ligands result 
in distinctive UV/vis absorbance.[112] The formation of dicyano-Cbl from diastereomeric 
mixtures of aquacyano cobinamides  has been successfully applied for cyanide sensing.
[90]
There are different protocols for the preparation of Cbi from B12. Most widely used for 
this  purpose are Ce(III) salts.[110,128] The disadvantage of this  methodology is  the need 
to generate dicyano-B12 from B12 with additional cyanide prior to the phosphodiester 
cleavage with the metal salt and the complicated workup procedures. Brown and co-
workers developed a useful method for the phosphodiester hydrolysis of 
alkylcobalamins under strictly anhydrous conditions.[129] Improvements of existing 
synthetic protocols as well as  the development of novel modified B12-derivatives  are 
important for further progress and new applications of corrinoids.
Apart from improvements of existing synthetic methods, the characterization of the 
aquacyano Cbi isomers is also critical for analytical purposes. Friedrich et al. devoted 
much effort to characterize axial diastereomers of aquacyano Cbi.[101,111,130] Brown et al. 
used chemically 13C enriched axial ligands and the corresponding Cbl analogs to assign 
the α- and β-cyanide positions in the mixture of diastereomeric aquacyano Cbi with 
NMR spectroscopy. Overlap of the 13C NMR signals impedes unfortunately the 
identification of the isolated isomers. For applications such as cyanide detection, only 
diastereomeric mixtures of “incomplete” aquacyano corrinoids  have been employed, 
and initial kinetic studies suggested differences in cyanide coordination. The 
identification and evaluation of well-defined isomers are important in regard of future 
improvements of corrin-based chemosensors. 
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2.2.1 Synthesis and characterization of aquacyano cobinamide
Based on an earlier report of Müller and Müller[126], we explored and developed a metal-
ion catalyzed transesterification reaction for the synthesis of diastereomeric aquacyano 
Cbi from B12.
Scheme 9: The synthesis scheme of aquacyano cobinamide. Charges have been 
omitted.
After screening of different combinations of metal ions (Co2+, Ni2+, Cu2+, Mg2+ or Zn2+) 
and anions (Cl-, NO3-, SO42-), we identified Cu(NO3)2·3H2O as the most efficient catalyst 
for this reaction (Scheme 9). Thorough optimizations led to the following general 
procedure: B12 (1, 20 mg, 15 µmol) and Cu(NO3)2·3H2O (50 mg, 163 µmol) were 
dissolved in methanol (2 ml) and stirred for 20 min at 100 °C in a Young Tube (1 cm × 
15 cm) sealed with a Teflon cap. After cooling the solution to room temperature, the 
methanol was  removed under reduced pressure. The residue was dissolved in water (5 
ml) and desalted with the help of SPE. Subsequently, it was separated by preparative 
reverse phase HPLC to yield α-cyano-β-aqua-cobinamide (19α; 6.9 mg, 6.0 µmol, 40%) 
and α-aqua-β-cyano-cobinamide (19β; 3.9 mg, 3.4 µmol, 23%) as their corresponding 
TFA salts.[131]
The advantage of this method is shown in Figure 29 and includes (i) straightforward 
procedure, (ii) cyanide free condition and (iii) a convenient workup procedure. More 
1"
19β" 19α"
20a" 20b"
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details are shown in the paper attached in the end (Appendix III). [131]
Figure 29: The comparison of three protocols for the synthesis of aquacyano 
cobinamide.[131]
After the separation by preparative Reversed-phase HPLC, we shifted our interest to 
the identification of these two isomers. The two isomers have the same molecular mass 
and very similar absorption spectra, but distinctive NMR signals. The latter makes it 
possible to assign the configuration at the cobalt center of 19α and 19β by comparing 
their NMR spectra to a reference compound with known structure. The concept is 
shown in Scheme 10.
Ce(OH)3!
CF3SO3H!
Cu(NO3)23H2O!
Gel preparation, excess cyanide,  phenol 
extraction, HCN solution, ion exchange 
chromatography, column chromatography!
Strictly anhydrous condition, extra dehydration 
procedure, glovebox or nitrogen glovebag, 
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Time, h!
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Scheme 10: (Top) Synthesis  of 19α and 19β from 19αβ. (Bottom) Synthesis of 21α and 
21on from 21αβ.[132] Charges on the corrin rings have been omitted.
The reference compound α-cyano-β-aqua peptide B12 (21α) was synthesized as a 
mixture with 21on from dicyano peptide B12 (21αβ) (Scheme 10, bottom). However, due 
to their difference in stability, the mixture of 21on and 21α will slowly change to pure 21on 
(Scheme 10, bottom). This transformation can be monitored with both UV/vis and NMR 
spectra. Subtracting the NMR spectra of 21on from the mixture of 21on and 21α leads to 
the spectrum of 21α, which is the reference spectrum. We assumed that the NMR 
spectrum of the corrrin was only affected by the axial ligands. Therefore, the NMR 
spectrum of 21α was expected to be the same as  19α in the corrin ring region, and thus 
19α could be identified. More detailed discussions  are described in the paper attached in 
the end of the thesis (Appendix II).[132]
19αβ% 19α% 19β%
21αβ% 21α% 21on%
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Figure 30: 1H-NMR comparison of 21α and 19α. The arrows show the assignment of the 
peaks to the according compounds.[132] Charges on the corrin rings have been omitted.
21on% 21α%
!
19α%19β%
(2on%+%2α)%
!
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2.2.2 Some unexpected byproducts
Depending on the applied metal salts, different byproducts were detected by MS and/or 
NMR spectroscopy.
When ZnCl2 was used as catalyst, byproducts  with a 15 units higher m/z ratio than the 
expected aquacyano Cbi were observed (Figure 31, 23, less than 5 % according to 
LCMS; only one out of six possible esters  is shown). Further hydrolysis of this 
byproducts led to a 14 unit lower m/z value. The changes of the molecular masses fit 
with the chemical groups alternation from amide (-CONH2, 44) to ester (COOCH3, 59) 
and finally to acid (-COOH, 45). It is well-known that amides  react with alcohols to 
esters at high temperatures.[133]
Figure 31: Three possible byproducts during the synthesis of Cbi.
C10-Cl Cbi (Figure 31, 22) was observed when CuCl2 was used as  catalyst (C10-Cl 
Cbi : Cbi ≈ 1 : 1, according to integrals of the molecule ion peak of the LCMS spectra). 
The formation of C10-Cl Cbi  was deduced from mass and NMR spectra. An m/z ratio of 
1049.5 fitted the pattern of substituting a hydrogen with chlorine, and 1H NMR spectra 
further confirmed the missing H10 signal. Since C10-Cl Cbi was not observed with 
Cu(NO3)2·3H2O or ZnCl2, we speculated that the chlorination is a combined effort of 
Cu2+ and Cl-. UV/vis spectrum of the reaction mixture showed an absorption peak at 
314 nm, which is characteristic peak for Co(II) species. Exposure of this solution to air 
led to the disappearance of this peak and showed a typical Co(III) species with an 
absorption peak at 350 nm. Although a redox mechanism is assumed, the mechanism 
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of reduction of cobalt is not clear yet (Scheme 11).
Scheme 11: Reduction of cobalt(III) to Co(II) during the formation of C10-Cl Cbi.
Lactone Cbi (Figure 31, 24) is a minor byproduct , when Cu(NO3)2·3H2O was applied 
(less than 5 %, according to the intensity ratio of Lactone Cbi and Cbi). This compound 
was proposed from a series of MS experiments. An m/z ratio of 1014.5 was first 
observed during the reaction, and after hydrolization the m/z ratio changed to 1032.6. 
This  mass change is  consistent with the cyclization and ring opening process. The 
common method for lactone formation of Cbl is the use of Chloramine T or bromine as 
oxidants to activate the cyclization and form the five-membered ring.[134] In the case of 
Cu(NO3)2 the possible resource for the oxidant is the nitro group, but the detailed 
mechanism still needs to be further investigated.
?"
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2.3 Self-assembly of a B12 derivative with a flexible loop
Modified heme derivatives are capable to dimerize thought side chain-metal interaction.
[117] Although hemes and corrinoids  bear similar structures, the intermolecular 
coordination mode has not been reported for “complete” corrinoids yet. We believe that 
with careful design dimerization of corrinoids  can be achieved, if the convenient 
intramolecular coordination is inhibited.
2.3.1 Synthesis and design of a loop-modified B12
Scheme 12: Synthesis  of compound 26-26.[135] Charges on the corrin rings  have been 
omitted.
26-H was synthesized from dicyanocobyric acid with a yield of 38 % and then dimerized 
       7 25 
26-H 26-26 
27 
28 
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to 26-26 (Scheme 12). The coordination environment at the cobalt center was proven 
with UV/vis spectroscopy (base on constitution) and ROESY NMR spectroscopy (β-
coordinated imidazole ligand).[135] The structure of 26-26 was deduced from a dilution 
experiment. We observed that the “base off” monomer was increasing at lower 
concentrated solution, which is a unique property of a dimer (multipliers  are also 
possible, but they can be excluded. See part 3.2).
We investigated the configuration at the metal center as well as the artificial loop 
structure as a structural prerequisite for self-assembly in more detail. The former was 
tested with the α-aqua-β-cyano compound (29-H) which was synthesized with the same 
method as 26-H, but they only coordinated intramolecularly (Scheme 13, 29-M). The 
importance of the loop structure was proved by comparison with β-aqua-α-cyano B12 
(B12-CNα), which does not dimerise up to 1 mM (Scheme 13, down). 
The details  of this  subject can be found in reference[136] attached at the end (Appendix 
IV).
Scheme 13: (Up) “Base on/base off” equilibrium of compound 29-M. (Down) B12-CNα 
does not dimerize in an ‘‘intra base off/ inter base on’’ fashion. Charges on the corrin 
rings have been omitted.
B12-CNα B12-B12 
29-M 29-H 
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2.3.2 Thermodynamic investigations
Figure 32: Structures of compound 26-26 (left) and 29-M (right). Charges on the corrin 
rings have been omitted. The red dots indicate the cyanide ligands.
We did a thorough thermodynamic study of the “intra-base on” (Figure 32, right) and 
“inter-base on” (Figure 32, left) compounds with pH titration, cyanide titration, dilution 
experiments and theoretical calculations. The full equilibrium circle is shown in Scheme 
14. 
The grey dashed line (Scheme 14) shows the routine of calculation of the equilibria 
constants. K1, K2, K4 and K6 can be calculated from the experiments directly. K7 can be 
derived from K1 and K2. It’s  reasonable to assume that K7 equals K10, and with the 
experimental result of K6, we can calculate the value of K5. Combining K5 and K4, K9 can 
be easily deduced, which equals K8. Finally K3 is  calculated through K2 and K8,  and 
with K4, K17 can be calculated. The results are summarized in Table 2.
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Scheme 14: Full equilibrium of compound 26 and 29. 26-M and 29-29 are hypothetical 
structures. The red crosses indicate the changes. The red dots indicate the cyanide 
ligands. Charges on the corrin rings have been omitted.
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Table 2: Equilibrium constants:
Constant Terms Equilibrium constant
K1 [26-H]2/[26-26][H]2 7.95×107 M-1 [a]
K2 [26]2/[26-26] 1.29×10-6 M [a]
K3 [26-CN]2[H]2/[HCN]2[26-26] 2.67×10-6 M [b]
K4 [26-CN][H]/[29-M][HCN] 5.40×10-4 [a]
K5 [29]/[29-M] 3.65×10-4 [b]
K6 [29-M][H]/[29-H] 3.48×10-4 M [a]
K7 [26][H]/[26-H] 1.27×10-7 M [b]
K8 [26-CN][H]/[26][HCN] 1.44[b]
K9 [26-CN][H]/[29][HCN] 1.44[b] (1.83[c], 0.38[d])
K10 [29][H]/[29-H] 1.27×10-7 M [b]
K12 [26]/[26-M] /
K14 [26-CN]2[H]2/[HCN]2[29-29] /
K17 [29-M]2/[26-26] 9.15 M [b]
a: experimental determined, b: calculated via the therodynamic cycle, c: reference [60], 
d: reference [136]
Calculation of the equilibrium constants K1 and K6
Figure 33: pH titration of monomer (29-M, blue) and dimer (26-26, red) in KCl solution 
(0.2 M) at 25o C.
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Spectrophotometric pH titration method was applied to determine the pKbase off value of 
29-M and 26-26 (Figure 33). By Boltzmann fitting of the titration curve, the pKbase off 
values of compound 29-M and 26-26 are 3.46 and 5.83, translating into binding 
constants K6 and K1 of 3.48×10-4 M-1 and 7.95×107 M-1 respectively.
Calculation of the equilibrium constants K2
For the determination of the dissociation constant K2 (K2 = [26]2/[26-26]), a series  of 
solution with different total cobalt concentrations ([Co]total) was prepared starting from 
26-H (in a Britton-Robinson buffer at pH 8): 174 µM, 49.3 µM, 35.1 µM, 17.4 µM, 9.79 
µM and 4.44 µM. The total “cobalt concentration” ([Co]total) of a compound was 
determined from the absorbance of the γ-band at 367-368 nm (εγ (367-368 nm) = 3.04 x 
104 M-1 cm-1)[112] after conversion of the corresponding corrinoid to the dicyano-
compound 26-CN.
Figure 34: Normalized UV-vis spectra (to the intersection at 508 nm) of 26-26 ([Co]total: 
174 µM, (red)) and mixtures of 26-26 and 26 ([Co]total: 49.3 µM (blue), 35.1 µM (brown), 
17.4 µM (green), 9.79 µM (violet), 4.44 µM (yellow)). Black dashed line indicates the 
spectrum of 26-H as a reference for the “base off” constitution.
It was analyzed as follows and the results are summarized in Table 3:
Base%on%
Base%oﬀ%
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2 26− 26 + 26 = [Co] 26 = A!"!!"(!!")!– !A!(!!")!!!A!"!!"(!!") !− !A!"(!!")×[Co] 26− 26 = A!(!!")!– !A!"(!!")!!!A!"!!"(!!") !− !A!"(!!")× Co /2 !! = [!"]![!"!!"] = (!!"!!" !!" !–! ! !!" )! !!!(!!(!!") ! ! ! !!" )(!!"!!"(!!") ! ! !" !!" )×2 Co   
Table 3: Calculation of the equilibrium constant K2 at different total cobalt 
concentrations:
[Co]total 17.4 µM 9.79 µM 4.44 µM Average
A26-26(551) 0.174 0.0979 0.0444
A26(551) 0.0677 0.0388 0.0175
Ax(551) 0.155 0.0836 0.0367
K2 / M 1.35×10-6 1.51×10-6 1.02×10-6 1.29×10-6
The K2 values were calculated from solutions with low total cobalt concentrations  (17.4 
µM, 9.79 µM and 4.44 µM), for which equilibria between 26-26 and 26 was explicitly 
observed. If the assumption of dimer is  right, the K2 values calculated from different 
concentrations should be same. As  shown in Table 3, the consistency of K2 values is 
very well. The average value of K2 is 1.29 (± 0.27) ×10-6 M.
A26-26(551) and A26(551) are the absorbance at 551 nm of pure 26-26 and 26 at the 
indicated total cobalt concentration and have been calculated with the corresponding 
extinction coefficients. The extinction coefficient of 26-26 is ε (551 nm) = 2.00×104 M-1 
cm-1 and has been derived from the spectrum of 26-26 (87 µM). 
It is reasonable to assume that the extinction coefficient of 26 is the same as  for 26-H at 
a wavelength above 250 nm. The imidazole base in either the protonated or 
deprotonated form has no UV/Vis  absorbance above 250 nm and does not affect the π 
to π* transitions of the corrin ring. The extinction coefficient of 26 is ε (551 nm) = 
3.96×103 M-1 cm-1.
Ax(551) represents the actual absorbance at 551 nm at the indicated concentration. 
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Calculation of the actual equilibrium constant K4 and the hypothetical 
constant K14
Cyanide titration experiments were performed to verify the existence of monomer 29-M 
in solution and to exclude the presence of the hypothetical dimer 29-29 with an 
extraordinary stable “intra base-off/ inter base-on” coordination mode (Figure 35).
Figure 35: Cyanide titration (cCN: 0 – 160 µM) of 29-M (33.4 µM) at pH 10 (Britton-
Robinson buffer).
Based on the experimental data, the binding constants K4 and K14 were calculated and 
the consistency was tested (Table 4). 
!! = ! [26− CN][H][29−M][HCN] = ! [26− CN]!HCN[29−M][CN] !
!!! = ! [26− CN]![H]![29− 29][HCN]! = ! [26− CN]!HCN2[29−M][CN]! !
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Table 4: Calculation of the equilibrium constants K4 and K14 at different cyanide 
concentrations:
 [CN]0 /µM [1-CN] /µM [CN] /µM [2-M] /µM K4 [29-29] /µM K14 /M
0 0 0 33.4 / 16.7 /
10 9.00 1.00 24.4 6.71×10-4 12.2 21.9×10-12
20 16.2 3.8 17.2 4.50×10-4 8.6 6.96×10-12
30 22.6 7.4 10.8 5.13×10-4 5.4 5.73×10-12
40 26.8 13.2 6.6 5.59×10-4 3.3 4.14×10-12
60 30.65 29.35 3.75 5.08×10-4 1.88 1.92×10-12
160 33.4 126.6 0 / 0 /
A solution of compound 29-H (c = 33.4 µM; Britton-Robinson buffer, pH 10) was 
prepared in an UV/Vis  cuvette (1 mL, 1 cm) and cyanide (0 - 160 µM) was added 
stepwise (Figure 35). 
The total cyanide concentration ([CN]0 = [CN] + [26-CN], [CN] indicates the 
concentration of “free” cyanide) is  listed in Table 4. The actual concentration of 26-CN 
can be calculated as follows:
26− CN = A! !"# !– !A!!!! !"# !!!A!"!!" !"# !– !A!!!! !"# ×33.4!!M 
If we assume monomeric 29-M ([29-M]0 = 33.4 µM), the actual concentrations of [29-M] 
([29-M] = [29-M]0 - [26-CN]) and [CN] in solution can be easily derived (Table 4). The 
consistency of the five calculated K4 values from different concentrations  (Table 4; blue) 
is very good and the average value is 5.40 (± 1.31) ×10-4.
While assuming the hypothetical dimer 29-29 ([29-29]0 = 16.7 µM), the calculated 
equilibrium constants (K14) are not anymore in agreement (Table 4; red; The values  of 
K14 vary from 1.92×10-12  to 21.9×10-12, and the difference is over 11 times), which 
excludes this structural motif. 
Calculation of equilibrium constants K10, K5 and K9
It is reasonable to assume that the acidity constants of the protonated imidazole 
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moieties of 26-H and 29-H are not affected by the appended corrin ring.[136] Therefore, 
K10 is  the same as K7 (Scheme 14; K7/10 = 1.27×10-7). Under consideration of the 
thermodynamic cycle depicted in Scheme 14, the binding constants K6 and K10, the 
dissociation constant K5 for the conversion of 29-M to 29 with a non-protonated 
imidazole moiety can be calculated (Scheme 14; Table 2: K5 = K10/K6 = 3.65×10-4).
With binding constants K4 and K5, the binding constant K9 for the coordination between 
cyanide and base-off 29 can be calculated to be 1.44 (Table 1: K9 = K4/K5).
Calculation of the equilibrium constants K17, K3 and K8 
The equilibrium between dimer 26-26 and monomer 29-M with the opposite constitution 
of the axially bound ligands (K17 = [29-M]2/[26-26]) was calculated from the 
thermodynamic cycles depicted in Scheme 15 and the following considerations:
Scheme 15: (Left) Equilibria between 26, 29, 26-26, 29-M and 26-CN and  comparison 
of the equilibrium between 26 and 29 (K18) with that of (right) 19α and 19β (K’18). 
Experimentally determined and calculated constants are shown in red and blue, 
respectively. Charges on the corrin rings have been omitted.
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The value of K3 (Table 2, Scheme 15), which describes the formation of 26-CN from 
26-26 and cyanide can not be determined directly by cyanide titration, because of fast 
conversion of 26-26 to 29-M (K17) in the presence of catalytic amounts of cyanide.
Therefore, we applied a calculation via the thermodynamic cycles depicted in Scheme 
15. 
We assumed that the equilibrium between 26 and 29 (K18= [26]/[29]) is the same as for 
19α and 19β (K’18=[19α]/[19β] = 1[111,112]), because the dissociated imidazole base is 
expected not to influence cyanide coordination at the cobalt center. According to the 
violet colored thermodynamic cycle in Scheme 15 and the binding constant K9 = 1.44 
(Table 1), the binding constant K8 is  also 1.44 (K8 = K9/K18). With K8 and K2 (Table 1; K2 
= 1.29×10-6 M), we can calculate K3 (K3 = K2K82 = 2.67×10-7 M) following the green 
coloured thermodynamic cycle (Scheme 15). Finally, we can calculate K17 following 
either the red or blue coloured thermodynamic cycle. Both values of 9.15 and 10.6 M fit 
very well with each other (red: K17 = K3/K42 = 9.15 M; blue K17 = K2/K182K52 = 10.6 M) 
and demonstrated that dimer 26-26 is  a kinetically trapped species. By monitoring the 
NMR spectra, we observed that the dimer could be stable for hours.
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2.4 Biological studies of peptide B12 and B12 coenzyme derivatives
In part of project, we cooperated with Prof. Wolfgang Buckel from Marburg University 
and PD.Helmut Brandl from University of Zurich. Peptide B12 derivatives have potential 
applications as anti-vitamins in medicine. For this  purpose, we wanted to prove that the 
artificial B12 derivatives are still biologically active but less active than B12.
Figure 36: Crystal structures of AdoB12 in glutamate mutase[21] (left) and ribonucleotide 
reductase[137] (right).
We try to understand three key features through bioactivity tests with the peptide B12 
derivatives, that are (i) transportation and cellular uptake of B12 derivatives, (ii) the 
affinity to the apo-enzymes and (iii) the activity of the enzyme. Enzymatic reactions that 
require the cofactor either in the “base on” or “base off/his on” constitutions were 
conducted with ribonucleotide reductase[138] in Lactobacillus delbrueckii[139] (L. 
delbrueckii) and glutamate mutase[21,140] respectively (Figure 36).
L. delbrueckii (ATCC 7830) has ribonucleotide reductase as the only B12 dependent 
enzyme. With bacterial growth studies, we evaluated the combinational effect of the 
cellular uptake, transportation and enzyme activity.
Glutamate mutase is a B12-dependent enzyme which uses adenosylcobalamin to 
catalyze a reversible carbon skeleton rearrangement reaction between (S)-glutamate 
and (2S,3S)-3-methylaspartate. This is the first step of the fermentation of glutamate. 
The enzymatic activities of different cofactors such as backbone or β-ligand modified 
Cbls have been evaluated by this enzymatic reaction.
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2.4.1 L. delbrueckii (performed by as well as together with PD. Helmut 
Brandl)
The experimental procedure is shown in Figure 37. It starts with a L. delbrueckii source, 
which is cultivated in a B12 broth.[139] After 24 hours’ of growth, 1 mL of this  pre-culture 
(broth solution that contains active L. delbrueckii) is  centrifuged and washed three times 
with sterilized NaCl solution (0.9 %) to totally remove the broth. Finally, the L. 
delbrueckii is  suspended in 1 mL NaCl solution and injected to the each experimental 
tube as required (Figure 37).
Figure 37: Representative procedures for the L. delbrueckii experiments.
The absorbance of each tube will be measured every 6 h and compared to a positive 
(B12) and a negative (Cbl free) control to evaluate the relative activity.
B12$
pB12$$1$
pB12$$2$
pB12$$3$
Lactobacillus$
B12$free$medium+
Po
si1
ve
$
co
nt
ro
l$
Ex
pe
rim
en
ta
l$z
on
e$
N
ega1ve$control$
Lactobacillus$
Lactobacillus:+A$B12>dependent$bacteria$(Lactobacillus+++medium+++B12)$
Br
ot
h$
(B
12
)$
1$day$
La
ct
ob
ac
ill
us
$
centrifuge$
3$2$ 4$1$ 5$ 6$
A$
D$
C$
B$
Results and Discussion
55
Figure 38: The structures of eleven tested peptide B12 derivatives. Charges on the 
corrin rings have been omitted.
We tested 11 peptide B12 derivatives (Figure 38), cobyric acid (7) and B12 (1) in these 
experiments and the results are summarized in Figure 39.
As shown in Figure 39, compound 2 - 5, 12 - 14 and 17 were the most active ones from 
the preliminary studies. However, there is no clear connection between the base on 
stabilities and their bioactivities. Similar results have been observed by Toraya with 
methylene B12 derivatives tested with diol dehydratase[58]. This is expected since 
multiple steps of uptake, transportation and metabolism are assumed to respond to the 
modification differently and the consequences are difficult to estimate. The important 
4 14 15 5 
2 12 13 
17 18 3 16 
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information from this experiment is  the positive results suggesting that the peptide B12 
derivatives can still be recognized by multiple proteins and can catalyze the 
corresponding enzymatic reactions.
Figure 39: The absorbance value after 48 hours  growth of L. delbrueckii with compound 
1 - 5, 7, 12 - 18. The last column is the negative control without any B12 derivatives and 
1 is the positive control with B12. The absorbance is shown with the negative control as 
the base line (abs = 0).
These results need to be further confirmed and additional competition experiments are 
planned.
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2.4.2 Glutamate mutase
α-modified adenosyl peptide B12
We synthesized adenosyl peptide B12 to investigate the impact of the loop structure in 
the enzymatic reaction of glutamate mutase. The synthetic strategy is shown in Scheme 
16. Peptide B12 (2) was reduced by Zn in a 10 % aqueous NH4Cl solution and then 
reacted with 5’-Cl-5’-deoxy-adenosine (32) to give Ado-pB12 (30) with a yield of 55 %.
[76]
Scheme 16: Synthesis scheme of Adenosyl peptide B12 (30, left); AdoB12 (31, right).
Figure 40: (left) Temperature dependent UV/vis spectra of 30 in KCl solution (0.2 M, pH 
6.7); (right) pH titration of 30 in KCl solution (0.2 M) at 20 oC, inset: the absorbance at 
517 nm v.s. the corresponding pH values.
2 30 31 
32 
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The pH titration (Figure 40, right) shows that the pKbase off value of 30 is 4.5, which is 0.8 
unit higher than that of natural AdoCbl (31). By comparison of the pH titration spectra 
and the temperature dependent switch experiment of 30 (Figure 40, left), we can 
deduce the “base on/base off” proportion to be 1 at 70° C. By using the following 
equations 1 - 4, we got the values of  ΔH0 (- 31 kJ/mol) and  ΔS0 (- 86 J/molK). The ΔG 
value at 25 °C is -5.4 kJ/mol, which is  slightly lower than the corresponding value of 
AdoCbl (-2.57 kJ/mol).[54]
Eq.1  Kbase off = (1 + Kon) Kbz
Eq.2  ΔG = - RTlnKon
Eq.3  ΔH0 = ΔG20 + T20ΔS0
Eq.4  ΔH0 = ΔG70 + T70ΔS0
Enzymatic activity tests were conducted by Fredrick Edwin Lyatuu in cooperation with 
Prof. Wolfgang Buckel from Marburg University. The replacement of the loop caused a 
decrease of the enzymatic activity in proteins  with different ratios of the GlmS and GlmE 
subunits  to less than 10 % of the activity (kcat) of the natural coenzyme (Table 5). The 
similar Km values  suggest that the coenzyme B12 (31) and peptidocoenzyme B12 (30) 
have close affinity to the glutamate mutase, but the lower catalytic efficiency (kcat/Km) 
might be caused by the detailed binding position change due to the interaction of the 
dissociated, artificial loop that affects the environment and this catalysis at the opposite 
site of the macrocycle.
Table 5: Comparison of the enzymatic activities between coenzyme B12 and peptide 
coenzyme B12 at different ratios of GlmS:GlmE:
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Both biological studies showed that the peptide B12 derivatives (2 and 30) are still 
bioactive, either bound in “base on” or “base off/his  on” constitutions. The results 
suggest a broad application of peptide B12, and the tests  with other proteins are 
undergoing.
β-modified Cbls
This  part of the project was also accomplished in cooperation with Prof. Buckel. The aim 
is  to investigate the interaction of the upper ligand with the protein. We synthesized two 
compounds (Figure 41, 33 and 34) as described in the experimental section.
Figure 41: Structure of alkyl Cbl derivatives 33 and 34.
Compound 33 and 34 kept the same number of atoms between the base and the cobalt 
center. These two compounds were tested with glutamate mutase, but were inactive. 
This  behavior is reasonable because the radical upper ligand is the catalytically active 
species in the enzymatic reaction and small modification can result in the deactivation of 
the enzyme.[76]
33 34 
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3. Conclusion and outlook
3.1 Peptide B12
We introduced a new class of vitamin B12 mimics with a peptide linker tethering the 
corrin macrocycle with the Dmbz base. Various modifications of the linker such as 
length, charge, stereochemistry and nature of the base have been discussed and 
analyzed in this  thesis, providing a guideline for further structural modifications. 
Electrochemical and spectrophotometric studies with four different peptide B12 
derivatives demonstrated that the appropriate design of the peptide backbone allows 
readjusting the coordination as well as  the accompanying redox properties  at the Co 
centre. 
Initial results of peptide B12 analogs for biological applications with L. delbrueckii and 
glutamate mutase performed in cooperation with PD Helmut Brandl from University of 
Zurich and Fredrick Lyatuu and Prof. Wolfgang Buckel from the University of Marburg 
have demonstrated the deactivation effect of these backbone modified B12 derivatives 
in both “base on” and “base off/his on” enzymes. The interaction of this class of 
compound with the human transporting proteins transcobalamin II, intrinsic factor and 
haptocorrin are momentarily under investigation at the Paul Scherrer Institute.
Structural modification can be easily implemented into peptide B12 and a further 
increase of the base on stability accompanied by a lowering of the reduction potential 
are therefore expected in the near future. Peptide B12 with extraordinarily low reduction 
potentials of the Co(III)/Co(II) couple are very promising to suppress the enzymatic 
activities of “base on” enzymes. Presumably, additional factors have to be considered. 
The introduction of additional stabilizing hydrogen bonds in the loop part, which assists 
intramolecular coordination, is proposed. Another strategy is to intra-cross link the loop 
part with covalent bonds. If preorganization to the base on form is correct, this  approach 
will greatly impede the reverse opening to the base-off form.
Apart from the improvement of the coordination properties, high binding constants to the 
related enzymes are critical, especially for biological studies. Further modifications of 
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the side chains of the loop part such as increasing the number of hydrogen bond donors 
for stabilizing interactions with the protein are proposed. This strategy might help to 
block the natural cofactor and suppress the corresponding enzymatic activities.
3.2 Diastereomers of aquacyano cobinamides and intercoordinated 
Cbls
We identified Cu(NO3)2·3H2O and ZnCl2 in MeOH as an useful one-step alternative for 
the preparation of aquacyano cobinamides from B12. Advantages of these reagents 
compared to the well-established Ce(OH)3 and CF3SO3H methods is  the shorter 
reaction time and the simplified work-up procedure. Further improvement of the 
synthesis method could be focused to lower the reaction temperature and perform the 
reaction in water instead of methanol.
We applied a new backbone-modified vitamin B12 derivative with an unusual 
configuration at the cobalt center for the identification of the two axial diastereomers of 
aquacyano cobinamides (Cbi) with 1H NMR spectroscopy. Kinetic studies of the 
coordination of cyanide to the isolated diastereomers of aquacyano cobinamides are 
momentarily under investigation by my colleague Christine Männel-Croisé.  
On the basis  of the above mentioned studies, we developed a self-complementary, 
artificial B12 derivative that dimerizes in an unprecedented “intra base off/inter base on” 
mode. It was demonstrated that this novel coordination motif depends on both, the 
configuration at the metal centre as well as the flexibility of the artificial, connecting 
linker. We envisage constructing dimers with even more sophisticated loop structures 
which could be applied as molecule receptors  or hosts to selectively bind certain guest 
molecules into the cavity of the macrocycle.
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4 Experimental procedures
All chemicals were of reagent grade and used without further purification.
Deuterated solvents were obtained from Armar Chemicals (Döttingen, Switzerland).
Chromafix C18ec for solid phase extraction (SPE) was obtained from Macherey Nagel. 
In general the compound was dissolved in little water, transferred to the adsorbent, 
washed with water and eluted with MeOH.
HPLC solvents  were 0.1 aqueous trifluoroacetic acid (A) and methanol (B). HPLC 
analyses were performed on a Merck-Hitachi L-7000 system equipped with a diode 
array UV-Vis spectrometer and Macherey Nagel Nucleosil C-18ec RP columns (5 µm 
particle size, 100 Å pore size, 250 x 3 mm. Flow rate: 0.5 ml min-1). Preparative HPLC 
separations were performed on a Varian Prostar system equipped with two Prostar 215 
pumps, a Prostar 320 UV/Vis  detector and Macherey Nagel Nucleosil C-18ec RP 
columns (7 µm particle size, 100 Å pore size, 250 x 40 mm. Flow rate: 40 ml min-1).
UV-Vis spectra were recorded on a Cary 50 spectrometer using quartz cells with a path 
length of 1 cm. The pKbase-off values were obtained from the analysis of a Boltzmann 
function: y = A2+ (A1 - A2) / (1 + exp((x - x0) / dx)) fitting.
NMR spectra were recorded on a Bruker AV-500 spectrometer (Karlsruhe, Germany) or 
a Varian OXFORD NMR 200. The chemical shifts  are given in ppm relative to the signal 
from the deuterated solvent. Coupling constants J are given in Hz. The data processing 
was carried out with ACD/SpecManager (Advanced Chemistry Development).
Mass spectra were recorded either in the positive or negative mode on an Esquire HCT 
from Bruker (Bremen, Germany).
CV spectra were recorded with a 757 VA computrace electrochemical analyzer (Ω, 
Metrohm). 
UPLC solvents were 0.1% aqueous formic acid (C) and acetonitrile (D). UPLC 
measurements were performed on an Acquity™ Ultra performance LC and ACQUITY 
UPLC® BEH C18 column (1.7µm 2.1×50mm; flow rate: 0.5 ml min-1). The UPLC 
gradient was: 7 % D for 0.1 min, then in 2.9 min to 17 % D, then in 1 min to 100 % D, 
and finally 100% D for 1 min.
High-resolution electrospray mass spectra were recorded on a Bruker maXis QTOF-MS 
instrument (Bruker Daltonics GmbH, Bremen, Germany). The samples were dissolved 
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in MeOH and analyzed via continuous flow injection at 3 µL/min. The mass 
spectrometer was operated in positive ion mode with a capillary voltage of 4 kV, an 
endplate offset of –500 V, nebulizer pressure of 5.8 psig, and a drying gas flow rate of 4 
L/min at 180°C. The instrument was calibrated with a sodium formate solution (500µl 
H2O : 500µl iPrOH : 20ul HCOOH : 20µl 0.1M NaOHaq). The resolution was optimized 
at 30’000 FWHM in the active focus mode. The accuracy was better than 2 ppm in a 
mass range between m/z 118 and 1600. All solvent used were purchased in best LC-
MS qualities.
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4.1 Experimental procedures
Figure 42: The structures  of B12 derivatives (The numbers  in the brackets indicate the 
related loop compounds or the β-ligands). Charges on the corrin rings have been 
omitted.
4(10) 14(51) 15(50) 5(11) 
2 (8) 12(37) 13(57) 
17(54) 18(54) 3(9) 16(60) 
30(32) 29-H 26-H 
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Compound 2. 7 (4.9 mg, 5.0 µmol) was dissolved in dry DMF (1 mL) and cooled to 0°C, 
after which 4-dimethylaminopyridine (DMAP, 1.0 mg, 8.0 µmol) and 8 (3.4 mg, 10 µmol) 
were added. After 10 min, N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC·HCl, 3.0 mg, 15 µmol) was added and the solution was allowed to 
warm up to room temperature. After 4 h, the solvent was removed under reduced 
pressure and the residue was washed with acetone. The mixture was further purified by 
preparative HPLC to afford 2 (2+·CF3COO-) (4.2 mg, 3.4 µmol, 62 %).
1H-NMR (see Table 6).
UV/Vis (c = 0.30 mM, 0.2 M KCl, pH = 5.98): 550 nm (3.95), 520 nm (3.89), 411 nm 
(3.55), 362 nm (4.45), 322 nm (3.91), 304 nm (3.99), 279 nm (4.24).
HR-MS: [M]+ calcd for C61H84CoN16O9: 1243.59337, found: 1243.59334.
HPLC-UV/Vis: Rt = 14.5 min
Compound 3. 7 (4.9 mg, 5.0 µmol) was dissolved in dry DMF (1 mL) and cooled to 0°C 
before NEt3 (10 µL, 70 µmol) and ethylchloroformate (5 µL, 55 µmol) were added. After 
1 min, N-Boc-ethylenediamine (16 mg, 0.10 mmol) was added and the reaction was 
quenched with water after 10 min. The crude product (41) was precipitated with 
acetone, filtrated, dissolved in HCl (1 mL, 1 M) and stirred for 1 h. The solution was 
lyophilized to yield 25. The intermediate 25 was dissolved without further purification in 
DMF (1 mL) and cooled to 0°C, after which DMAP (1.0 mg, 8 µmol) and 9 (4.5 mg, 15 
µmol) were added. After 10 min, EDC·HCl (3.0 mg, 15 µmol) was added. The solution 
was allowed to warm up to room temperature and the solvent was removed under 
reduced pressure after 4 h. The residue was washed with acetone and further purified 
with preparative HPLC to afford 3 (3+·CF3COO-) (3.2 mg, 2.3 µmol, 46 %).
1H-NMR (see Table 6).
UV-Vis (c = 0.28 mM, 0.2 M KCl, pH = 5.98): 549 nm (3.93), 520 nm (3.91), 411 nm 
(3.57), 361 nm (4.44), 323 nm (3.90), 279 nm (4.27).
HR-MS: [M]+ calcd for C64H88CoN16O9: 1283.62467, found: 1283.62422.
HPLC-UV-Vis: Rt = 16.7 min
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Compound 4. 10 (3.5 mg, 6.0 µmol) and DMAP (1.8 mg, 15 µmol) were dissolved in 
DMF (0.1 mL). The reaction was  stirred for 3 days  at room temperature before 7 (4.9 
mg, 5.0 µmol) dissolved in DMF (1.5 mL) was added. The reaction was cooled down to 
0°C before EDC·HCl (8.0 mg, 40 µmol) was added. The solution was allowed to warm 
up to room temperature. After 4 h, the solvent was removed under reduced pressure. 
The residue was further purified by preparative HPLC to afford 4 (4+CF3COO-) (3.0 mg, 
2.1 µmol, 42 %).
1H-NMR, 13C-NMR: (see Table 6)
UV/Vis (c = 0.32 mM, 0.2 M KCl, pH = 5.98): 551 nm (3.96), 520 nm (3.91), 411 nm 
(3.58), 362 nm (4.47), 323 nm (3.90), 279 nm (4.23).
HR-MS: [M]+ calcd for C65H90CoN16O9: 1297.64032, found: 1297.63949.
HPLC-UV-Vis: Rt = 17.8 min
Compound 5. The synthesis was performed with 11 (7.0 mg, 12 µmol) and 7 (4.9 mg, 
5.0 µmol) as described for 4 to yield 5 (5+CF3COO-) (5.6 mg, 4.0 µmol, 80 %).
1H-NMR: (see Table 6)
UV/Vis (c = 0.33 mM, 0.2 M KCl, pH = 5.98): 551 nm (3.94), 520 nm (3.89), 409 nm 
(3.73), 362 nm (4.44), 322 nm (3.96), 279 nm (4.24).
HR-MS: [M]+ calcd for C65H90CoN16O9: 1297.64032, found: 1297.63997.
HPLC-UV-Vis: Rt = 17.2 min
Synthesis of 12. Intermediate 25 was synthesised from dicyanocobyric acid (4.9 mg, 
5.0 µmol) as described in compound 3. It was dissolved in DMF (1 mL) and cooled to 
0°C, after which DMAP (1.0 mg, 8 µmol) and 7 (4.5 mg, 15 µmol) were added. After 10 
min, EDC·HCl (3.0 mg, 15 µmol) was added. The solution was allowed to warm up to 
room temperature. After 4 h the solvent was removed under reduced pressure. The 
residue was washed with acetone and further purified with preparative HPLC to afford 
12 (3.8 mg, 2.9 µmol, 58 %) as the corresponding TFA salt.
1H NMR (500 MHz, [D2]D2O): (see Table 8) HR-MS: [M]+calcd for C59H81CoN15O8: 
1186.57191, found: 1186.57087; UV/Vis (c = 30 µM, 0.2 M KCl, pH = 5.98): 548 nm 
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(3.96), 521 nm (3.94), 413 nm (3.72), 361 nm (4.43), 279 nm (4.27), HPLC-UV/Vis: Rt = 
14.2 min; pKbase-off = 2.58.
Compound 13. 7 (5 mg, 5 µmol) was dissolved in dry DMF (1 mL) and cooled to 0°C, 
after which 4-dimethylaminopyridine (DMAP, 1.0 mg, 8.0 µmol) and 57 (6 mg, 19 µmol) 
were added. After 10 min, N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC·HCl, 3.0 mg, 15 µmol) was added and the solution was allowed to 
warm up to room temperature. After 7 h, the solvent was removed under reduced 
pressure and the residue was washed with acetone. The mixture was further purified by 
preparative HPLC to afford 13 (13+·CF3COO-) (2.1 mg, 1.6 µmol, 32 %).
1H-NMR (see Table 7).
MS (ESI-MS): m/z (%): 1257.6 (100) [M]+.
HPLC-UV-Vis: Rt = 15.7 min
Compound 14. 51 (5.0 mg, 8.6 µmol) and DMAP (5.0 mg, 41 µmol) were dissolved in 
DMF (0.2 mL). The reaction was stirred at room temperature for 2 days (to remove the 
Fmoc protecting group) before 7 (4.0 mg, 4.0 µmol) dissolved in DMF (2 mL) was 
added. The reaction was cooled down to 0°C before EDC·HCl (6.0 mg, 30 µmol) was 
added. The solution was  allowed to warm up to room temperature. After 4 h, the solvent 
was removed under reduced pressure. The residue was further purified by preparative 
HPLC to afford 14 (14+CF3COO-) (2.4 mg, 1.7 µmol, 43 %).
1H-NMR: (see Table 7)
MS (ESI-MS): m/z (%): 1297.8 (100) [M]+.
HPLC-UV-Vis: Rt = 16.5 min
Compound 15. 50 (5.0 mg, 8.6 µmol) and DMAP (4.0 mg, 33 µmol) were dissolved in 
DMF (0.2 mL). The reaction was  stirred for 2 days  at room temperature before 7 (5.0 
mg, 5.0 µmol) dissolved in DMF (2 mL) was added. The reaction was cooled down to 
0°C before EDC·HCl (8.0 mg, 40 µmol) was added. The solution was allowed to warm 
up to room temperature. After 6 h, the solvent was removed under reduced pressure. 
The residue was further purified by preparative HPLC to afford 15 (15+CF3COO-) (2.3 
mg, 1.8 µmol, 36 %).
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1H-NMR: (see Table 7)
MS (ESI-MS): m/z (%): 1297.8 (100) [M]+.
HPLC-UV-Vis: Rt = 16.3 min
Compound 16. 7 (4 mg, 4 µmol) was dissolved in dry DMF (1 mL) and cooled to 0°C, 
after which 4-dimethylaminopyridine (DMAP, 1.0 mg, 8.0 µmol) and 60 (3 mg, 9.4 µmol) 
were added. After 10 min, N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC·HCl, 4.0 mg, 20 µmol) was added and the solution was allowed to 
warm up to room temperature. After 6 h, the solvent was removed under reduced 
pressure and the residue was washed with acetone. The mixture was further purified by 
preparative HPLC to afford 16 (16+·CF3COO-) (3.2 mg, 2.3 µmol, 58 %).
1H-NMR (not characterised).
MS (ESI-MS): m/z (%): 1260.8 (100) [M]+.
HPLC-UV-Vis: Rt = 15.0 min
Compound 17. 7 (10 mg, 10 µmol) was dissolved in dry DMF (2 mL) and cooled to 0°C, 
after which 4-dimethylaminopyridine (DMAP, 2.0 mg, 16.0 µmol) and 54 (6 mg, 15 µmol) 
were added. After 10 min, EDC·HCl (8.0 mg, 40 µmol) was added and the solution was 
allowed to warm up to room temperature. After 3 h, the solvent was removed under 
reduced pressure and the residue was washed with acetone. The mixture was further 
purified by preparative HPLC to afford 17 (17+·CF3COO-) (5.5 mg, 3.8 µmol, 38 %).
1H-NMR (see Table 7).
MS (ESI-MS): m/z (%): 1341.9 (100) [M]+.
HPLC-UV-Vis: Rt = 16.0 min
Compound 18. 17 (1 mg, 0.7 µmol) and KCN (5 mg) were dissolved in H2O (2 mL), and 
the solution was stirred for 2 h at 50 oC. The solution was purified by C18 filter to afford 
18 (1 mg, 0.7 µmol, 100%).
1H-NMR (see Table 7).
MS (ESI-MS): m/z (%): 1327.7 (100) [M+H]+.
HPLC-UV-Vis: Rt = 14.5 min
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Synthesis of 19α and 19β. 19αβ (20.8 mg, 20 mmol) was dissolved in 0.1% aqueous 
TFA (10 mL) and the reaction solution was stirred for 10 min. 19α (10.1 mg, 8.8 mmol, 
44 %) and 19β (10.3 mg, 9.0 mmol, 45 %) were separated by preparative HPLC as the 
corresponding TFA salts.
1H NMR (500 MHz, [D2]D2O): (see Table 8); MS (ESI-MS): m/z (%): 1015.6 (100) [M – 
H2O]+; HPLC-UV/Vis: Rt = 8.8 min (19α), Rt = 13.5 min (19β).
Compound 30: compound 2 (2 mg, 0.0015 mmol) was dissolved in an aqueous NH4Cl 
solution (10 %; 5 ml). The solution was purged with argon for 20 min. Zn pellets  (1 g) 
were washed with an aqueous  HCl solution (3 ml, 1 M) freshly and were added to the 
reaction mixture in two portions. After 1 h, the chloro-precursor 32 (1.2 mg, 0.0042 
mmol) was added and the reaction was stirred for 24 h under protection from light. The 
zinc pellets  were filtered off and it was separated by preparative reverse phase HPLC in 
a dark room to afford 30 (0.8 mg; 0.00051 mmol, 34%).
1H-NMR: see table 9
HPLC-UV-vis: 15.6 min
MS (ESI-MS): m/z (%): 1467.8 (100) [M]+
Compound 26-26 and 29-M: Dicyanocyano cobyric acid (7, 9.8 mg, 10 µmol) was 
dissolved in dry DMF (2 mL) and cooled to 0 °C before DMAP (3.0 mg, 2.5 µmol) and 
EDC·HCl (9.0 mg, 45 µmol) was added. After 5 min, N-Boc-ethylenediamine (28, 16 mg, 
0.10 mmol) was added and the reaction was allowed to warm up to room temperature. 
After 6 hours, the solvent was  removed under reduced pressure and it was precipitated 
with acetone. The precipitate was dissolved in aqueous HCl (3 mL, 1 M) and it was 
stirred for 3 h. The solution was lyophilized to yield crude 25. The latter was dissolved in 
DMF (1 mL) and it was cooled to 0°C, after which DMAP (1.0 mg, 8 µmol) and deamino 
histidine (27, 4.5 mg, 15 µmol) were added. After 10 min, EDC·HCl (3.0 mg, 15 µmol) 
was added. The solution was allowed to warm up to room temperature. It was stirred for 
10 h and the solvent was removed under reduced pressure. The residue was washed 
with acetone and further purified with preparative HPLC to afford 26-H (5.2 mg, 3.8 
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µmol, yield: 38 %) and 29-H (5.6 mg, 4.1 µmol, yield: 41 %) as TFA salts. 26-26 and 29-
M are derived from 26-H and 29-H in water at pH 8.1 and pH 6.9, respectively.
UPLC-UV-vis: Rt = 0.9 min (26-H) and Rt = 1.7 min (29-H)
1H-NMR of 26-26, 29-M, 26-H and 29-H: see table 8.
ESI-MS: m/z (%): Compound 26-26: 1122.6 (100) [M/2]+, Compound 29-M: 1122.6 (100) 
[M]+
UV-vis  spectrum of 26-26 (c = 87 µM, 0.2 M KCl, pH = 8.1): 551 nm (4.31), 521 nm 
(4.28), 411 nm (3.84), 322 nm (4.21), 303 nm (4.27), 277 nm (4.37).
UV-vis  spectrum of 29-M (c = 24 µM, 0.2 M KCl, pH = 6.9): 555 nm (3.96), 524 nm 
(3.95), 411 nm (3.67), 362 nm (4.49), 322 nm (3.94), 306 nm (4.00), 278 nm (4.10).
Scheme 17: Synthesis of the linker 8.
Compound 36. 5,6-dimethylbenzimidazole (35, 1.46 g, 10 mmol) was dissolved in N,N-
dimethylformamide (DMF) (20 mL), after which Cs2CO3 (0.3 g, 1.5 mmol) and K2CO3 
(1.38 g, 10 mmol) were added. Tert-butyl bromoacetate (1.65 mL, 10.5 mmol) was 
added dropwise after 5 min and it was stirred for 10 h at room temperature. The solvent 
was removed under reduced pressure and the product was extracted with ethyl acetate 
(35 mL) from water (10 mL). The organic layer was washed with water and brine (2 x 10 
mL each), dried over Na2SO4 and then concentrated under reduced pressure. The 
35# 36# 37#
38# 39#28#
40# 8#
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crude product was purified by flash chromatography on silica gel (dichloromethane 
(DCM): ethyl acetate (EA) = 3:2) to afford 36 (1.08 g, 4.2 mmol, 42 %) as a white solid.
TLC (Silicagel 60 F254, DCM:EA = 3:2): Rf = 0.32.
1H-NMR (200 MHz, [D3]MeOD): δ = 1.45 (s, 9 H), 2.36 (s, 3 H), 2.38 (s, 3 H), 4.97 (s, 2 
H), 7.20 (s, 1 H), 7.44 (s, 1 H), 7.99 (s, 1 H).
MS (ESI-MS): m/z (%): 261.1 (100) [M + H]+.
Compound 37. A solution of 36 (0.52 g, 2 mmol) in DCM (5 mL) was treated with 
triethylsilane (3 mL), cooled to 0°C, after which trifluoroacetic acid (TFA, 6 mL) was 
added dropwise. After 5 min, the solution was allowed to warm up to room temperature 
and was stirred for 6 h. The solvent was removed under reduced pressure and the 
residue was azeotroped with DCM (3 x 5 ml) to yield 37 (0.41 g, 2 mmol, 100 %) as a 
white solid. An analytically pure sample of 37 was obtained by recrystallization from 
acetone.
1H-NMR (200 MHz, [D3]MeOD): δ = 2.47 (s, 6 H), 5.31 (s, 2 H), 7.60 (s, 1 H), 7.62 (s, 1 
H), 9.19 (s, 1 H).
MS (ESI-MS): m/z (%): 205.3 (100) [M + H]+.
Compound 38. Fmoc-glycine (297 mg, 1.0 mmol) was dissolved in DMF (1 mL) and the 
solution was cooled down to 0°C. First, 1-hydroxybenzotriazole (HOBt, 150 mg, 1.1 
mmol) and dicyclohexylcarbodiimide (DCC, 227 mg, 1.1 mmol) were added and after 10 
min of stirring, N-BOC-ethylenediamine (28, 160 µL, 1.0 mmol) was added. The reaction 
was stirred for 12 h at room temperature and the solvent was removed under reduced 
pressure. The residue was dissolved in DCM (5 mL) and washed with brine (5 mL). The 
organic layer was dried over Na2SO4, filtrated, and concentrated under reduced 
pressure. The residue was further purified by flash chromatography on silica gel (DCM : 
EA : MeOH = 12 : 8 : 5) to afford 38 (320 mg, 0.73 mmol, 73 %) as a white solid.
TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rf = 0.52. 
1H-NMR (500MHz, [D6]DMSO): δ = 1.37 (s, 9H), 2.98 (m, 2 H), 3.11 (m, 2 H), 3.58 (d, J 
= 5.5, 2 H), 4.22 (m, 1 H), 4.28 (d, J = 7, 2 H), 7.31 – 7.88 (m, 8 H).
MS (ESI-MS): m/z (%): 462.3 (100) [M + Na]+.
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Compound 40. Solution A: 38 (44 mg, 0.10 mmol) was dissolved in DMF (1 mL), after 
which triethylamine (NEt3, 35 µL, 0.28 mmol) and KF (35 mg, 0.6 mmol) were added. 
The mixture was stirred for 14 h. Solution B: 37 (20 mg, 0.1 mmol) was dissolved in 
DMF (1 mL), after which HOBt (15 mg, 0.11 mmol) and DCC (23 mg, 0.11 mmol) were 
added. After 10 min, solution A was added to solution B and the mixture was stirred for 
14 h. The solvent was removed under reduced pressure. The residue was purified by 
flash chromatography on silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford 40 (25 mg, 
0.062mmol, 62 %) as a white solid. 
TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rf = 0.43.
1H-NMR (500 MHz, [D3]MeOD): δ = 1.43 (s, 9 H), 2.37 (s, 3 H), 2.39 (s, 3 H), 3.15 (m, 2 
H), 3.27 (m, 2 H), 3.88 (s, 2 H), 5.02 (s, 2 H), 7.29 (s, 1 H), 7.44 (s, 1 H), 8.04 (s, 1 H).
MS (ESI-MS): m/z (%): 404.3 (100) [M + H]+.
Compound 8. 40 (20 mg, 0.050 mmol) was dissolved in methanol (10 mL), after which 
aqueous HCl (3 M, 3 mL) was added. The turbid solution was stirred for 4 h until it 
turned clear. After removal of the organic solvent under reduced pressure, it was 
lyophilized to afford 8 (15 mg, 0.050 mmol, 100 %).
1H-NMR (500 MHz, [D3]MeOD): δ = 2.47 (s, 3 H), 2.48 (s, 3 H), 3.08 (t, J = 6, 2 H), 3.51 
(t, J = 6, 2 H), 3.98 (s, 2 H), 5.41 (s, 2 H), 7.62 (s, 1 H), 7.72 (s, 1 H), 9.36 (s, 1 H).
13C-NMR (125 MHz, [D3]MeOD): δ = 20.55, 20.72, 38.30, 41.00, 43.84, 114.00, 115.37, 
130.57, 131.90, 138.65, 138.83, 142.29, 168.15, 172.49. 
MS (ESI-MS): m/z (%): 304.3 (100) [M + H]+.
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41#7# 25#
37# 42# 9#
Scheme 18: Synthesis of the linker 9 and the intermediate 25. Charges on the corrin 
rings have been omitted.
Compound 25. 7 (4.9 mg, 5.0 µmol) was dissolved in dry DMF (1 mL) and cooled to 
0°C before NEt3 (10 µL, 70 µmol) and ethylchloroformate (5 µL, 55 µmol) were added. 
After 1 min, N-Boc-ethylenediamine (16 mg, 0.10 mmol) was added and the reaction 
was quenched with water after 10 min. The crude product (41) was precipitated with 
acetone, filtrated, dissolved in HCl (1 mL, 1 M) and stirred for 1 h. The solution was 
lyophilized to yield crude 25., which was used directly in the next step without 
purification.
Compound 42. 37 (20.4 mg, 0.10 mmol) was dissolved in DMF (1 mL) and cooled to 
0°C, after which DMAP (2.0 mg, 16 µmol) and (L)-Proline methyl ester hydrochloride (20 
mg, 0.12 mmol) were added. After 10 min, EDC·HCl (28 mg, 0.14 mmol) was added 
and the solution was allowed to warm up to room temperature. It was stirred for 2 h and 
the solvent was removed under reduced pressure. The residue was purified by flash 
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chromatography on silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford 42 (22 mg, 0.070 
mmol, 70 %).
TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rf = 0.55.
1H-NMR (500 MHz, [D3]MeOD) (main rotamer): δ = 2.10 – 2.35 (m, 3 H), 2.36 (s, 3 H), 
2.39 (s, 3 H), 3.69 (s, 3 H), 3.70 – 3.85 (m, 3 H), 4.49 (m, 1 H), 5.20 (s, 2 H), 7.25 (s, 1 
H), 7.43 (s, 1 H), 7.98 (s, 1 H). (The characteristic  presence of syn/anti rotamers originating from 
the restricted rotation around the tertiary amide bond has been observed as indicated by a doubling of 
relevant resonances[141]. A ratio of approx. 85 :15 of the two isomers was calculated from the signals 7.98 
and 7.96.).
MS (ESI-MS): m/z (%): 316.1 (100) [M + H]+. 
Compound 9. 42 (16 mg, 50 µmol) was dissolved in methanol (1 mL) and aqueous 
NaOH (3 mL, 0.1 M) was added. After 2 h, the solution turned clear. After removal of the 
organic solvent, the solution was acidified to pH 5 with HCl solution (32%) and 
lyophilized to afford 9 (15 mg, 50 µmol, 100 %).
1H-NMR (500 MHz, [D3]MeOD)(main rotamer): δ = 1.90 – 2.36 (m, 4 H), 2.37 (s, 6 H), 
3.81 (m, 1 H), 3.72 (m, 1 H), 4.39 (m, 1 H), 5.18 (s, 2 H), 7.33 (s, 1 H), 7.43 (s, 1 H), 
8.10 (s, 1 H). (A ratio of approx. 65 : 35 of syn/anti  rotamers was calculated from the signals at 8.10 
and 8.17. The total integral of 18 is consistent with the molecular formula of compound 9 (C16H19N3O3)).
MS (ESI-MS): m/z (%): 302.2 (100) [M + H]+, 300.2 (100) [M – H]-.
43#(45)# 44#(46)#
43,#44:#R1#=#CH3,#R2#=#H#
45,#46:#R1#=#H,#R2#=#CH3#
Scheme 19: Synthesis of the compound 44, and 46.
Compound 44. (R)-(+)-1,2-Diaminopropane dihydrochloride (43, 30 mg, 0.2 mmol) was 
dissolved in water (20 µL) before DMF (6 mL) and N-ethyldiisopropylamine (DIPEA, 50 
µL) were added. The solution was cooled down to 0°C before Fmoc-Cl (25 mg, 0.10 
mmol) dissolved in DCM (1 mL) was added dropwise. After 2h, a saturated aqueous 
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NaHCO3 solution (5 mL) and DCM (5 mL) were added and the organic layer was 
concentrated under reduced pressure. Methanol (0.1 mL) and water (5 mL) were added. 
The water was removed after centrifugation and the precipitate was lyophilized to yield 
44 (12 mg, 0.040 mmol, 20 %).
1H-NMR (500 MHz, [D6]DMSO): δ = 1.10 (d, J = 5.5, 3 H), 3.08 (m, 1 H), 3.15 (m, 2 H), 
4.23 (t, J = 6, 1 H), 4.37 (d, J = 6, 2 H), 7.33 (t, J = 7, 2 H), 7.43 (t, J = 7, 2 H), 7.69 (d, J 
= 7.5, 2 H), 7.90 (d, J = 7.5, 2 H). (The protection at the indicated nitrogen of 44 has been 
confirmed by 1H-NMR, 13C-NMR, 1H-COSY, CH-COSY, COLOC (data not shown). An 1H-NMR spectra of 
Fmoc-NH-CH(CH3)-CH2-NH2 has been reported by McMurray[142] that differs significantly from that of 44).
13C-NMR (125 MHz, [D3]MeOD): δ = 159.6, 145.4, 142.8, 129.0, 128.3, 126.2, 121.1, 
68.1, 45.2, 16.5.
MS (ESI-MS): m/z (%): 297.1 (100) [M + H]+.
Compound 46. The synthesis was performed with (S)-(+)-1,2-Diaminopropane 
dihydrochloride (45, 30 mg, 0.20 mmol) as described for 44 to yield 46 (14 mg, 0.047 
mmol, 24 %).
1H-NMR (500 MHz, [D6]DMSO): 1.12 (d, J = 5.5, 3 H), 3.11 (d, J = 2, 1 H), 3.17 (m, 2 
H), 4.24 (t, J = 6.5, 1 H), 4.37 (d, J = 6.5, 2 H), 7.34 (t, J = 7.5, 2 H), 7.42 (t, J = 7.5, 2 
H), 7.69 (d, J = 7.5, 2 H), 7.90 (d, J = 7.5, 2 H).
MS (ESI-MS): m/z (%): 297.1 (100) [M + H]+.
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Scheme 20: Synthesis of the linker 10, 11, 50, 51 and 54.
Compound 10. 9 (11 mg, 37 µmol) was  dissolved in DMF (3 mL). HOBt (8.4 mg, 60 
µmol) and DCC (12 mg, 60 µmol) were added to the solution, after which 44 (9.0 mg, 30 
µmol) was added after 10 min. The solvent was removed under reduced pressure after 
2h of stirring at room temperature. The residue was purified by flash chromatography on 
silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford 10 (3.5 mg, 6.2 µmol, 21 %).
TLC (Silicagel 60 F254, CH2Cl2 : EA : MeOH = 12 : 8 : 5): Rf = 0.44.
37#
9#
44#
44#
46#
46#
10#
11#
49#
50#
51#
52#
53#
48# 54#
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1H-NMR (500 MHz, [D3]MeOD): 1.08 (d, J = 6.5, 3 H), 1.90 – 2.40 (m, 12 H), 3.05 – 
3.26 (m, 2 H), 3.72 – 4.40 (m, 5 H), 5.03 – 5.19 (m, 2 H), 7.17 – 7.93 (m, 11 H). (A ratio of 
the two syn/anti isomers of approx. 80:20 was calculated from the signals at 1.08 and 1.20 ppm 
(CH3CH). The total integral of 35 is consistent with the molecular formula of compound 10 (C34H37N5O4).)
MS (ESI-MS): m/z (%): 580.3 (100) [M + H]+.
Compound 11. The synthesis was performed with 46 (11 mg, 37 µmol) as described for 
10 to afford 11 (7.1 mg, 12 µmol, 32 %).
TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rt = 0.44.
1H-NMR (500 MHz, [D3]MeOD)(main rotamer): 1.09 (d, J = 6.5, 3 H), 1.94 - 2.03 (m, 4 
H), 2.15 – 2.20 (m, 1 H), 2.30 – 2.38 (m, 7 H), 3.07 (m, 1 H), 3.23 (m, 1 H), 3.70 – 4.38 
(m, 5 H), 5.18 (s, 2 H), 7.26 – 7.29 (m, 3 H), 7.35 – 7.39 (m, 3 H), 7.60 (dd, J = 2, J = 
7.5, 2 H), 7.78 (d, J = 7.5, 2 H), 7.97 (s, 1 H). (A ratio of the syn/anti rotamers of approximately 
80 : 20 was calculated from the signals at 1.09 and 1.18 ppm (CH3CH). The total  integral  of 35 is 
consistent with the molecular formula of compound 11 (C34H37N5O4).)
MS (ESI-MS): m/z (%): 580.3 (100) [M + H]+.
54#Boc' 54'
Compound 54. 9 (9.0 mg, 0.03 mmol) was dissolved in DMF (1 mL) and cooled to 0°C, 
after which DMAP (2.0 mg, 16 µmol) and 48 (10.2 mg, 0.04 mmol) were added. After 10 
min, EDC·HCl (10 mg, 0.05 mmol) was added and the solution was allowed to warm up 
to room temperature. It was stirred for 2 h and the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography on silica gel (DCM : EA : 
MeOH = 12 : 8 : 5) to afford 54-Boc, which was then dissolved in TFA/CH2Cl2 solution. 
After 2 hours, the solvent was  removed under reduced pressure to give 54 (7.2 mg, 
0.018 mmol, 60%).
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TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rt = 0.40.
1H-NMR (500 MHz, [D3]MeOD): 2.00 - 2.45 (m, 4 H), 2.49 (s, 6 H), 3.10 - 3.75 (m, 4 H), 
2.30 – 2.38 (m, 7 H), 3.07 (m, 1 H), 3.23 (m, 1 H), 3.70 – 4.38 (m, 3 H), 4.51 (m, 2H), 
5.58 (s, 2 H), 7.64 (s, 1 H), 7.73 (s, 1 H), 9.25 (s, 1 H). 
MS (ESI-MS): m/z (%): 402.2 (100) [M + H]+.
49#Me& 49&
Compound 49. 37 (45 mg, 0.22 mmol) was dissolved in DMF (2 mL) and cooled to 0°C, 
after which DMAP (10 mg, 82 µmol) and (S)-Proline methyl ester hydrochloride (53, 31 
mg, 0.20 mmol) were added. After 10 min, EDC·HCl (50 mg, 0.26 mmol) was added 
and the solution was allowed to warm up to room temperature. It was stirred for 2 h and 
the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography on silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford white solid 49-
Me, which was then dissolved in a mixture of methanol (1 mL) and aqueous NaOH (3 
mL, 0.1 M). After 2 h of stirring at 20oC, the solution turned clear. After removal of the 
organic solvent, the solution was acidified to pH 5 with aqueous HCl (32%) and purified 
by SPE with C18 filter to give 49 (34 mg, 0.011 mmol, 55 %)
1H-NMR (500 MHz, [D3]MeOD)(main rotamer): 2.02 – 2.36 (m, 4 H), 2.40 (m, 6 H), 3.77 
(m, 1 H), 3.83 (m, 1 H), 4.48 (m, 1 H), 5.28 (s, 2 H), 7.43 (s, 1 H), 7.47 (s, 1 H), 8.37 (s, 
1 H). (A ratio of approx. 69 : 31 of syn/anti rotamers was calculated from the signals at 8.37 and 8.49.
The total integral of 18 is consistent with the molecular formula of compound 49 (C16H19N3O3)).
MS (ESI-MS): m/z (%): 302.4 (100) [M + H]+.
Compound 50. The synthesis  was performed with 44 (12 mg, 40 µmol) as described for 
10 to afford 50 (6.0 mg, 10 µmol, 25 %).
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TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rt = 0.42.
1H-NMR (500 MHz, [D3]MeOD)(main rotamer): 1.09 (d, J = 7, 3 H), 1.94 - 2.03 (m, 4 H), 
2.15 – 2.20 (m, 1 H), 2.30 – 2.36 (m, 7 H), 3.07 (m, 1 H), 3.23 (m, 1 H), 3.70 – 4.38 (m, 
5 H), 5.19 (s, 2 H), 7.26 – 7.29 (m, 3 H), 7.36 – 7.40 (m, 3 H), 7.59 -7.62 (m, 2 H), 7.78 
(d, J = 7.5, 2 H), 7.98 (s, 1 H). (A ratio of the syn/anti rotamers of 82 : 18 was calculated from the 
signals at 1.09 and 1.18 ppm (CH3CH). The total integral of 35 is consistent with the molecular formula of 
compound 50 (C34H37N5O4).)
MS (ESI-MS): m/z (%): 580.3 (100) [M + H]+.
Compound 51. The synthesis  was performed with 46 (13 mg, 44 µmol) as described for 
10 to afford 51 (8.9 mg, 15 µmol, 35 %).
TLC (Silicagel 60 F254, DCM : EA : MeOH = 12 : 8 : 5): Rt = 0.36.
1H-NMR (500 MHz, [D3]MeOD)(main rotamer): 1.08 (d, J = 7, 3 H), 1.94 - 2.40 (m, 12 
H), 3.10 (m, 1 H), 3.25 (m, 1 H), 3.73 – 4.38 (m, 5 H), 5.18 (m, 2 H), 7.26 – 7.39 (m, 6 
H), 7.50 (m, 2 H), 7.76 (m, 2 H), 7.92 (s, 1 H). (A ratio of the syn/anti rotamers of approximately 
80 : 20 was calculated from the signals at 1.08 and 1.20 ppm (CH3CH). The total  integral  of 35 is 
consistent with the molecular formula of compound 51 (C34H37N5O4).)
MS (ESI-MS): m/z (%): 580.3 (100) [M + H]+.
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Scheme 21: Synthesis of linker 56, 57 and 60.
Compound 55. 73 (31 mg, 0.1 mmol) was dissolved in DMF (1 mL) and the solution 
was cooled down to 0°C. First, 1-hydroxybenzotriazole (HOBt, 15 mg, 0.11 mmol) and 
dicyclohexylcarbodiimide (DCC, 22.7 mg, 0.11 mmol) were added and after 10 min of 
stirring, N-BOC-ethylenediamine (28, 16 µL, 0.1 mmol) was added. The reaction was 
stirred for 5 h at room temperature and the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography on silica gel (DCM : EA : 
MeOH = 24 : 16 : 5) to afford 55. (36 mg, 0.079 mmol, 79 %) as a white solid.
TLC (Silicagel 60 F254, DCM : EA : MeOH = 24 : 16 : 5): Rf = 0.61. 
1H-NMR (500MHz, [D6]DMSO): 1.42 (s, 9 H), 3.10 - 3.50 (m, 8 H), 4.20 (t, 1 H), 4,34 (d, 
J = 7, 2 H), 7.31 (t, 2 H), 7.39 (t, 2 H), 7.64 (d, J = 7, 2 H), 7.79 (d, J = 6, 2 H).
MS (ESI-MS): m/z (%): 476.3 (100) [M + Na]+.
73# 37#
55# 56#
52#
28#
48#
57#
58# 59# 60#
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57#Boc' 57'
Compound 57. 55 (18 mg, 0.040 mmol) and DMAP (10 mg, 0.082 mmol) were 
dissolved in DMF (0.3 mL) and after 20 h, 55 turned into 56 indicated as by TLC. To this 
solution, 37 (10 mg, 0.050 mmol) and DMF (2 mL) were added. The reaction was stirred 
for 7 h before the solvent was removed under reduced pressure. The residue was 
purified by flash chromatography on silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford 
57-Boc, which was dissolved and stirred in aqueous HCl (3 mL, 1 M) at 55 oC for 1 h. 
The solution was lyophilised to afford 57 (8.5 mg, 0.027 mmol, 67 %).
1H-NMR (500 MHz, [D3]MeOD): δ = 2.47 (s, 3 H), 2.48 (s, 3 H), 2.51 (t, 2 H), 3.04 (t, 2 
H), 3.46 (t, 2 H), 3.56 (t, 2 H), 5.30 (s, 2 H), 7.63 (s, 1 H), 7.66 (s, 1 H), 9.36 (s, 1 H).
MS (ESI-MS): m/z (%): 318.3 (100) [M + H]+.
Compound 59. 58 (32 mg, 0.26 mmol) was dissolved in DMF (2 mL) and cooled to 0°C, 
after which DMAP (10 mg, 82 µmol) and (L)-Proline methyl ester hydrochloride (52, 25 
mg, 0.19 mmol) were added. After 10 min, EDC·HCl (60 mg, 0.31 mmol) was added 
and the solution was allowed to warm up to room temperature. It was stirred for 4 h and 
the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography on silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford the methyl ester 
of 59, which was hydrolysed to 59 with aqueous KOH (5 mL, pH 13) during 2 h. The 
solution of 59 was neutralised by aqueous HCl (0.1 M) and purified by SPE with C18 
filter to give pure 59 (39 mg, 0.18 mmol, 95 %).
1H-NMR (500 MHz, [D3]MeOD) (main rotamer): 1.95 - 2.12 (m, 4 H), 3.49 - 3.78 (m, 2 
H), 4.63 (t, 1 H), 7.95 (d, J = 5, 2 H), 8.87 (d, J = 5.5, 2 H) (A ratio of the syn/anti  rotamers of 
approximately 76 : 24 was calculated from the signals at 8.87 and 8.81 ppm)
MS (ESI-MS): m/z (%): 221.6 (100) [M + H]+.
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Compound 60. 59 (36 mg, 0.16 mmol) was dissolved in DMF (3 mL) and the solution 
was cooled down to 0°C, after which DMAP (10 mg, 82 µmol) and 48 (60 mg, 0.24 
mmol) were added. After 10 min, EDC·HCl (60 mg, 0.31 mmol) was  added and the 
solution was allowed to warm up to room temperature. It was stirred for 2 h and the 
solvent was removed under reduced pressure. The residue was purified by flash 
chromatography on silica gel (DCM : EA : MeOH = 12 : 8 : 5) to afford 60-Boc, which 
was dissolved in a mixture of CH2Cl2 (3 mL) and TFA (1 mL) for 1 h to afford 60. The 
solvent was removed under reduced pressure, and the residue was redissolved in water 
and purified by C18 filter to give pure 60 (35 mg, 0.11 mmol, 69 %).
1H-NMR (500 MHz, [D3]MeOD)(main rotamer): 1.98 (m, 1 H), 2.09 (m, 2 H), 2.39 (m, 1 
H), 3.16 – 3.70 (m, 4 H), 3.82 (s, 3 H), 4.57 (t, 1 H), 4.93 (t, 1 H), 7.66 (d, J = 4, 2 H), 
8.73 (d, J = 5, 2 H) (A ratio of the syn/anti rotamers of approximately 93 : 7 was calculated from the 
signals at 8.73 and 8.67 ppm)
MS (ESI-MS): m/z (%): 321.4 (100) [M + H]+.
25#
27#
26&H#
29&H#
26&26#
29&M#
Scheme 22: Synthesis of compound 26-26 and 29-M. Charges have been omitted.
Compound 26-26 and 29-M: Dicyanocyano cobyric acid (7, 9.8 mg, 10 µmol) was 
dissolved in dry DMF (2 mL) and cooled to 0 °C before DMAP (3.0 mg, 2.5 µmol) and 
EDC·HCl (9.0 mg, 45 µmol) was added. After 5 min, N-Boc-ethylenediamine (28, 16 mg, 
0.10 mmol) was added and the reaction was allowed to warm up to room temperature. 
After 6 hours, the solvent was  removed under reduced pressure and it was precipitated 
with acetone. The precipitate was dissolved in aqueous HCl (3 mL, 1 M) and it was 
stirred for 3 h. The solution was lyophilized to yield crude 25. The latter was dissolved in 
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DMF (1 mL) and it was cooled to 0°C, after which DMAP (1.0 mg, 8 µmol) and deamino 
histidine (27, 4.5 mg, 15 µmol) were added. After 10 min, EDC·HCl (3.0 mg, 15 µmol) 
was added. The solution was allowed to warm up to room temperature. It was stirred for 
10 h and the solvent was removed under reduced pressure. The residue was washed 
with acetone and further purified with preparative HPLC to afford 26-H (5.2 mg, 3.8 
µmol, yield: 38 %) and 29-H (5.6 mg, 4.1 µmol, yield: 41 %) as TFA salts. 26-26 and 29-
M are derived from 26-H and 29-H in water at pH 8.1 and pH 6.9, respectively.
UPLC-UV-vis: Rt = 0.9 min (26-H) and Rt = 1.7 min (29-H)
1H-NMR of 26-26, 29-M, 26-H and 29-H: see table 8.
ESI-MS: m/z (%): Compound 26-26: 1122.6 (100) [M/2]+, Compound 29-M: 1122.6 (100) 
[M]+
UV-vis  spectrum of 26-26 (c = 87 µM, 0.2 M KCl, pH = 8.1): 551 nm (4.31), 521 nm 
(4.28), 411 nm (3.84), 322 nm (4.21), 303 nm (4.27), 277 nm (4.37).
UV-vis  spectrum of 29-M (c = 24 µM, 0.2 M KCl, pH = 6.9): 555 nm (3.96), 524 nm 
(3.95), 411 nm (3.67), 362 nm (4.49), 322 nm (3.94), 306 nm (4.00), 278 nm (4.10).
Scheme 23: Synthesis of compound B12-CNα. Charges on the corrin rings have been 
omitted.
B12-CNα: B12 (27 mg, 20 µmol) was dissolved in water (5 ml), before KCN (13 mg, 200 
µmol) was added. After observation of a colour change from red to violet, the solution 
was injected directly into the preparative HPLC to yield B12-CNα (17 mg, 12.5 µmol, 
62.7 %) (The solvent waste was collected into a bottle containing solid NaOH to 
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neutralize the acidic solution and to absorb potential HCN as cyanide; an HCN-detector 
from Dräger was used.)
HPLC-UV-vis: Rt = 11 min 
1H-NMR of B12-CNα: see table 8 (The chemical shifts  of the protons  of the corrin ring 
are consistent with those of Cbi-CNα, but differ significantly from those of Cbi-CNβ)
ESI-MS: m/z (%): Compound B12-CNα: 1355.6 (100) [M-H2O+H]+
UV-vis  spectrum of B12-CNα (c = 35 µM, pH = 4.5): 528 nm (3.88), 496 nm (3.92), 407 
nm (3.67), 354 nm (4.49), 321 nm (4.43), 276 nm (4.22). 
Scheme 25: (Up) Synthesis of 19α and 19β from 19αβ. (Down) Synthesis of 21α and 21on 
from 21αβ. Charges on the corrin rings have been omitted.
Synthesis of 21on. Intermediate 25 was synthesised from dicyanocobyric acid (4.9 mg, 
5.0 µmol) as described in compound 3. It was dissolved in DMF (1 mL) and cooled to 
0°C, after which DMAP (1.0 mg, 8 µmol) and 7 (4.5 mg, 15 µmol) were added. After 10 
min, EDC·HCl (3.0 mg, 15 µmol) was added. The solution was allowed to warm up to 
room temperature. After 4 h the solvent was removed under reduced pressure. The 
residue was washed with acetone and further purified with preparative HPLC to afford 
21on (3.8 mg, 2.9 µmol, 58 %) as the corresponding TFA salt.
19αβ% 19α% 19β%
21αβ% 21α% 21on%
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1H NMR (500 MHz, [D2]D2O): (see Table 8) HR-MS: [M]+calcd for C59H81CoN15O8: 
1186.57191, found: 1186.57087; UV/Vis (c = 30 µM, 0.2 M KCl, pH = 5.98): 548 nm 
(3.96), 521 nm (3.94), 413 nm (3.72), 361 nm (4.43), 279 nm (4.27), HPLC-UV/Vis: Rt = 
14.2 min; pKbase-off = 2.58.
Synthesis of (21on+21α). 21on (1.3 mg, 1.0 µmol) and KCN (1.3 mg, 20 µmol) were 
dissolved in water (5 mL) to obtain a violet coloured solution of 21αβ.The pH value of the 
solution was adjusted to 2 with trifluoroacetic acid. After purging the solution with N2 for 
20 min to remove HCN, the reaction solution was adsorbed on a reverse-phase 
Chromafix® C18ec cartridge. It was washed with water (30 mL) and then eluted with 
MeOH (3 mL). The solvent was removed under vacuum to yield 21on and 21α as a 
mixture of the corresponding TFA salts (1.3 mg, 100%).
ESI-MS: m/z (%): 1186.6 (100) [M]+ for 21on or [M-H2O]+ for 21α. 
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61# 62# 63# 64# 33#
65#
69#67# 68# 70#
66#
65#
71#72#34#
Scheme 24: Synthesis of compound 33 and 34.
Compound 62: Benzimidazole (61, 0.292 g, 2.5 mmol) was dissolved in N,N-
dimethylformamide (DMF; 4 ml), before Cs2CO3 (0.060 g, 0.9 mmol) and K2CO3 
(0.276 g, 2.0 mmol) were added. Methyl bromoacetate (0.2 ml, 2.1 mmol) was added 
dropwise 5 min later. After stirring for 18 h, the organic solvent was removed under 
reduced pressure. The product was extracted with ethyl acetate (15 ml) from water (4 
ml). The organic layer was washed twice with a saturated NaHCO3-solution (10 ml) and 
dried over Na2SO4. It was filtrated, the organic layer was concentrated under reduced 
pressure (4 ml) and it was precipitated with hexane (3 ml) to yield 62 (66 mg, 0.35 
mmol, 14 %).
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1H-NMR (500 MHz, [D3]MeOD): δ = 8.17 (s, 1 H), 7.70-7.68 (dd, J =1.5, J = 7.0, 1 H), 
7.49-7.48 (dd, J= 1.5, J = 6.5, 1 H), 7.33-7.30 (m, 2 H), 5.20 (s, 2 H), 3.78 (s, 3 H).
MS (ESI-MS): m/z (%): 191.8 (100) [M + H]+.
Compound 63: 62 (66 mg, 0.35 mmol) was dissolved in MeOH (2 ml) and it was added 
an aqueous KOH- solution (2 M; 0.35 ml) as well as water (0.5 ml). The reaction mixture 
was stirred at 50°C for 50 minutes. The organic solvent was  removed under reduced 
pressure and the pH was adjusted to 2.5 with an aqueous HCl-solution (6 M; 0.12 ml). 
Lyophilization yielded pure product 63 (77 mg, 0.36 mmol, 100%). 
1H-NMR (500 MHz, [D3]MeOD): δ = 9.39 (s, 1 H), 7.89-7.86 (m, 2 H), 7.68-7.66 (m, 2 
H), 5.42 (s, 2 H).
MS (ESI-MS): m/z (%): 177.8 (100) [M + H]+.
Compound 64: 63 (21 mg, 0.12 mmol) was dissolved in DMF (3 ml) and 2-chloroethane 
amine hydrochloride (0.29 mg, 0.25 mmol) was added. The reaction mixture was cooled 
to 0°C. DMAP (0.49 mg, 0.4 mmol) was added. EDC·HCl (60 mg, 0.3 mmol) was added 
after 5 min. The reaction was stirred for 3 h at room temperature. The organic solvent 
was removed under reduced pressure. The crude product was purified by flash 
chromatography (silica; ethyl acetate (EA)/ dichloromethane (DCM)/MeOH = 8:12:5) to 
yield pure product 64 (17.3 mg, 0.073 mmol, 61 %).
Rf: 0.5 (Silicagel 60 F254, EA/DCM/MeOH = 8/12/5)
1H-NMR (500 MHz, [D3]MeOD): δ = 8.17 (s, 1 H), 7.70-7.68 (dd, J = 1.0, J = 8.5, 1 H), 
7.49-7.47 (dd, J = 1.5, J = 7.5, 1 H), 7.34-7.31 (m, 2 H), 5.02 (s, 2 H), 3.64-3.61 (m, 2 
H), 3.57-3.55 (m, 2 H).
MS (ESI-MS): m/z (%): 238.5 (100) [M + H]+.
Compound 68: Anhydrous DMF (7.5 ml) was added to sodium hydride (304 mg, 7.6 
mmol) at -4 °C. Afterward adenine (67; 250 mg, 1.9 mmol) was added in small portions. 
The suspension was stirred vigorously for 3 min and benzyl chloroformate (0.58 ml, 4.8 
mmol) was added dropwise. After stirring for 4 h, the reaction mixture was poured into 
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ice water (15 ml) and the pH was adjusted to 7 with aqueous HCl (1 N). The white 
precipitate was collected by filtration and was washed with water (1 ml) and ethyl ether 
(5 ml). Recrystallization from MeOH/DCM (1:1; 10 ml) afforded 171 mg of pure product 
62 (0.64 mmol, 33%).
1H-NMR (500MHz, [D6]DMSO): δ = 8.59 (s, 1 H), 8.43 (s, 1 H), 7.48-7.34 (m, 5 H), 5.28 
(s, 2 H).
MS (ESI-MS): m/z (%): 270.5 (96) [M + H]+, 561.2 (100) [2M + Na]+
Compound 69: 68 (50 mg, 0.19 mmol) was dissolved in DMF (2 ml), before Cs2CO3 (5.2 
mg, 0.02 mmol) and K2CO3 (23.8 mg, 0.17 mmol) were added. Methyl bromacetate 
(0.03 ml, 0.35 mmol) was added dropwise. After 2.5 h the reaction was stopped and the 
organic solvent was removed under reduced pressure. The product was extracted with 
ethyl acetate (15 ml) from water (4 ml). The organic layer was washed twice with an 
aqueous, saturated NaHCO3-solution (5 ml) and dried over Na2SO4. The organic layer 
was concentrated under reduced pressure (2 ml) and it was precipitated with hexane (4 
ml). The precipitate was filtrated off to yield 69 (30 mg, 0.09 mmol, 47 %).
1H-NMR (500 MHz, [D3]MeOD): δ = 8.61 (s, 1 H), 8.31 (s, 1 H), 7.49-7.28 (m, 5 H), 5.30 
(d, 2 H), 5.18 (s, 2 H), 3.78 (s, 3 H). 
MS (ESI-MS): m/z (%): 342.2 (100) [M + H]+.
Compound 70: 69 (15 mg, 0.05 mmol) was dissolved in MeOH (2 ml) and it was added 
an aqueous KOH-solution (2 M; 0.1 ml) as well as water (0.5 ml). After 45 min of stirring 
at room temperature, the solvents were removed under reduced pressure to yield 70 
(15 mg, 0.05 mmol, 100%).
1H-NMR (500 MHz, [D3]MeOD): δ = 8.58 (s, 1 H), 8.29 (s, 1 H), 7.48-7.33 (m, 5 H), 5.30 
(d, 2 H), 4.86 (s, 2 H).
MS (ESI-MS): m/z (%): 328.2 (100) [M + H]+. 
Compound 71: 70 (15 mg, 0.05 mmol) was dissolved in DMF (3 ml). After the addition of 
2-chloroethane amine hydrochloride (8 mg, 0.07 mmol), the reaction mixture was cooled 
to 0°C and DMAP (10 mg, 0.09 mmol) and EDC·HCl (18 mg, 0.09 mmol) were added. 
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The solvents were removed under reduced pressure after 6 h. The crude product was 
purified by flash chromatography (EA/DCM/MeOH = 16/24/5) to yield 71 (8 mg, 0.02 
mmol, 46 %).
Rf: 0.5 (Silicagel 60 F254, EA/DCM/MeOH = 8/12/5
1H-NMR (500 MHz, [D3]MeOD): δ = 8.58 (s, 1 H), 8.31 (s, 1 H), 7.48 (d, 2 H), 7.32-7.40 
(m, 3 H), 5.50 (s, 2 H), 5.30 (s, 1 H), 5.07 (s, 1 H), 4.43 (m, 1 H), 4.10 (m, 1 H), 3.54 – 
3.64 (m, 2 H).
MS (ESI-MS): m/z (%): 387.1 (100) [M + H]+.
Compound 72: 71 (30 mg, 0.077 mmol) was dissolved in MeOH (6 ml) and Pd on 
charcoal (10 %; 20 mg) was added. The mixture was stirred for 1.5 h at 65°C under an 
atmosphere of H2. The precipitate and the catalyst were filtered off, and the solid was 
washed with water (3x 10 ml). The aqueous  phase was collected and the solvent was 
removed under reduced pressure to yield pure product 72 (6 mg, 0.024 mmol, 31 %). 
1H-NMR (500 MHz, [D3]MeOD): δ = 8.20 (s, 1 H), 8.10 (s, 1 H), 5.04 (s, 2 H), 3.65 (t, 2 
H), 3.58 (t, 2 H).
MS (ESI-MS): m/z (%): 277.4 (100) [M + Na]+. 
Cobalamins 33 and 34: B12 (16 mg, 0.012 mmol) was dissolved in an aqueous NH4Cl 
solution (10 %; 5 ml). The solution was purged with argon for 20 min. Zn pellets  (2 g) 
were washed with an aqueous HCl-solution (3 ml, 1 M) and were added to the reaction 
mixture in two portions. After 1 h, the chloro-precursor 64 (or 72; 4 mg) was added and 
the reaction was stirred for 24 h under protection from light. The zinc pellets were 
filtered off and it was separated by preparative reverse phase HPLC in a dark room. The 
following yields were obtained: 33 (6.1 mg; 33%,) and 34 (12.1 mg; 65 %). 
NMR: see table 9.
Compound 33: HPLC-MS: Rt = 19.0 min; m/z (%) 1531.7 (100) [M + H]+. Calcd. for 
C73H100CoN16O15P: 1530.7.
Compound 34: HPLC-MS: Rt = 18.7 min; m/z (%) 1548.8 (100) [M + H]+. Calcd. for 
C71H99CoN19O15P: 1547.7.
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4.2 NMR tables
Figure 43: Atom labelling for B12 derivatives. Charges have been omitted.
2"–"7,"14"15"and"31" 17"and"18"
21on" 19αβ,"19α"and"19β" 13"
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33"and"34" 30"and"31"1,"31,"33"and"34"
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Table 6: NMR chemical shift values of 1 - 5 and 7
δ 1H[ppm] δ 13C[ppm]
Δδ (1-2)
1 2 3c 5 4c 7 4 7
C1 87.9 85.9
C1A 0.49 0.57 0.64 0.51 0.64 1.54 22.6 24.4 - 0.08
C2 50.0 49.0
C2A 1.44 1.46 1.46 1.50 1.44 1.58 19.6 19.2 - 0.02
C3 4.22 4.23 3.25 4.23 4.24 3.88 59.2 59.0 - 0.01
C4 182.8 179.4
C5 110.1 107.7
C6 168.2 165.6
C7 54.1 51.9
C7A 1.90 1.88 1.88 1.89 1.88 1.73 21.8 21.5 + 0.02
C8 3.46 3.46 3.46 3.51 3.45 3.44 58.5 57.9 + 0.00
C9 176.6 174.5
C10 6.11 6.12 6.14 6.15 6.13 5.92 97.8 93.6 - 0.01
C11 179.8 180.3
C12 51.4 49.6
C12A 1.48 1.47 1.49 1.48 1.49 1.48 21.6 21.3 + 0.01
C12B 1.23 1.19 1.20 1.20 1.20 1.23 33.4 33.0 + 0.04
C13 3.37 3.39 3.40 3.42 3.38 3.34 56.4 55.9 - 0.02
C14 168.7 165.7
C15 107.0 106.3
C16 181.4 180.8
C17 62.3 61.8
C17B 1.42 1.46 1.48 1.46 1.48 1.35 19.3 20.3 - 0.04
C18 2.78 2.78 2.84 2.77 2.85 2.94 41.7 41.8 + 0.00
C19 4.12 4.14 4.15 4.15 4.13 3.79 77.9 78.0 - 0.02
C21 2.43 2.43 2.44 2.41 2.45 2.28/2.31 45.5 44.9 + 0.00
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C31 2.01 2.08 2.13 2.09 1.95 2.04/2.34 28.7 27.6 - 0.07
C32 2.55 2.58 2.58 2.57 2.70 2.51/2.60 37.7 37.7 - 0.03
C51 2.57 2.57 2.58 2.56 2.58 2.29 18.2 17.9 + 0.00
C71 2.22/2.59 2.23/2.62 2.22/2.63 2.23/2.65 2.22/2.61 2.42/2.63 45.6 46.5 - 0.01/- 0.03
C81 1.03/2.02 0.97/2.07 0.92/1.96 1.01/2.00 2.10 1.82/2.17 28.8 29.3 + 0.06/- 0.05
C82 1.04/1.85 0.97/1.96 0.95/1.81 1.06/1.92 0.95/1.79 2.32 34.4 34.5 + 0.07/- 0.11
C131 2.00 2.05 1.92/2.10 2.01 1.90/2.11 1.87/2.17 30.7 28.5 - 0.05
C132 2.66 2.73 2.72 2.74 2.70 2.18/2.40 36.9 34.5 - 0.07
C151 2.60 2.58 2.58 2.53 2.59 2.35 17.5 17.6 + 0.02
C171 2.18/2.53 1.78/2.45 1.78/2.67 1.73/2.47 1.75/2.68 2.06/2.55 35.6 36.0
C172 1.88/2.64 2.85 2.80 2.60/2.81 1.99/2.26 1.90/2.45 33.8 36.2
C175 2.98/3.63 3.29/3.57 b 3.16/3.80 b 3.22/3.55 2.66/3.59 48.1
C176 4.31 3.09/3.57 b 3.60/3.80 b 3.97 4.30 46.5
C177 1.28/1.30 1.17 1.14 19.4
C181 2.74 2.74 2.70 2.74 2.74 2.77 34.8 35.5 + 0.00
C3P 3.77/3.96 4.39 4.32 4.34 63.4
C31P 2.02/2.28 2.07/2.29 1.99/2.30 32.7
C32P 2.08/2.16 2.07/2.18 2.10 27.1
C33P 3.78 3.83/3,87 3.75/3.82 50.0
C1R 6.38 4.94/5.04 4.97/5.17 4.96/5.18 4.95/5.17 49.4
C2N 7.12 7.01 6.95 7.03 6.94 146.0 + 0.11
C4N 6.54 6.49 6.50 6.48 6.51 119.3 + 0.05
C5N 136.0
C6N 138.1
C7N 7.31 7.18 7.15 7.04 7.18 113.9 + 0.13
C8N 134.3
C9N 139.2
C10N 2.29 2.29 2.30 2.28 2.30 22.6 + 0.00
C11N 2.29 2.27 2.28 2.26 2.29 22.2 + 0.02
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Assignment by 1H-NMR, 13C-NMR, 1H,13C-HSQC correlation and comparison with B12 (1) and dicyano-cobyric acid 
(7). aCarboxamide resonances C22, C33, C72, C83, C133, C173, C182 were not assigned. bThe protons at C175 
and C176 were not assigned specifically. cmain rotamer.
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Table 7: 1H-NMR chemical shift values of 12 - 15, 17 and 18
δ 1H[ppm]
12a 13b 14 15c 17c 18c
C1
C1A 0.55 0.45 0.67 0.52 0.63 0.63
C2
C2A 1.53 1.43 1.42 1.37 1.45 1.44
C3 4.22 4.21 4.24 4.25 4.24 4.25
C4
C5
C6
C7
C7A 1.88 1.88 1.82 1.86 1.87 1.87
C8 3.46 3.45 3.41 3.41 3.44 3.44
C9
C10 6.15 6.12 6.05 6.07 6.13 6.12
C11
C12
C12A 1.47 1.46 1.43 1.46 1.48 1.48
C12B 1.19 1.19 1.16 1.18 1.19 1.19
C13 3.37 3.37 3.39 3.40 3.38 3.38
C14
C15
C16
C17
C17B 1.47 1.36 1.47 1.39 1.48 1.47
C18 2.74 2.78 2.87 2.62 2.86 2.86
C19 4.16 4.12 4.16 4.11 4.13 4.13
C21 2.40 2.43 2.45 2.44 2.44 2.44
C31 2.12 2.03 2.10 2.05 2.14 2.11
C32 2.58 2.56 2.65 2.57
Experimental Procedures
95
C51 2.64 2.58 2.60 2.52 2.58 2.58
C71 2.23/2.63 2.23/2.62 2.21/2.61 2.20/2.60 2.22/2.63 2.22/2.62
C81 0.95/1.98 1.04/2.12 2.16 2.04 0.91/1.98 0.94/1.91
C82 0.97/1.88 1.05/1.48 1.78 0.92/1.79 0.97/1.82 0.95/1.81
C131 1.92/2.03 1.91/2.01 1.87 1.89 1.93/2.10 1.91/2.09
C132 2.71 2.68 2.66 2.65 2.72 2.71
C151 2.57 2.56 2.55 2.57 2.58 2.58
C171 2.33/2.71 1.94/2.72 2.71 2.68 1.75/2.69 1.75/2.68
C172 1.84 2.12/2.42 2.40 2.36 2.14 2.05/2.20
C175 3.64 3.79/3.57/3.33/3.2 3.66 3.67 3.05/3.97 2.90/3.96
C176 3.12 3.79/3.57/3.33/3.2 3.98 4.03 5.06 4.77
C177 1.13 1.06 3.82
C181 2.74 2.78 2.75 2.78 2.77 2.75
C3P 3.79/3.57/3.33/3.2 4.27 4.29 4.45 4.45
C31P 3.79/3.57/3.33/3.2 1.93/2.36 2.01/2.36 2.06/2.30 2.09/2.29
C32P 2.10 2.13 2.14 2.12
C33P 3.66 3.81 3.80 3.78
C1R 4.66/5.05 4.86/5.28 4.63/5.22 4.72/5.31 4.94/5.18 4.95/5.16
C2N 6.99 6.97 7.41 7.83 6.93 6.93
C4N 6.46 6.49 6.45 6.51 6.50 6.50
C5N
C6N
C7N 7.24 7.16 7.31 7.40 7.17 7.18
C8N
C9N
C10N 2.29 2.28 2.28 2.30 2.29 2.29
C11N 2.27 2.28 2.28 2.32 2.28 2.28
Assignment by 1H-NMR, 1H,13C-HSQC correlation and comparison with B12 (1). aThe protons at C175 and C176 
were not assigned specifically. bThe protons at C175, C176, C3P and C31P were not assigned specifically. cmain 
rotamer.
Experimental Procedures
96
Table 8: Comparison of NMR chemical shift values for 26-26, 29-M, 26-H, 29-H, α-
aqua-β-cyano-cobinamide (Cbi-CNβ) and β-aqua-α-cyano-cobinamide (Cbi-CNα):
                        δ 1H[ppm]
29-M 29-H [a] Cbi-CNβ 26-26 26-H [a] Cbi-CNα B12-CNα
α-imidazole 
β-cyano
 α-aqua
β-cyano
α-aqua
β-cyano
α-cyano
β-imidazole
α-cyano
β-aqua
α-cyano
β-aqua
α-cyano
β-aqua
C1
C1A 0.69 1.37 1.38 1.54 1.71 1.73 1.67
C2
C2A 1.50 1.61 1.62 1.54 1.64 1.64 1.56
C3 4.11 4.11 4.11 4.11 3.99 4.00 3.98
C4
C5
C6
C7
C7A 1.81 1.82 1.82 1.67 1.74 1.74 1.76
C8 3.47 3.68 3.68 3.67 3.68 3.69 3.69
C9
C10 6.10 6.53 6.52 6.03 6.46 6.45 6.48
C11
C12
C12A 1.50 1.41 1.42 1.54 1.35 1.37 1.32
C12B 1.21 1.17 1.18 1.21 1.35 1.35 1.35
C13 3.33 3.48 3.48 3.51 3.57 3.57 3.54
C14
C15
C16
C17
C17B 1.45 1.61 1.61 1.38 1.58 1.58 1.59
C18 2.71 3.09 3.10 3.40 3.11 3.13 3.07
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C19 4.09 4.26 4.25 3.21 4.08 4.08 4.08
C21 2.34/2.47 2.39/2.49 2.37/2.47 1.51/2.05 2.23/2.34 2.24/2.35 2.22/2.33
C31 2.05/2.24 2.18
C32 2.59 2.59
C51 2.40 2.37 2.38 2.42 2.42 2.44 2.41
C71 2.26/2.61 2.23/2.57 2.23/2.56 2.71/2.88 2.74 2.74 2.75
C81 1.37/2.17 2.00/2.45
C82 1.37/2.56 2.20/2.38
C131 1.96 1.96/2.19
C132 2.64 2.37
C151 2.50 2.45 2.47 2.52 2.41 2.41 2.40
C171 2.44/2.50 2.35/2.50
C172 1.82/2.02 2.11/2.82
C175 3.18/3.37[b] 3.21/3.40[b]
C176 3.29[b] 3.34[b]
C177
C181 2.74/2.85 2.66
C3P
C179 2.15/2.30 2.06/2.42
C180 2.70 2.68/2.83
C2N 6.65 8.62 7.05 8.53
C4N 5.84 7.26 5.35 7.17
Assignment by 1H-NMR, 13C-NMR, 1H, 13C-HSQC correlation, ROESY and comparison with B12. 
aCompound 1-H and 2-H are partially signed for comparison with Cbi-CNβ and Cbi-CNα.
bThe protons at C175 and C176 positions were not assigned specifically.
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Table 9: NMR chemical shift values for 30, 31, 33 and 34:
δ 1H[ppm]
31 30 33 34
C1
C1A 0.50 0.61 0.48 0.48
C2
C2A 1.40 1.36 1.40 1.37
C3 4.13 4.18 4.07 4.03
C7A 1.75 1.78 1.76 1.79
C8 3.33 3.44 3.26 3.25
C9
C10 5.97 6.20 6.02 6.02
C11
C12
C12A 1.36 1.42 1.45 1.43
C12B 0.88 0.72 1.14 1.1
C13 2.91 2.96 3.23 3.21
C17B 1.39 1.43 1.36 1.39
C18 2.66 2.52 2.67 2.67
C19 4.36 4.35 4.09 4.13
C21 2.45 2.43 2.21/2.30 2.33
C31 2.00/2.10 2.09 1.98/2.06 2.02/2.08
C32 2.53 2.55 2.48/2.54 2.49/2.55
C51 2.50 2.42 2.45 2.48
C71 1.77/2.26 1.85/2.34 1.66/2.04 1.86/2.26
C81 0.84/1.79 1.00/1.87 0.85/1.80 0.83/1.78
C82 0.95/1.75 1.24/1.84 1.00/1.76 0.83/1.82
C131 2.04/2.24 1.99/2.20 2.09 2.08
C132 2.58 2.51 2.64 2.63
C151 2.47 2.50 2.50 2.5
C171 2.10/2.48 1.97 1.82/2.54 1.81/2.55
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C172 1.86/2.58 1.83/2.53 2.10/2.46 2.44
C175 3.18/3.57 3.53/3.35 3.14/3.57 3.14/3.56
C176 4.26 3.43/3.16 4.34 4.33
C177 1.24 1.24 1.21
C181 2.67 2.67 2.63/2.72 2.64/2.73
C3P 3.77/3.94
C1R 6.27 4.96/4.89 6.27 6.27
C2R 4.26 4.24 4.23
C3R 4.78 4.74 4.72
C4R 4.12 4.10 4.1
C5R 3.77/3.92 3.77/3.92 3.75/3.91
C2N 6.97 7.03 6.95 6.95
C4N 6.27 6.49 6.24 6.25
C5N
C6N
C7N 7.19 7.10 7.18 7.17
C8N
C9N
C10N 2.24 2.25 2.23 2.22
C11N 2.24 2.24 2.22 2.22
C1RL 5.60 4.83 4.76
C2RL 4.57 4.51
C3RL 3.78 3.83
C4RL 2.68 2.75 1.71/2.21 1.68/2.22
C5RL 0.60/1.56 0.47/1.30 0.32/1.11 0.49/1.21
C2L(C1L) 8.26 8.27 7.26(7.41) 8.15
C3L 7.26
C6L 7.77
C8L 8.04 8.04 8.12 8.03
Assignment by 1H-NMR, 1H, 13C-HSQC correlation and comparison with adenosyl B12.
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Vitamin B12 Mimics Having a Peptide Backbone and Tuneable
Coordination and Redox Properties**
Kai Zhou and Felix Zelder*
Cobalamines (Cbls) are corrinoids that can adopt different
constitutional states, in which the dimethylbenzimidazole
base (Dmbz) is either bound (base on) or has been displaced
(base off) from the Co center of the macrocycle.[1,2] This
equilibrium plays an important role for the delivery, trans-
formation, and reactivity of vitamin B12 (1, CNCbl) and its
organometallic analogues.[3] Small amounts of base-on vita-
min B12 (10 mg per day) are channeled through a sophisticated
and highly selective pathway into the cells before it is
converted to the cofactors adenosylcobalamin (AdoCbl)
and methylcobalamin (MeCbl).[4]
Only recently, the reductive decyanation of base-on
CNCbl to a base-off CoII species catalyzed by the trafficking
chaperone MMACHC was reported.[5] Difficulties in this
reduction are related to mutations of the corresponding
MMACHC genes,[4] and medical studies suggest some ther-
apeutic effect for Cbl derivatives that are easier to reduce
than 1 to the intermediate CoII state.[6,7]
Detailed studies have been reported for the inorganic
chemistry of Cbls with different ligands at the b side (upper
side),[8–10] but rather little is known how structural changes at
the a side (lower side) of the molecule influence the
coordination behavior of the Dmbz base[11–13] and the
corresponding redox properties of the metal ion. Herein, we
report on the coordination chemistry and accompanying
electrochemical properties of a new class of vitamin B12
mimics in which a peptide linker tethers the corrin macrocycle
to the Dmbz base.
Kr!utler et al. demonstrated in an elegant study that a
single methyl group quite distant from the coordination site
stabilizes the base-on form of natural Cbls, as had been
predicted earlier by Eschenmoser et al.[11,14] In another
pioneering study, Toraya and Ishida replaced the a-ribofur-
anotide moiety in vitamin B12 with “methylene bridges” of
different length.[12]
With a view toward future biological applications, we are
interested in the development of artificial derivatives of
vitamin B12 with tuneable coordination and electrochemical
properties. We decided to investigate the replacement of the
ribose phosphodiester moiety of vitamin B12 with peptide
structures containing the same number of atoms between the
corrin macrocycle and the nitrogen donor of the Dmbz base
(Scheme 1), because amides have already been excellent
mimics of phospodiesters in other natural products leading to
derivatives with interesting novel physico-chemical properties
and biological functions.[17–20]
An energy-minimized structure of 2+ (Scheme 2, top
right) was obtained from semiempirical quantum chemical
calculations (PM3, Spartan "06 software) in which the Dmbz
base is in a similar position as in its natural counterpart 1. The
artificial linker 8was synthesized in six steps and coupled with
dimethylaminopyridine and N’-(3-dimethylaminopropyl)-N-
ethylcarbodiimide hydrochloride to dicyanocobyric acid 7[15]
to yield 2 in 62% yield (Scheme 2).[16]
The high-resolution mass spectrum of 2 displays the signal
of a [M]+ ion atm/z 1243.59334 (m/zcalc 1243.59337) consistent
with the molecular formula C61H84CoN16O9. Compound 2 was
further characterized by UV/Vis spectroscopy, RP-HPLC,
1H NMR analysis, and 1H,13C-HSQC correlations.[16] The UV/
Vis spectra of base-on vitamin B12 (1) and 2 are identical, but
differ significantly (Dlmax= 29 nm) from the absorption
spectra of aquocyano-cobinamide indicating that 2 occurs in
its base-on form.[16] The corresponding 1H NMR spectra show
only minor shifts for the signals of the corrin macrocycle as
well as the Dmbz base, but differ substantially for the
connecting linker (Figure 1).[16]
Scheme 1. Structural formula of vitamin B12 (1) and the peptide B12
prototype 2+. The natural linker in 1 and the peptide mimic in 2+
contain the same number of atoms (shown in blue; the complete
atom numbering is given in the Supporting Information).
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The intramolecular dissociation of the Dmbz base
(Table 1, top left) of 2 was studied by spectrophotometric
pH titration. The stability of the coordinated base-on form of
2 (pKbase-off= 1.38) is 19 times lower (K*; Table 1 entry 2 vs. 1)
than that of the natural counterpart, which displays strong
intramolecular coordination and a low pKbase-off value of 0.1.[2]
On the other hand, the value indicates that the preference of 2
for the base-on constitution is 25 times greater than that of
another artificial vitamin B12 analogue, 6,[12,21] in which the
linker contains a phosphodiester (Table 1 entry 6). The
altered coordination properties of 2 affect the reduction of
the octahedral cobalt(III) to the square-pyramidal cobalt(II)
complex with loss of the b-cyano group (Table 1, top right)
and was investigated with cyclic voltammetry (CV) in water
([Tris]= 0.2m, pH 8.0; Tris= tris(hydroxymethyl)aminome-
thane). The CV trace of 2 displays a cathodic Epc* value at
!1.056 V, a value 70 mV more positive than in 1. The
facilitated reduction of cobalt(III) in 2 can be explained by
a lower electron density at the metal center resulting
from the weaker coordination of the Dmbz base.
We envisaged that an enhanced rigidity of the linker
structure might lead to a tighter intramolecular coordi-
nation which would make the reduction from cobalt(III)
to cobalt(II) more difficult. First, we decided to replace
the glycine unit in the linker of 2with (l)-proline to yield
3 (Scheme 2). We thought that this cyclic building block
might act as a turn mimic; it would mimic the a-ribose
moiety of natural cobalamines and thus stabilize the
base-on form. Compound 3 (Scheme 2) was synthesized
as described in the Supporting Information. The stability
of the base-on form of 3 (pKbase-off= 0.97) increased by a
factor of 2.6 compared to the prototype 2, and electro-
chemical studies showed that 3 is—as expected—more
difficult to reduce to CoII than 2 (DV=!21 mV; Table 1,
entry 3).
In natural cobalamines the methyl group at C176 of
R configuration plays an important role in the stabiliza-
tion of the base-on form,[11] and we envisaged a
comparable effect for the peptide B12 mimics. To test
this hypothesis, derivative 4, which has an R-configured
methyl group at C176, was synthesized from 10 and 7
(Scheme 2).[16] The base-on form of 4 (pKbase-off= 0.62) was
favored by a factor of two, and the reduction fromCoIII to CoII
was more difficult than in 3 (DV=!19 mV; Table 1 entry 4 vs.
3), which lacks this modification. The influence of the remote
methyl group on the base-on/base-off equilibrium in 4 is
almost identical to that observed for natural cobalamines;[11]
this underscores the utility of peptide structures as artificial
linkers in vitamin B12 analogues.
In earlier studies Eschenmoser et al. claimed that a
change in configuration at C176 from R to S may destabilize
the base-on constitution of vitamin B12.
[14] This behavior can
be explained by an additional gauche effect in the base-on
form.[16] Encouraged by our findings with 4, we synthesized
and characterized its epimer 5 (Scheme 2). This derivative, in
Scheme 2. Synthesis of peptide B12 derivatives 2
+–5+ from dicyanocobyric
acid (7)[15]and peptide linkers 8–11.[16] Compounds 2+–5+ were isolated as
2+·CF3COO
!–5+·CF3COO
! (2–5). Derivative 2+(top right) is shown as the
energy-minimized structure (Spartan ’06, PM3 semiempirical calculation; H
atoms not shown). Fmoc=9-fluorenylmethoxycarbonyl.
Figure 1. 1H NMR spectrum of 2 (top) and 1 (bottom) in D2O. The
arrows indicate corresponding positions of signals arising from the
corrin ring and the Dmbz base. The assignments refer to the protons
of the linker (Scheme 1).
Table 1: Base-on/base-off (left) and CoIII/CoII equilibria (right).
Entry Compound pKbase-off K*
[a] Epc* [V]
[b]
1 1 0.1[c] 19 !1.126
2 2 1.38 1 !1.056
3 3 0.97 2.6 !1.077
4 4 0.62 5.8 !1.096
5 5 1.64 0.55 !1.039
6 6[d] 2.8[d] 0.04 n.r.[e]
[a] K*=Kbase!off(x)/Kbase!off(2). [b] Epc*=Epc!E0’ (see the Supporting Infor-
mation). [c] Ref. [2]. [d] Refs. [12,21]. [e] n.r.=not reported.
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which the methyl group at C176 has an S configuration,
displays a pKbase-off of 1.64, an tremendous tenfold destabili-
zation of the base-on form compared to that of 4. It is
remarkable that the energetically unfavorable conformation
of the cyclic base-on structure of 5 outweighs the entropic
gain obtained from the preorganization of the linker struc-
ture; this is reflected in a higher pKbase-off value of 5 compared
to that of the prototype 2 (Table 1 entry 5 vs. 2). The switch of
configuration at C176 also has electrochemical consequences:
derivative 5 is roughly 60 mVeasier to reduce than its epimer
4.
The peptide B12 mimics 2–5 show a linear correlation
between the cathodic Epc* values of the Co
III/CoII reduction
and their pKbase-off values (DV= 57 mV, DpKbase-off= 1.02;
Figure 2). Since the same b-cyano group is released from
the cobalt center during reduction from cobalt(III) to
cobalt(II) (Table 1, top right), the entropy of the reaction
must be comparable and thus the reduction potentials are
directly related to the enthalpy of the Co!CN bond. A lower
pKbase-off value corresponds to a stronger coordination of the
Dmbz base and increasing back-donation from the Co ion to
the ß-cyano group. This may subsequently hamper reduction
and shift the redox potential to a more negative value.
In summary, we have introduced a new class of vitamin B12
mimics in which a peptide linker tethers the corrin macrocycle
to the Dmbz base. Studies with four different peptide B12
derivatives demonstrated that through the appropriate design
of the peptide backbone both the coordination and the
accompanying redox properties at the Co center can be
adjusted. This implies that it might be possible to fine-
tunereactivity in cofactor-catalyzed reactions in which an
intermediate base-on cobalt(II) species is the catalytically
active species. The development of organometallic peptide
B12 analogues for biological applications as well as further
modifications of the linker for physico-chemical studies are
subjects of current research.
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Identification of Diastereomeric Cyano–Aqua Cobinamides with a Backbone-
Modified Vitamin B12 Derivative and with 1H NMR Spectroscopy
Kai Zhou[a] and Felix Zelder*[a]
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A new backbone-modified vitamin B12 derivative with an
unusual configuration at the cobalt center has been used for
Introduction
Cobinamides (Cbi) are “incomplete” corrinoids lacking
the dimethylbenzimidazole (Dmbz) -containing α-ribazole-
3!-phosphate linker of natural cobalamins (Cbl).[1,2] These
biologically important vitamin B12 (B12) precursors repre-
sent useful starting materials for the preparation of chemi-
cally modified analogues.[3,4] Recently, “incomplete” corrin-
oids have regained considerable attention as biologically in-
spired catalysts[5–7] as well as chemosensors for the straight-
forward detection of cyanide (Figure 1).[8–10]
Enormous effort has been devoted by Friedrich et al. to
characterize axial diastereomers of cyano–aqua Cbi.[11–13]
In other important studies, Brown et al. assigned, by het-
eronuclear NMR spectroscopy, the α- (lower side) and β-
(upper side) positions of various Cbi with the help of chem-
ically enriched axial ligands and the corresponding Cbl ana-
logues.[14,15] For mixtures of diastereomeric cyano–aqua
Cbi, the 13C NMR signals of the axially coordinated cyano
ligands partially overlap.[16] This behavior seems disadvan-
tageous for the unequivocal assignment of the isolated iso-
mers. For applications such as cyanide detection, only dia-
stereomeric mixtures of “incomplete” cyano–aqua corrin-
oids have been employed,[17–20] whereas initial kinetic stud-
ies suggest differences in cyanide coordination.[20] The iden-
tification and evaluation of well-defined isomers are impor-
tant with regard to future improvements of corrin-based
chemosensors. In this communication, we report the identi-
fication of diastereomeric cyano–aqua Cbi with a back-
bone-modified vitamin B12 derivative and with 1H NMR
spectroscopy.
Results and Discussion
Diastereomeric mixtures of “incomplete” cyano–aqua
corrinoids are generally synthesized by non-selective dis-
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the identification of the two axial diastereomers of cyano–
aqua cobinamides (Cbi) by using 1H NMR spectroscopy.
Figure 1. “Complete” cobalamines 1on–3on and “incomplete” Cobi-
namides 4αβ, 4α, and 4β. The subscript “on” refers to the “base on”
constitution. The subscripts “α” and “β” indicate the position of
the cyano ligand at the lower and upper side of the macrocycle,
respectively (charges have been omitted).
placement of one cyanide from the corresponding dicyano
species under acidic conditions.[20] For instance, α-aqua, β-
cyano- (4β) and α-cyano, β-aqua- (4α) cobinamide are de-
rived from 4αβ (Scheme 1, I) and separated by preparative
reverse-phase C18 chromatography. Differences in their 1H
NMR spectra (Figure 3, bottom) can easily be identified in
a clearly arranged region between 3.9 and 6.6 ppm for the
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Scheme 1. Synthesis of 4α and 4β from 4αβ (I) and of 2α and 2on from 2αβ (II). 4α and its structural analogue 2α are depicted in a frame.
characteristic signals of H3, H10, and H19 of the corrin
ring (Table 1, Entries 1 and 2; Figure 3, bottom). These dif-
ferences are not conclusive with regard to the configuration
at the cobalt center. In order to structurally identify these
isomers, we planned to design a backbone-modified B12
derivative that mimics the structural and spectroscopic fea-
tures of cyano–aqua Cbi in solution. We envisaged that the
removal of one cyano ligand from a “complete” “base off”
dicyano-Cbl derivative (Cblαβ) may lead to a mixture of
Cblα and Cblon (see Supporting Information). “Base off”
Cblα with a well-defined configuration at the metal center
would represent a perfect surrogate of its “incomplete”
counterpart and has comparable 1H NMR signals for the
protons at the corrin macrocycle.
Table 1. 1H NMR data for 4α, 4β, 1on, 2on and (2on + 2α).[a,b]
Entry Corrinoid Configuration H3[c] H10 H19[d]H2N H4N H7N
1 4α α-cyano, β-aqua 4.00 6.45 4.08
2 4β α-aqua, β-cyano 4.11 6.52 4.25
3 2on α-Dmbz, β-cyano 4.23 6.15 4.16 6.99 6.46 7.24
4a (2on + 2α) α-Dmbz, β-cyano 4.24 6.17 4.18 7.01 6.48 7.25
4b (2on + 2α) α-cyano, β-aqua 4.00 6.46 4.06 9.15 7.57 7.71
5 1on α-Dmbz, β-cyano 4.22 6.11 4.12 7.12 6.54 7.31
[a] 500 MHz, 300 K, [D2]D2O. [b] δ, ppm. [c] J = 8 Hz. [d] J =
11 Hz.
In a first experiment, dicyano-B12 (1αβ) was treated with
trifluoroacetic acid at pH 2 (see Supporting Information).
Cyanide removal was indicated by a color change from
violet to red (∆λmax = 30 nm), and the reaction products
were subsequently isolated by using solid-phase extraction
(SPE) techniques as described in the Experimental Section.
The UV/Vis spectrum of the reaction solution coincide with
that of 1on (Figure 2, top) and suggests the rapid formation
of “base on” B12.
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Figure 2. (bottom) UV/Vis spectra of (2on + 2α) (solid line) derived
from 2αβ (Scheme 1, II) in comparison with 2on (dashed line); (top)
UV/Vis spectra of 1on (solid line) derived from 1αβ (see Supporting
Information) in comparison with 1on (dashed line).
1H NMR spectroscopy supports this observation and in-
dicates the formation of more than 85% of 1on after SPE.
Additionally, the formation of a minor product (!15%)
was observed that further converted to 1on. The signals of
the corrin moiety of this intermediate overlap with the sig-
nals of 1on. These drawbacks impede the analysis of the
reaction mixture and preclude potential applications for the
identification of diastereomeric Cbi. Apparently, cyanide
removal from the lower side (α side) of the macrocycle fol-
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lowed by simultaneous coordination of the Dmbz base to
the cobalt center as well as isomerization to 1on are strongly
favored. This behavior can be explained by the strong intra-
molecular coordination of the Dmbz base to the metal cen-
ter, which is expressed by a low pKbase-off value of 0.1[2] for
1on. We assumed that the synthesis of “base off” isomers of
cyano–aqua Cbl would be more favorable, if intramolecular
coordination of the Dmbz base to the metal center would
be weaker than that in 1on. Peptide B12, a recently intro-
duced class of B12 mimics, possesses such tunable coordi-
nation properties.[21] These B12 derivatives with a corrin
macrocycle and a peptide backbone instead of the α-ribo-
furanotide moiety of B12 have the same number of atoms
between the metal center and the nitrogen-anchoring group
of the Dmbz base.
For this project, we decided to synthesize a novel deriva-
tive 2on with a 3-atom shorter backbone than the linker of
the previously described prototype 3on.[21] We speculated
that this structural deviation would lead to a destabilization
of the coordinated “base on” form. A “shortened linker” is
also advantageous with regard to 1H NMR analysis, since
it contains fewer protons that potentially interfere with the
protons of the corrin ring. The B12 derivative 2on was syn-
thesized from dicyano-cobyric acid (5) through an interme-
diate 6 and then coupled with 7 as reported earlier for 3on
(Scheme 2).[21] The high-resolution mass spectrum of 2on in-
dicates a [M]+ ion peak at 1186.57087 (m/zcalcd. =
1186.57191), which suggests a molecular formula of
C59H81CoN15O8. The UV/Vis spectrum (Figure 2, bottom
in dashed line) and 1H NMR signals of the corrin ring and
the Dmbz base of 2on were in accordance to those of 1on
(Table 1, Entries 3 vs. 5) and other peptide B12 derivatives
in its “base on” forms.[21] Spectrophotometric pH titration
reveals that the “base on” stability of 2on (pKbase-off = 2.58)
is indeed 16 and 302 times lower than that of 3on
(pKbase-off = 1.38[21]) and 1on (pKbase-off = 0.1[2]), respec-
tively. For the synthesis of axial diastereomers of 2
(Scheme 1, II), we followed the same strategy as that de-
scribed for the experiments with 1αβ.
The UV/Vis spectrum of the reaction product differs this
time significantly from that of the corresponding “base on”
form (2on) and suggests rather the existence of a mixture of
Scheme 2. Synthesis of 2on from 5: (a) NEt3, ethyl chloroformate, N-Boc-ethylenediamine, DMF, 5 min, 25 °C. (b) HCl (1 ), 1 h, 25 °C.
(c) EDC·HCl, DMAP, DMF, 4 h, 0–25 °C.
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“base on” and “base off” compounds (Figure 2, bottom).
The 1H NMR spectrum shows clearly two sets of signals
for the characteristic signals of the corrin ring at H3, H10,
and H19 [Figure 3, top (2on + 2α)] and of the aromatic
Dmbz base (Table 1, Entries 4a and 4b) in a ratio of ap-
proximately 1:1. This information indicates univocally the
existence of only two forms of backbone-modified B12 de-
rivatives in solution. The chemical shifts and the coupling
constants of one set of signals are identical to those of 2on
(Table 1, Entries 3 vs. 4a). Cobalt-coordinated cyanide at
the lower side (α side) of 2αβ was substituted by the Dmbz
base during cyanide removal to form 2on (Scheme 1, II).
The other set of signals in the mixture show an indicative
downfield shift for the protonated Dmbz base between
0.46–2.14 ppm (Table 1, Entries 4a vs. 4b).[22] This suggests
the existence of 2α with a cyano ligand at the lower side of
the macrocycle derived from the abstraction of the β-cyano
ligand from 2αβ. A “complete” cyano–aqua Cbl with a cy-
ano ligand at the α position has not yet been reported under
neutral conditions, to the best of our knowledge.[23] This
behavior can be explained by the 300-times higher prefer-
ence of the “base off” form of 2on relative to that of 1on.
The mixture of (2on + 2α) synthesized from 2αβ with two
separated sets of indicative 1H NMR signals (H3, H10 and
H19; Table 1, Entries 4a and 4b) serve now for the identifi-
cation of 4α and 4β. Subtraction of the characteristic set of
signals of pure 2on (Table 1, Entry 3) from that of (2on +
2α) (Table 1, Entries 4a + 4b) leads to signals (almost) that
are identical to those of 4α (Table 1, Entry 1; Figure 3, top).
Friedrich et al. reported earlier on “incomplete” cyano–
aqua corrinoids such as cyano–aqua cobinamide and cy-
ano–aqua cobyric acid. They assumed that the slower mi-
grating derivatives shared the same configuration at the co-
balt center and assigned it to the α- (lower side) cyano form
on a tentative basis (Figure 4, inset).[12,13] Later, Firth et al.
showed that a freshly dissolved sample of crystallographi-
cally characterized α-cyano, β-aqua cobyric acid was indeed
the slower migrating derivative.[24] The UV/Vis spectra of
4α was slightly blueshifted relative to that of 4β (Figure 4).
This is in agreement with earlier reports and confirms now
unequivocally Friedrich’s earlier assumptions on the config-
uration at the metal center.[11–13]
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Figure 3. (Bottom) 1H NMR spectra of 4α (above) compared to 4β (below). Characteristic signals are indicated. (Top) Identification of
4α by analysis of the chemical shifts of H3 and H19: signals (4α) = signals [(2on + 2α) – 2on] (500 MHz, 300 K, D2O).
Figure 4. UV/Vis spectra of 4α (α-cyano,β-aqua-cobinamide:
dashed line) and 4β (α-aqua,β-cyano-cobinamide, solid line). [4α] =
[4β] = 46 µ. The dotted lines over layer and indicate 4αβ from the
reaction of 4α and 4β with excess KCN* (ref.[11–13]).
www.eurjic.org © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Inorg. Chem. 2011, 53–5756
Conclusions
We present a new backbone-modified vitamin B12 deriv-
ative with an unusual configuration at the cobalt center.
This compound has been used for the identification of the
two axial diastereomers of cyano–aqua cobinamides (Cbi)
by using 1H NMR spectroscopy. The results are in agree-
ment with earlier tentative assignments. We envisage that
backbone-modified B12 derivatives with adjustable coordi-
nation properties will find further interesting chemical, ana-
lytical and biological applications.
Experimental Section
Synthesis of 4α and 4β: Compound 4αβ (20.8 mg, 20 mmol) was dis-
solved in 0.1% aqueous TFA (10 mL), and the reaction solution
was stirred for 10 min. Compound 4α (10.1 mg, 8.8 mmol, 44%)
and 4β (10.3 mg, 9.0 mmol, 45%) were separated by preparative
Appendix II! XII
Identification of Diastereomeric Cyano–Aqua Cobinamides
HPLC as the corresponding TFA salts. 1H NMR (500 MHz, [D2]-
D2O): see Supporting Information. MS (ESI-MS): m/z (%) =
1015.6 (100) [M – H2O]+. HPLC-UV/Vis: Rt = 8.8 min (4α), Rt =
13.5 min (4β).
Synthesis of 2on: Intermediate 6 was synthesized from dicyano-
cobyric acid (4.9 mg, 5.0 µmol) as described in previous work.[21]
It was dissolved in DMF (1 mL) and cooled to 0 °C, after which
DMAP (1.0 mg, 8 µmol) and 7[21] (4.5 mg, 15 µmol) were added.
After 10 min, EDC·HCl (3.0 mg, 15 µmol) was added. The solution
was warmed up to room temperature. After 4 h, the solvent was
removed under reduced pressure. The residue was washed with ace-
tone and further purified with preparative HPLC to afford 2on
(3.8 mg, 2.9 µmol, 58%) as the corresponding TFA salt. 1H NMR
(500 MHz, [D2]D2O): see Supporting Information. HR-MS: calcd.
for C59H81CoN15O8 [M]+ 1186.57191; found 1186.57087. UV/Vis
(c = 30 µ, 0.2  KCl, pH = 5.98): 548 nm (3.96), 521 nm (3.94),
413 nm (3.72), 361 nm (4.43), 279 nm (4.27), HPLC-UV/Vis: Rt =
14.2 min; pKbase-off = 2.58.
Synthesis of (2on + 2α): Compound 2on (1.3 mg, 1.0 µmol) and KCN
(1.3 mg, 20 µmol) were dissolved in water (5 mL) to obtain a violet
solution of 2αβ. The pH value of the solution was adjusted to 2
with trifluoroacetic acid. After purging the solution with N2 for
20 min to remove HCN, the reaction solution was adsorbed on a
reverse-phase Chromafix® C18ec cartridge. It was washed with
water (30 mL) and then eluted with MeOH (3 mL). The solvent
was removed under vacuum to yield 2on and 2α as a mixture of the
corresponding TFA salts (1.3 mg, 100%). ESI-MS: m/z (%) =
1186.6 (100) [M]+ for 2on or [M – H2O]+ for 2α.
Synthesis of (1on + 1α): The synthesis and separation was performed
as described for the synthesis of (2on + 2α) starting from 1αβ. The
UV/Vis spectrum of (1on + 1α) is shown in Figure 2 (top).
Supporting Information (see footnote on the first page of this arti-
cle): Materials and methods, the general atom numbering of B12
derivatives, the synthesis of Cblα and Cblon, and NMR chemical
shifts for 2on, 4α, and 4β.
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INTRODUCTION
Cobinamides (Cbi), the “incomplete” biological pre-
cursors of vitamin B12 (B12) are cobalt complexes with 
a tetradentate corrin macrocycle at the equatorial posi-
tions, while the two axial vacant binding sites can be 
bound by other ligands [1, 2]. The nature of these ligands 
influences strongly the electronic properties of the cor-
rin chromophore [3, 4]. This behavior makes this class 
of compounds useful for analytical applications [5–7]. 
“Incomplete” corrinoids are among the most promis-
ing chemosensors for the rapid, visual detection of µM 
cyanide in water [8–12]. This class of compounds was 
also the first that has been successfully applied to visu-
ally detect endogenous cyanide in plants [13]. Up to now, 
only mixtures of “incomplete” diasteromeric cyano-aqua 
corrinoids such as cyano-aqua Cbi have been applied 
[9, 13]. Different synthetic protocols for the preparation 
of cyano-aqua Cbi are available. Most widely used for 
this purpose are Ce(III) salts [14]. Disadvantages of this 
methodology is the need to generate dicyano-B12 from 
B12 with additional cyanide prior to the phosphodiester 
cleavage with the metal salt [14, 15]. Brown and cowork-
ers developed a useful method for the phosphodiester 
hydrolysis of alkylcobalamins under strictly anhydrous 
conditions [16]. Improvements of existing synthetic pro-
tocols [17] as well as the development of novel modi-
fied B12-derivatives with altered properties are important 
for further progress and new applications of corrinoids 
[18–21]. Based on earlier work of Müller and Müller 
[22], we present a metal-ion mediated one-step synthe-
sis of cyano-aqua Cbi as a useful alternative to existing 
 synthetic protocols.
EXPERIMENTAL
General
Chemicals: B12 was a generous gift from DSM Nutri-
tional Products AG (Basel/Switzerland). All salts were 
either obtained from Fluka or Aldrich with a purity r98%.
HPLC solvents were 0.1% aqueous trifluoroacetic 
acid (A, TFA) and methanol (B). HPLC analyses were 
performed on a Merck-Hitachi L-7000 system equipped 
with a diode array UV-vis spectrometer and Macherey 
Nagel Nucleosil C-18ec RP columns (5 µm particle size, 
100 Å pore size, 250 × 3 mm. Flow rate: 0.5 mLmin-1). 
Preparative HPLC separations were performed on a 
Varian Prostar system equipped with two Prostar 215 
pumps, a Prostar 320 UV-vis detector and Macherey 
Nagel Nucleosil C-18ec RP columns (7 µm particle size, 
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100 Å pore size, 250 × 40 mm. Flow rate: 32 mLmin-1). 
HPLC-ESI-MS spectra were measured on a Bruker HCT 
spectrometer equipped with an Aquinity UPLC (Waters) 
using Nucleosil C-18ec RP columns (5 µm particle size, 
100 Å pore size, 250 × 3 mm. Flow rate: 0.3 mLmin-1). 
HPLC-ESI-MS solvents were 0.1% formic acid (solvent 
A) and methanol (solvent B). The following gradient 
was used for all HPLC, HPLC-ESI-MS and preparative 
HPLC measurements: 25% B for 5 min, then in 25 min 
to 100% B, then 100% B for 10 min.
UV-vis spectra were recorded on a Cary 50 spectrom-
eter using quartz cells with a path length of 1 cm.
NMR spectra were recorded on a Bruker AV-500 spec-
trometer (Karlsruhe, Germany). The data processing was 
carried out with ACD/SpecManager (Advanced Chemis-
try Development) as described in Ref. 31.
Chromafix C18ec for solid phase extraction (SPE) was 
obtained from Macherey Nagel. In general the compound 
was dissolved in little water, transferred to the adsorbent, 
washed with water and eluted with MeOH.
For safety reasons, the removal of cyano-ligands from 
the corresponding dicyano-complexes was performed 
under a well-ventilated fume hood and an HCN-detector 
from Dräger was used.
For security reasons, reactions with nitrates were 
 performed behind an additional safety shield.
Synthesis
Preparation of B-aqua-C-cyano-cobinamide (2) and 
B-cyano-C-aqua-cobinamide (3) as the corresponding 
TFA salts. General procedure: B12 (1, 20 mg, 15 µmol) 
and Cu(NO3)2·3H2O (50 mg, 163 µmol) were dissolved 
in methanol (2 mL) and stirred for 20 min at 100 °C 
in a Young Tube (1 cm × 15 cm) sealed with a Teflon 
cap. After cooling the solution to room temperature, 
the methanol was removed under reduced pressure. The 
residue was dissolved in water (5 mL) and desalted with 
the help of SPE. Subsequently, it was separated by pre-
parative reverse phase HPLC to yield A-cyano-B-aqua-
cobinamide (3; Rt = 8.8 min; 6.9 mg, 6.0 µmol, 40%) and 
A-aqua-B-cyano-cobinamide (2; Rt = 13.5 min; 3.9 mg, 
3.4 µmol, 23%) as their corresponding TFA salts. 1H NMR, 
UV-vis, ESI-MS data of 2 and 3 were in agreement with 
the analytical data of 2 and 3 reported in Ref. 31. For 
security reasons, the reactions were performed behind an 
additional safety shield.
RESULTS AND DISCUSSION
Synthesis of 2 and 3 from 1
Müller and Müller applied highly concentrated solu-
tions of ZnCl2 in MeOH (1 g/mL) at 170 °C for the con-
version of vitamin B12 to cyano-aqua cobyric acid via 
a cobinamide intermediate [22, 23]. In contrast to the 
well-established Ce(III)-method, this procedure did not 
need to generate dicyano-B12 from B12 with additional 
cyanide before phosphodiester hydrolysis. Inspired by 
these important studies, we intended to screen different 
metal salts for their ability to cleave B12 to cyano-aquo 
Cbi 2 and 3. For this purpose we selected different metal 
salts with cations such as Co2+, Ni2+, Cu2+, Mg2+ or Zn2+ 
HN
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3: R1 = CN, R2 = H2O
CH3OH, 100 ˚C
Scheme 1. Conversion of B12 (1) to A-aqua-B-cyano-cobinamide (2) and A-cyano-B-aqua-cobinamide (3) obtained as the corre-
sponding TFA salts. Charges have been omitted
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as summarized in Table 1. Metal-complexes of some of 
these cations were already successfully applied towards 
the hydrolysis of phosphodiester bonds in other mole-
cules than B12 [24–28]. The sulfate and chloride salts of 
these cations as well as Cu(NO3)2·3H2O were tested. We 
did not test other nitrates due to their potentially explo-
sive nature [29]. CoSO4 was not soluble under the reac-
tion conditions. First, the reactions were carried out as 
described in the Experimental section, but at 140 °C.
The reaction mixtures were analyzed at different 
time-intervals with HPLC-ESI-MS spectrometry and the 
retention times of the molecular ion peaks were compared 
to those of commercially available B12 (1; Rt = 14.9 min; 
[M + H]+, m/z: 1355.6) and a mixture of diastereomeric 
cyano-aqua cobinamide (2: Rt = 13.5 min, [M - H2O]+, 
m/z: 1015.6; 3: Rt = 8.8, [M - H2O]+, m/z: 1015.6). The 
latter compounds have been obtained from the non-selec-
tive abstraction of one cyano-ligand from commercially 
available dicyano-cobinamide (4) under acidic condi-
tions [4, 9]. Cobalt(II), nickel(II), and magnesium(II) 
salts did not convert B12 to 2 and 3 (Table 1). In contrast, 
the formation of 2 and 3 was observed within a complex 
reaction mixture using CuCl2. Substituting CuCl2 with 
Cu(NO3)2·3H2O led to more than 90% conversion of B12 
to cyano-aqua Cbi (2, 3). Similar results were obtained 
with ZnCl2 (Table 1). Under these reaction conditions, 
the formation of less than 5% of side-products has been 
observed with HPLC-ESI-MS.
We assume that amide side-chains of the corrin ring 
have been unselectively transformed to the corresponding 
methyl-esters as suggested by molecular ion peaks with a 
15 units higher m/z ratio. Isomerization of the B-(upper) 
cyano ligand to the A-(lower) position of the macrocyclce 
occurred during conversion of 1 to a mixture of 2 and 3. 
This behavior has been observed earlier for “incomplete” 
cyano-aqua corrinoids at elevated temperatures [3, 30]. 
The most promising two candidates, Cu(NO3)2·3H2O and 
Table 1. Screening of different metal salts for the synthesis of 
cyano-aqua Cbi (2, 3) from B12 (1)
 Zn2+ Co2+ Ni2+ Mg2+ Cu2+
Cl-  × × × /×
NO3- n.t. n.t. n.t. n.t. 
SO42- × n.t. × × ×
Conditions: B12 (20 mg; 15 Mmol), metal salt concentration 
(25 mg/mL in MeOH (2 mL)), T = 140 °C, Young Tube (see 
Experimental section for details). LC-MS-Analysis: : obser-
vation of >90% of 2 and 3. /×: 2 and 3 was observed within a 
complex reaction mixture ×: observation of <5% of 2 and 3. 
n.t.: not tested.
Co
CN
HN O
CN
Co
OH2
HN O
CN
Co
CN
HN O
OH2
or
OHOH OH
+ CN
3 2 4
Scheme 2. Top: Synthesis of dicyano-cobinamide (4) from cyano-aqua cobinamide (2 or 3). Bottom: Comparison of the 1H NMR 
spectra of 4 from a commercial source (down) and from the reaction of cyanide with a mixture of 2 and 3 (up). The latter compounds 
have been obtained from the Cu(NO3)2·3H2O mediated cleavage of B12. Charges have been omitted
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ZnCl2 (Table 1), were selected for further optimization. 
Lower temperature and metal salt loading as well as shor-
ter reaction time were aimed to reduce the formation of 
the undesired side-products.
We identified Cu(NO3)2·3H2O (25 mgmL-1) as the 
most efficient metal salt for the formation of 2 and 3 at 
100 °C in 20 min. With ZnCl2 higher reaction tempera-
ture and longer reaction time were necessary (Table 2). 
Compound 2 and 3 were isolated with preparative C18-
reverse phase HPLC in a total yield of 63%. The isolated 
yield of 2 (23%) was lower than that of 3 (40%) since 
it could not be completely separated from B12 and the 
A-ribazole moiety by preparative HPLC. It is possible 
to improve the isolated yield of 2 to 41% with an addi-
tional Amberlite XAD-2 column prior to separation by 
preparative HPLC [16]. The products were analyzed 
with 1H NMR, UV-vis spectroscopy and ESI-MS spec-
trometry and the analytical data were in agreement with 
earlier reports [31]. Coordination of cyanide to a mixture 
of 2 and 3 obtained from the Cu(II) mediated cleavage of 
B12 led to the formation of the corresponding dicyano-
species 4.
The corresponding 1H NMR spectra were identical 
to those of commercially available 4 (Scheme 2). This 
behavior suggests that undesired isomerization at the 
periphery of the corrin ring did not occur.
CONCLUSION
We identified Cu(NO3)2·3H2O and ZnCl2 in MeOH 
as a useful one-step alternative for the preparation of 
cyano-aqua cobinamides from B12. Advantages of these 
reagents compared to the well-established Ce(OH)3 [14, 
15] and CF3SO3H [16] methods seem to be the shorter 
reaction time and the simplified work-up procedure. In 
contrast to the application of Ce(III) salts, there is no 
need to use additional cyanide (Fig. 1), but large excess 
of metal salts, high temperatures and separation with 
preparative HPLC are still required. The practicability 
of this method for the preparation of large quantities 
(e.g. in gram scale) of the products still has to be demon-
strated. On the basis of these experiments, we intend to 
identify the underlying cleavage mechanism and develop 
metal-complexes for the catalytic phosphodiester hydro-
lysis of B12 in the near future.
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‘‘Intra base off/inter base on’’ coordination: self-assembly of a dimeric
vitamin B12 derivative with a versatile tailw
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A self-complementary, artificial vitamin B12 derivative dimerises in
an unprecedented ‘‘intra base off/inter base on’’ coordination mode.
Coordination chemistry is fundamental for understanding
the form, function and reactivity of many protein-cofactor
complexes.1–3 The three dimensional structure of these biological
assemblies is controlled by multiple intermolecular interactions.
Binding of a cofactor to a protein side chain through
non-covalent coordinative bonds is often observed.4–7 These
principles have inspired chemists to develop artificial porphyrin
assemblies.8–12
Supramolecular complexes of ‘‘complete’’ corrinoids are
rare. Examples include a rotaxane cobalamin (Cbl)-dimer that
is bridged by a metallorganic linker13 and a Cbl with a
dissociated, encapsulated dimethylbenzimidazole (Dmbz)
base.14
Herein, we describe a new structural motif for ‘‘complete’’
corrinoids: self-assembly of a dimeric B12 derivative in an
‘‘intra base off/inter base on’’ mode (Fig. 1, right). The design
of the self-complementary building block was based on our
understanding of the structure and function of natural
Cbls.15,16 In the latter, the accessibility of the Co(III) centre
at the a-face of the macrocycle combined with connection of
the u-turn shaped nucleotide loop to the a-directing f-side
chain defines intramolecular coordination of the Dmbz base to
this face of the macrocycle (Fig. 1 left).17
To overcome this limitation and render self-assembly possible,
we envisaged a modified Cbl having a flexible loop at the f-side
chain, a free coordination site at the b-, but denied access at
the opposite face of the octahedral complex (Fig. 1 right).
Coordination of cyanide to the a-face is ideal for prevention
of intramolecular coordination. The binding of cyanide to
diaqua-corrinoids with formation constants of 1014 M!1
is much higher compared to those with other ligands.3,18
Coordination can therefore only occur at the b-face of the
corrin macrocycle (Fig. 1 right). Compound 1-H with a
deamino-histidine linker as well as the desired b-aqua, a-cyano
constitution at the Co(III) centre seemed to be a good choice to
be tested as self-complementary building block and was
synthesized from dicyano cobyric acid (Cby-CN) in 38% yield
as outlined in Scheme 119,20
The constitution of the axially bound ligands of 1-H
was verified with 1H-NMR spectroscopy and comparison to
characteristic signals of the corrin macrocycle of b-aqua,
a-cyanocobinamide.20,21 Deprotonation of the imidazole base
of 1-H under neutral conditions (pH 7.0, ‘‘Britton-Robinson
buffer’’) led to a red shift in the UV-vis spectrum suggesting
the formation of a base on Cbl species.3,20 Coordination of
imidazole to the cobalt(III) centre of 1-1 was also observed with
1H-NMR spectroscopy.The signals of the imidazole ligand are
characteristically upfield shifted (Dd = 1.48 ppm for H2N and
1.82 ppm for H4N; H2N and H4N are indicated in Fig. 2)
because of shielding from the ring current of the macrocycle.
1H-ROESY spectroscopy has been used to investigate the
coordination sites of the imidazole groups in 1-1. NOEs
between imidazole (H2N and H4N) and side chains of the corrin
macrocycle directing to the b-face confirm Co(III)-imidazole
coordination at this site of the macrocycle (Fig. 2). The proton
H2N is oriented toward the northern and H4N to the southern
part of the corrinoid suggesting that the base is positioned
parallel to the C51- C151 axis.
Dimerisation of 1 to 1-1 was also indicated by concentration
dependent UV-vis spectroscopy at pH 8.0. At high total
‘‘cobalt concentration’’22 ([Co]total = 174 mM), the spectrum
is similar to those of Cbls in the base on form.
Fig. 1 Left: Intramolecular coordination of vitamin B12 (B12; ‘‘intra
base on’’). Right: Intermolecular coordination of an artificial B12
derivative to the ‘‘intra base off/inter base on’’ dimer 1-1 (The corrin
ring is simplified for clarity. Charges of the macrocycle and counterions
(CF3COO
!) have been omitted. The same principles have been applied
in the following Schemes and Figures).
Institute of Inorganic Chemistry, University of Zu¨rich,
Winterthurerstrasse 190, 8057 Zu¨rich, Switzerland.
E-mail: zelder@aci.uzh.ch, www.zelder.ch.vu; Fax: + 41 44 635 6803
w Electronic supplementary information (ESI) available: Experimental
details and additional schemes, tables and figures. See DOI: 10.1039/
c1cc14996b
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Stepwise dilution leads to a blue shift and a change of the
intensity ratio of the a-, and b-bands. This behaviour is shown
in Fig. 3, in which the spectra have been normalized to the
intersection at 508 nm. This wavelength represents an isosbestic
point of the spectra of the base on (pH 8.0) and base off (pH 4)
forms, respectively (Fig. 3, red line: ‘‘intra base off/inter base
on’’ dimer 1-1, dashed line: base off monomer 1-H). The
spectral changes observed during dilution are consistent with
the partial formation of a base off species having an aqua,
cyano-, instead of a cyanoimidazolyl constitution (base on) at
the metal centre.23,24
The concentration dependence excludes intramolecular
coordination of the imidazole ligand to the b-face of a
hypothetical monomer 1-M (Scheme 2) and rather suggests
the ‘‘intra base off/inter base on’’ dimer 1-1 (Scheme 1, 2).
A dissociation constant of 1.29 ! 10"6 M was determined
for the equilibrium between dimer 1-1 and the two monomers
of 1 from the corresponding UV-vis spectra as described in
the ESIw (Scheme 2; Table 1: K2).20 Acid induced dissociation
of dimer 1-1 to the monomeric subunits 1-H has been
identified with pH-dependent spectrophotometric titrations
(Scheme 2; Table 1: K1). A concentrated solution of 1-1
(87 mM) was applied to suppress undesired self-dissociation.
An inflection point at 5.83 was obtained from the Boltzmann
fit of an absorbance versus pH plot.20 At this pH value half of
dimer 1-1 is dissociated to the protonated, base off monomers
1-H. A dissociation constant K1 of 7.95 ! 107 M"1 was
calculated based on this consideration.20 Further strong
evidence for the existence of dimer 1-1 was obtained from
calculations of the thermodynamic cycle between 1-1, 1 and
Scheme 1 Synthesis of 1-H from dicyano cobyric acid (Cby-CN): (a)
EDC#HCl, DMAP, BocNHCH2CH2NH2, DMF, and then HCl 1M;
(b) EDC#HCl, DMAP, deamino histidine (for details see ESIw).
Self-assembly of the self-complementary building block 1-H to the
dimer 1-1 (Red dots indicate the coordination sites of the cyano ligand
and 1-1 is shown as a schematic structure).
Fig. 2 ROESY spectra (500 MHz, 300 K) of 1-1. NOEs between the
imidazole moiety (H2N, H4N) and hydrogen atoms at the periphery of
the corrin ring of 1-1 are indicated.
Fig. 3 Normalized UV-vis spectra (to the intersection at 508 nm)
of 1-1 ([Co]total: 174 mM, (red)) and mixtures of 1-1 and 1 ([Co]total:
49.3 mM (blue), 35.1 mM (brown), 17.4 mM (green), 9.79 mM (violet),
4.44 mM (yellow)). Black dashed line indicates the spectrum of 1-H as a
reference for the ‘‘base off’’ constitution.
Scheme 2 Summary of potential equilibria in solution (Red dots
indicate the coordination sites of the cyano ligand, while cobalt
coordinated water has been omitted. Red ‘‘+’’ symbols indicate
protonation of the imidazole moiety (Hypothetical 1-M and K4 are
depicted in grey color).
Table 1 Binding constants
Constant Terms Equilibrium constant
K1 [1-H]
2/[1–1][H]2 7.95 ! 107 M"1a
K2 [1]
2/[1–1] 1.29 ! 10"6 Ma,b
K3 [1][H]/[1-H] 1.27 ! 10"7 Mc
K4 [1]/[1-M] /
a Experimentally determined. b ESI.w c Calculated via the thermodynamic
cycle depicted in Scheme 2.
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1-H (Scheme 2 top) using the experimentally determined
equilibrium constants K1 and K2. The calculated pKa of
the dissociated, protonated imidazole moiety of 1-H (pKa =
pK3 = p(K2/K1)
1/2 = 6.89) is in excellent agreement with the
acidity constant of protonated imidazole (pKa = 6.95
25),
which further supports our assumptions.
After the existence of dimer 1-1 with an intra base off/inter
base on coordination mode was shown with different spectro-
scopic methods and thermodynamic calculations, we investigated
the configuration at the metal centre as well as the artificial loop
structure as a structural prerequisite for self-assembly in more
detail. The importance of the b-aqua, a-cyano configuration at
the Co(III) centre for dimerisation was demonstrated with
monomer 2-H (Scheme 2 bottom). This compound is identical
to 1-H, but has the opposite constitution of the axially
bound ligands (a-aqua, b–cyano).20 Concentration as well as
pH dependent UV-vis studies demonstrated -as expected-
intramolecular coordination in 2-M as the only structural
motif (Scheme 2 bottom).20 Size exclusion-, and ion exchange
chromatography of a mixture of 1-1 and 2-M gave further
evidence for the existence of both species as described in
the ESI.w20
The necessity of the artificial loop structure for dimerisation
was demonstrated by comparison of 1-H to base off B12
having the same b-aqua, a-cyano constitution at the metal
centre (B12-CNa, Scheme 3).
20 In contrast to dimerisation of
1 to 1-1, B12-CNa has no trend of self-assembly even up to
1 mM at pH 8. We assume that this behaviour is due to the
more bulky Dmbz base as well as the less flexible loop
structure compared to 1. In natural Cbls, the nucleotide loop
seems to be preorganized for intramolecular coordination to
the metal centre from the lower face of the corrin ring.16 Until
today, ‘‘complete’’ corrinoids are considered to coordinate
exclusively in an intramolecular fashion. Recently, Gruber,
Kra¨utler and coworkers reported about an ‘‘incomplete’’
corrinoid that dimerises in the solid-state.26
We developed a self-complementary, artificial B12 derivative
that dimerises in an unprecedented ‘‘intra base off/inter base
on’’ mode. It was demonstrated that this novel coordination
motif depends on both, the configuration at the metal centre as
well as the flexibility of the artificial, connecting linker. On the
basis of these findings, we envisage constructing even more
complex assemblies.
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Scheme 3 Base off b-aqua, a-cyano B12 (B12-CNa) does not dimerise
in an ‘‘intra base off/ inter base on’’ fashion.
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